On this page
Quick Reference
Overview and Recommendations
Background
- • cares for the fetus and when gestational age, growth, congenital disease, perinatal events, or postnatal illness exceed routine newborn-care capability. The comprises the first 28 completed days after birth, while the conventionally begins at 22 completed weeks of gestation and ends 7 completed days after birth.
- • occurs before 37+0 completed weeks, from 37+0 through 41+6 weeks, and at or after 42+0 weeks. Population surveillance further classifies extremely preterm birth as <28 weeks, early preterm birth as 28-31 weeks, moderate preterm birth as 32-33 weeks, and late preterm birth as 34-36 weeks.
- •Birth weight describes size rather than maturity: is <2,500 g, is <1,500 g, and is <1,000 g. Always interpret weight with gestational age and size-for-gestational-age status.
- •Neonatology includes extremely preterm and ELBW infants, growth-restricted or small-for-gestational-age infants, infants with congenital, genetic, metabolic, or functional disease, and critically ill term or post-term newborns. Term infants may require neonatal expertise after perinatal asphyxia, respiratory failure, severe infection, hypoglycemia, congenital heart disease, or acute deterioration.
- •Organize care across the , , (NICU), regionalized perinatal networks, neonatal transport, and neonatal follow-up. Judge care by timely and safe stabilization, survival, morbidity, neurodevelopmental function, family experience, and equitable access rather than mortality alone.
Evaluation
- •Before birth, review gestational age, fetal growth and testing, anatomy, placental function, maternal disease, expected mode and timing of birth, and the capability of the proposed birth site. Transfer the mother before birth when foreseeable risk exceeds local neonatal resources, and brief obstetrics, neonatology, anesthesia, nursing, respiratory therapy, and relevant subspecialists.
- •At birth, ask whether the infant is preterm, has poor muscle tone, or is breathing or crying effectively. A vigorous term or late-preterm infant can remain skin-to-skin; any “yes” answer requires assessment under a radiant warmer and preparation for resuscitation.
- •Assess breathing and heart rate together. Use a three-lead when available for rapid heart-rate assessment, retain to guide oxygen therapy, and apply the sensor to the right hand or wrist for preductal saturation when respiratory support or supplemental oxygen is required.
- •After transition, perform a complete examination including general appearance, skin, head, airway, heart, lungs, abdomen, genitalia, spine, limbs, perfusion, and neurologic status. Repeat the examination after a substantial feed, before transfer or discharge, and whenever feeding, temperature, respiratory effort, color, tone, or perfusion changes.
- •Assign gestational age from the best obstetric estimate, preferably a reliable last menstrual period corroborated by first-trimester ultrasound. Use the when dating is uncertain or the clinical appearance is discordant, and interpret it cautiously in severe illness, neuromuscular disease, edema, or birth trauma.
- •Classify birth weight as appropriate for gestational age between the 10th and 90th percentiles, small for gestational age below the 10th percentile, or large for gestational age above the 90th percentile. Do not equate SGA with ; assess growth trajectory, proportionality, placental findings, and antenatal Dopplers.
- •Monitor temperature, heart rate, respiratory rate, oxygenation, perfusion, urine output, feeding, weight, intake, output, and bilirubin risk serially. A practical stable-newborn axillary temperature target is 36.5-37.5°C; persistent hypothermia, fever, apnea, cyanosis, poor perfusion, or feeding deterioration requires evaluation rather than repeated observation alone.
- •For respiratory distress, obtain a blood gas when distress is moderate or worsening, oxygen or pressure needs rise, apnea recurs, invasive ventilation is considered, or pulmonary hypertension is suspected. Use chest radiography, , and according to the differential, and use right-hand and foot saturations when hypoxemia is disproportionate or is suspected.
- •Screen glucose in SGA and LGA infants, infants of diabetic mothers, late-preterm infants, infants with perinatal stress or hypothermia, and symptomatic or poorly feeding newborns. A commonly used operational threshold is below 2.6 mmol/L (47 mg/dL), but interpret it with gestation, clinical status, feeding, and trajectory because no single concentration reliably separates injury from safety.
- •Evaluate infection when apnea, temperature instability, feeding intolerance, respiratory distress, lethargy, poor perfusion, hypotension, seizures, or unexplained deterioration occurs. Obtain an adequately filled blood culture before antibiotics when feasible, add urine or CSF studies when indicated and safe, and do not use a normal CBC, CRP, procalcitonin, or other screening result to rule out sepsis.
- •Evaluate jaundice with serial bilirubin assessment rather than visual examination alone. Use total serum bilirubin for treatment decisions, plot it by postnatal age, gestational age, and neurotoxicity risk factors, and measure direct or conjugated bilirubin for persistent jaundice, pale stools, dark urine, hepatomegaly, poor growth, or illness.
Management
- •Match the infant to the safest available level of care and transfer before birth when risk is foreseeable. A regionalized perinatal system requires explicit admission and escalation criteria, continuous communication, transport-capable equipment and clinicians, and a return pathway when intensive care is no longer required.
- •Prepare the delivery team for the highest credible level of need. Confirm appropriately sized airway and respiratory equipment, vascular-access supplies, monitoring, temperature-control equipment, emergency medications, compatible blood products when indicated, and disease-specific resources such as prostaglandin, pacing, or difficult-airway expertise.
- •For a vigorous infant who does not need resuscitation, maintain warmth and defer cord clamping for at least 60 seconds. Intact cord milking may be considered in selected nonvigorous term or late-preterm infants and in infants born at 28+0 to 36+6 weeks when delayed clamping is not performed, but do not use it below 28 weeks because of concern about intraventricular hemorrhage.
- •Provide warmth, neutral head positioning, drying, removal of wet linen, and brief tactile stimulation. Do not let stimulation or suctioning delay ventilation; do not routinely suction clear fluid, and suction only when obstruction is suspected.
- •Start within approximately 60 seconds for apnea, gasping, or heart rate below 100/min. Begin with 21% oxygen in term and late-preterm infants, use at least 30% oxygen as reasonable below 32 weeks, and titrate with a blender when the initial concentration for 32+0 to 34+6 weeks is uncertain.
- •For a spontaneously breathing preterm infant who needs support, begin (CPAP), commonly at 5-6 cm H₂O, rather than proceeding directly to intubation. Give PPV at 30-60 inflations/min with initial PIP 20-30 cm H₂O; use at least 5 cm H₂O PEEP in preterm infants when equipment permits and adjust pressure only enough to produce chest movement and a rising heart rate.
- •If the chest does not move or the heart rate remains below 100/min, correct ventilation using mask seal, head and airway position, suspected obstruction, mouth opening, gradual pressure increase, and an alternative airway. If the heart rate remains below 60/min after at least 30 seconds of effective PPV, preferably through an endotracheal tube, begin compressions with ventilation at a 3:1 ratio and reassess after at least 60 seconds.
- •For persistent heart rate below 60/min despite effective ventilation and compressions, give epinephrine 0.01-0.03 mg/kg intravenously or intraosseously using 1:10,000 solution (0.1 mg/mL), equivalent to 0.1-0.3 mL/kg, and repeat every 3-5 minutes if required. For confirmed or strongly suspected acute blood loss, give 0.9% saline or emergency-release blood at 10 mL/kg over 5-10 minutes; do not use routine volume expansion for unexplained bradycardia.
- •Escalate respiratory support according to work of breathing, oxygen requirement, gas exchange, apnea, acidosis, and hemodynamic effect. For probable preterm RDS worsening despite CPAP pressure ≥6 cmH₂O, a commonly used surfactant trigger is FiO₂ >0.30; prefer LISA/MIST when expertise and rescue-airway capability are available, with poractant alfa commonly given at 200 mg/kg.
- •Intubate for ineffective spontaneous ventilation, recurrent apnea with bradycardia, severe or worsening respiratory acidosis, refractory hypoxemia, exhaustion, shock attributable to respiratory failure, or required controlled ventilation during transport or surgery. Use the least injurious effective ventilation, avoid excessive tidal volume and oxygen exposure, and consider HFOV for selected severe oxygenation failure, diffuse atelectasis, pulmonary hemorrhage, air leak, or failure of optimized conventional ventilation.
- •For suspected ductal-dependent congenital heart disease, obtain pre- and postductal saturations, begin alprostadil when the circulation is uncertain or deteriorating, and obtain urgent echocardiography and pediatric cardiology involvement. A practical initial infusion is 0.01 microgram/kg/min by continuous intravenous infusion; monitor for apnea, hypotension, fever, and flushing.
- •Treat hypoglycemia promptly without delaying symptomatic treatment for laboratory confirmation. Feed an alert infant who can safely feed; selected asymptomatic infants may receive buccal 40% dextrose gel, 0.5 mL/kg (200 mg/kg), while symptomatic, unable-to-feed, or persistent cases require intravenous 10% dextrose, with 2 mL/kg (200 mg/kg) used in one protocol for glucose below 25 mg/dL.
- •Start empiric ampicillin 50 mg/kg IV plus gentamicin 4-5 mg/kg IV or IM for suspected neonatal bacterial infection, using gestation-, postnatal-age-, renal-function-, and local-protocol-adjusted intervals. Broaden treatment for severe late-onset or line-associated disease according to the unit antibiogram, then narrow promptly to culture and susceptibility results.
- •Start acyclovir 20 mg/kg IV every 8 hours immediately when neonatal HSV is suspected, especially with vesicles, seizures, focal neurologic signs, CSF pleocytosis, hepatitis, thrombocytopenia, shock, or maternal genital HSV. Obtain HSV surface swabs, blood PCR, CSF HSV PCR, hepatic and coagulation studies, and renal assessment without waiting for skin lesions or bacterial results.
- •For suspected hypoxic-ischemic encephalopathy in an infant at least 35 weeks’ gestation with a significant perinatal hypoxic-ischaemic event and moderate or severe encephalopathy, assess urgently for whole-body therapeutic hypothermia. Start as soon as possible, ideally within 6 hours, maintain the protocol-defined target for 72 hours, and rewarm slowly with continuous monitoring; correct glucose, oxygenation, carbon dioxide, perfusion, and seizures in parallel.
- •Confirm suspected seizures with conventional multichannel EEG, using aEEG as an early bedside screen rather than a replacement. Treat confirmed electrographic seizures with phenobarbital 20 mg/kg IV over at least 20 minutes; if needed, give additional 10 mg/kg doses to a cumulative 40 mg/kg, then use levetiracetam 40-60 mg/kg IV or fosphenytoin 20 mg phenytoin equivalents/kg IV for persistent seizures according to local protocol.
- •Use human milk as the preferred enteral substrate for most neonates, with donor human milk when maternal milk is unavailable or insufficient, particularly for very preterm or VLBW infants at NEC risk. Advance feeds according to perfusion, respiratory support, abdominal findings, stooling, and growth; stop feeds and obtain urgent assessment for bilious emesis, progressive distension, abdominal discoloration, bloody stool, tenderness, apnea, systemic instability, or metabolic acidosis.
- •Start parenteral nutrition when enteral intake cannot safely provide adequate energy and protein, particularly with extreme prematurity, shock, severe respiratory failure, obstruction, NEC, perforation, postoperative ileus, or evolving short bowel syndrome. Begin amino acids at approximately 2-3 g/kg/day, glucose at 4-6 mg/kg/min, and intravenous lipid at 1-2 g/kg/day, advancing toward the article’s stated targets while monitoring glucose, electrolytes, triglycerides, direct bilirubin, liver tests, and line complications.
- •Discharge only after physiologic stability, temperature control, safe feeding or a documented tube-feeding plan, medication competence, caregiver teach-back, safe transport, completed or scheduled screening, and owned follow-up arrangements. Provide a plain-language plan for danger signs, pending results, equipment failure, feeding deterioration, breathing difficulty, cyanosis, apnea, fever or hypothermia, seizures, worsening jaundice, bilious vomiting, blood in stool, dehydration, and reduced urine output.
- •Continue neonatal care after discharge through corrected-age developmental surveillance and coordinated follow-up for growth, feeding, respiratory, neurologic, motor, cognitive, language, hearing, vision, behavior, family mental health, and social needs. Include early-intervention, rehabilitation, primary-care, and subspecialty services, and measure access, transfer time, treatment differences, family burden, and loss to follow-up to assess equity.
Deep Dive — Evidence Details
Neonatology: Scope, Population, Levels of Care, and Core Outcomes
- ▸Use gestational age as the primary organizing variable: preterm is before 37+0 weeks, term is 37+0 through 41+6 weeks, and post-term is at or after 42+0 weeks; birth-weight categories complement but do not replace gestational-age assessment.
- ▸Match anticipated maternal or neonatal risk to the safest available level of care through regionalized referral, with stabilization of temperature, airway, ventilation, circulation, glucose, vascular access, analgesia, and documentation before neonatal transport.
- ▸Report mortality with a defined denominator and time point, and report survival with neurodevelopmental impairment together when possible because mortality alone does not capture functional outcome.

Neonatology is the discipline devoted to the fetus and newborn when gestational age, growth, congenital condition, perinatal event, or postnatal illness creates a risk that exceeds routine newborn-care capability. The comprises the first 28 completed days after birth; neonatal deaths are therefore deaths during the first month of life. [8] A is the developing human before birth. A , or , is an infant from birth through the neonatal period, whether born preterm, term, or post-term. The is the interval surrounding birth, conventionally beginning at 22 completed weeks of gestation and ending 7 completed days after birth; its precise limits vary among surveillance systems.
Gestational age is the primary organizing variable because it predicts physiologic reserve, expected morbidity, and the level of support likely to be required. means birth before 37+0 completed weeks; means 37+0 through 41+6 weeks; and means birth at or after 42+0 weeks. For population surveillance, one contemporary classification separates extremely preterm birth (<28 weeks), early preterm birth (28-31 weeks), moderate preterm birth (32-33 weeks), late preterm birth (34-36 weeks), and term birth (≥37 weeks). [9] These labels describe risk groups rather than independent diagnoses: a late-preterm infant may need respiratory, thermal, metabolic, or feeding support, whereas an extremely preterm infant commonly requires prolonged multisystem intensive care.
Birth weight describes size at birth, not gestational maturity. (LBW) is birth weight <2,500 g. [7] (VLBW) is <1,500 g, and (ELBW) is <1,000 g. Weight categories complement, but do not replace, gestational-age assessment: a 1,400-g infant may be appropriate, small, or large for gestational age, with different clinical implications in each case. Growth restriction is assessed against gestational-age standards and may reflect placental insufficiency, maternal disease, fetal disease, or adverse social conditions; it can require neonatal care even when gestational age is near term.
The population served by neonatology therefore extends beyond very small preterm infants. It includes extremely preterm and ELBW infants; growth-restricted or otherwise small-for-gestational-age infants; infants with structural, chromosomal, genetic, metabolic, or functional congenital disease; and critically ill term or post-term newborns. Term infants may require neonatal expertise after perinatal asphyxia, respiratory failure, severe infection, hypoglycemia, congenital heart disease, or other acute deterioration. In a Ugandan prospective cohort of newborns of women with diabetes, respiratory distress, hypoglycemia, low 5-minute Apgar score, macrosomia, and early neonatal death formed a clinically relevant composite, illustrating why neonatal acuity cannot be inferred from gestational age alone. [17]
Organization of neonatal care
Care is organized as a system rather than a single ward. The provides immediate stabilization, assessment, thermal protection, respiratory support, and decisions about disposition. A manages infants who need observation, enteral or intravenous support, phototherapy, noninvasive respiratory support, or treatment of moderate physiologic instability but not continuous multisystem intensive care. The (NICU) provides continuous cardiorespiratory monitoring and invasive or noninvasive organ support for infants with respiratory failure, circulatory instability, severe infection, neurologic injury, major congenital disease, or extreme immaturity. Oxygen delivery requires reliable monitoring because both hypoxemia and hyperoxemia can cause harm; wired oximetry remains the reference technology in the NICU, whereas a small validation study found that two Bluetooth devices did not meet the relevant accuracy standard and tended to overestimate oxygen saturation. [13]
A links facilities with different capabilities so that a pregnant patient and fetus are transferred before birth when risk is foreseeable, while a newborn requiring higher-acuity care is transferred after birth when necessary. Effective systems require explicit admission and escalation criteria, continuous communication between referring and receiving teams, neonatal transport clinicians, transport-capable equipment, and a return pathway when intensive care is no longer required. The objective is not to centralize every birth, but to match anticipated risk with the safest available level of care while preserving access for families who live far from tertiary centers.
The NICU is a clinical environment in which technology must be matched by trained personnel and standardized practice. Contemporary neurocritical programs, for example, combine bedside brain monitoring, standardized imaging, neuroprotection, neurodevelopmental assessment, and family partnership; education and competency determine whether those resources translate into consistent care. [15] Staffing must therefore include clinicians skilled in neonatal resuscitation and intensive care, neonatal nurses, respiratory therapists, pharmacists, nutrition specialists, developmental and rehabilitation professionals, and ready access to pediatric subspecialists, surgery, radiology, laboratory services, and social work. Staffing intensity should follow census and acuity rather than bed number alone; prolonged shifts and fatigue can threaten perceived safety among neonatal nurse practitioners. [14]
is an extension of intensive care, not merely movement between hospitals. Before departure, stabilize temperature, airway, ventilation, circulation, glucose, vascular access, analgesia, and documentation; during transport, provide the same monitoring and treatment continuity expected in the NICU. Transport systems should also account for geography, referral delays, language, cost, and family ability to reach the receiving hospital. These operational factors are central to equity because facility-based datasets may miss the sickest infants who cannot reach care, particularly during conflict or health-system disruption. [8]
Discharge does not end neonatal care. A program should identify infants at risk for developmental, sensory, motor, feeding, respiratory, and growth problems; provide surveillance linked to corrected age; and connect families with early-intervention, primary-care, rehabilitation, and subspecialty services. Follow-up must assess the child and the family together, including caregiver understanding, mental health, financial strain, transportation, housing, language access, and the practical burden of repeated appointments. In a registry study of children born extremely preterm, 25.5% had clinically significant motor difficulties after exclusion of cerebral palsy and severe neurodevelopmental disorders, yet only 16.9% of those receiving the relevant data had physiotherapy visits, demonstrating why follow-up based only on recognized major disability will miss important needs. [5] Family participation is also part of treatment: a structured, nurse- and midwife-supported kangaroo-care model was associated with improved physiologic measures and shorter hospitalization in a retrospective quasi-experimental cohort, although that design cannot establish causation. [11]
| Population or care setting | Defining criteria | Typical clinical needs | Required staffing and technology | Principal outcomes |
|---|---|---|---|---|
| Fetus and perinatal-risk pregnancy | Fetus before birth; perinatal period conventionally 22+0 weeks through 7 postnatal days | Risk assessment, fetal surveillance, counseling, delivery planning, and anticipated neonatal stabilization | Maternal-fetal medicine, obstetric, anesthesia, neonatal, genetics, and surgical coordination; ultrasound, fetal monitoring, and a prepared resuscitation area | Stillbirth, neonatal mortality, birth injury, need for postnatal escalation, and family-informed decision-making |
| Delivery room or newborn stabilization area | Every birth; highest risk when extreme prematurity, fetal growth restriction, congenital disease, or anticipated respiratory or circulatory compromise is present | Thermal protection, airway and respiratory support, cardiovascular assessment, glucose evaluation, and disposition | Skilled neonatal resuscitation team, radiant warmer, airway equipment, oxygen/air blending, pulse oximetry, ventilation devices, and emergency medications | Successful transition, avoidance of preventable hypothermia or hypoxemia, time to stabilization, and appropriate transfer |
| Special care nursery | Clinically stable newborn needing more observation or treatment than a routine nursery but not continuous multisystem intensive care | Feeding and glucose support, phototherapy, temperature control, intravenous therapy, and selected noninvasive respiratory support | Neonatal nurses and medical staff with escalation access; cardiorespiratory monitoring, infusion pumps, bilirubin measurement, oxygen, and noninvasive respiratory equipment | Avoidance of deterioration, discharge readiness, breastfeeding or feeding competence, parent confidence, and reduced separation |
| NICU | Extreme prematurity or critical illness requiring continuous monitoring, invasive ventilation, circulatory support, complex nutrition, surgery, or specialized neurologic care | Multiorgan intensive care, infection evaluation, respiratory support, nutritional management, neurologic monitoring, and family-integrated care | Neonatologists, neonatal nurses, respiratory therapists, pharmacists, allied health professionals, 24-hour monitoring, ventilators, incubators, infusion systems, blood-gas and laboratory access, imaging, and subspecialty support | Mortality, severe morbidity, duration of intensive care, hospital length of stay, survival without neurodevelopmental impairment, and family experience |
| Regionalized perinatal network and neonatal transport | Referral across facilities when maternal or neonatal risk exceeds local capability | Antenatal referral, postnatal stabilization, transport, communication, and repatriation when appropriate | Network governance, referral protocols, transport team, transport incubator, ventilator, monitoring, infusion capability, and reliable communication | Timely access, fewer avoidable delays, survival, morbidity, continuity, geographic access, and equitable use of tertiary care |
| Neonatal follow-up program | Infants at developmental or medical risk after discharge, especially extremely preterm, growth-restricted, neurologically injured, or medically complex infants | Growth, feeding, respiratory, hearing, vision, motor, cognitive, language, behavior, and family-support assessment | Coordinated pediatric, developmental, rehabilitation, psychology, social-work, and community services with standardized developmental assessment and data linkage | Survival with neurodevelopmental function, early detection, participation, caregiver well-being, school readiness, and reduced inequity |
Outcomes by which neonatal practice is judged
Mortality remains the most immediate outcome, but it is an incomplete measure of neonatal performance. Unit and population analyses distinguish mortality from severe necrotizing enterocolitis, duration of intensive care, and duration of parenteral nutrition; these outcomes reflect different aspects of illness and care delivery rather than a single hierarchy of success. [1] Report mortality with a clearly defined denominator and time point, such as delivery-room, in-hospital, 7-day, or 28-day mortality, because changing the observation window changes the clinical meaning.
Morbidity should be reported by severity and functional consequence. Relevant outcomes include severe respiratory disease, chronic lung disease, necrotizing enterocolitis, late-onset sepsis, severe brain injury, retinopathy of prematurity, major surgery, prolonged invasive ventilation, growth failure, feeding impairment, and prolonged hospitalization. Associations require cautious interpretation: in a retrospective cohort of ventilated infants born before 32 weeks, extubation failure identified infants with more adverse respiratory and infectious courses, but the authors cautioned that it may primarily reflect underlying disease severity rather than independently cause those outcomes. [2]
The outcome most aligned with the child’s future is (NDI), defined in a given study by its prespecified neurologic, cognitive, language, motor, behavioral, hearing, and vision criteria. Report survival and NDI together when possible, because mortality reduction accompanied by severe disability may represent a different clinical achievement from survival with preserved function. Follow-up must extend beyond cerebral palsy: non-cerebral-palsy motor difficulties were found in one quarter of extremely preterm children assessed at 5 years 6 months, and many affected children were not receiving motor-related care. [5]
Family-centered outcomes are clinical outcomes. Measure parental presence and participation, understanding of the care plan, confidence in feeding and caregiving, psychological distress, sleep, financial burden, satisfaction, and the quality of communication during uncertainty or end-of-life decision-making. Kangaroo care and other structured forms of family participation may improve physiologic stability and shorten hospitalization, but observational or quasi-experimental evidence should not be treated as proof of a causal effect. [11]
Health equity is assessed by asking who receives timely, high-quality neonatal care and who is missed. Stratify outcomes by geography, socioeconomic position, race and ethnicity where locally appropriate, language, disability, migration or displacement, insurance or ability to pay, and distance from specialized care. Conflict can disrupt antenatal services, emergency transport, nutrition, and surveillance; a systematic review found that pooled associations with preterm birth, stillbirth, and neonatal mortality became non-significant after accounting for substantial heterogeneity, and the authors emphasized that facility-based selection and missing out-of-hospital births may obscure harm. [8] Equity therefore requires measuring access, transfer time, treatment differences, family burden, and loss to follow-up alongside mortality and morbidity.
Pearl: Neonatology is judged not only by whether a newborn survives intensive care, but by whether care is timely, safe, equitable, family-partnered, and followed by survival with the best attainable health and development.
Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation
- ▸In healthy term infants, functional residual capacity is largely established within the first five breaths, and preserving end-expiratory pressure can stabilize developing FRC while residual lung liquid remains in the interstitium.
- ▸Lung aeration rapidly lowers pulmonary vascular resistance and increases pulmonary blood flow; if aeration fails, hypoxemia, hypercapnia, metabolic acidosis, and persistent fetal-pattern shunting can result.
- ▸The frequently used operational threshold for neonatal hypoglycemia is below 2.6 mmol/L (47 mg/dL), but glucose must be interpreted with gestation, clinical condition, feeding status, and trajectory rather than as a universal diagnosis.
At birth, the newborn loses placental gas exchange and must establish pulmonary gas exchange while converting a parallel fetal circulation into a series circulation. The fetal lungs are liquid-filled and provide little gas exchange; most right-ventricular output bypasses them through the ductus arteriosus, while the low-resistance placenta supports systemic flow. [25] Successful transition therefore depends on coordinated lung aeration, pulmonary vasodilation, cord separation, and redistribution of ventricular preload rather than on any single event.
Respiratory transition
Before the first effective breaths, the airways and gas-exchange regions contain fetal lung liquid, so oxygen cannot enter the pulmonary circulation and carbon dioxide cannot be eliminated through the lungs. [21] Lung-fluid clearance begins before birth through epithelial sodium reabsorption, particularly via amiloride-sensitive sodium channels, and continues after birth as inspiratory pressure gradients move air into the distal lung. [26] Mechanical compression during vaginal birth contributes less than epithelial fluid absorption; elective cesarean birth before labor can therefore increase the burden of residual lung liquid. [26]
The first breaths establish an end-expiratory lung volume that becomes the functional residual capacity (FRC), allowing gas exchange to continue between inspirations. In healthy term infants, FRC is largely established within the first five breaths, although early ventilation is regionally uneven and the initial tidal volumes are substantially larger than post-transitional breaths. [30] Neonates also brake expiration through glottic and respiratory-muscle activity; this helps retain air, redistribute gas, and limit re-entry of liquid into newly aerated regions. [28] During the intermediate phase, liquid that has left the airways remains temporarily in the lung interstitium and raises the risk of alveolar reflooding, which explains why expiratory support that preserves end-expiratory pressure can stabilize the developing FRC. [21]
Lung aeration is also the initiating vascular event. Air entry and the accompanying rise in alveolar oxygen tension dilate the pulmonary vascular bed, causing a rapid fall in (PVR) and a large increase in pulmonary blood flow. [25] This increased flow is essential for gas exchange and replaces umbilical venous return as the principal source of left-ventricular preload. [22] Failure of aeration leaves PVR high, restricts pulmonary blood flow, impairs oxygen transfer, and perpetuates hypoxemia, hypercapnia, and metabolic acidosis. [33]
Cardiovascular transition
Cord clamping removes the low-resistance placental circuit and raises (SVR), increasing left-ventricular afterload. [24] At the same time, umbilical venous return falls. If cord clamping precedes lung aeration, left-ventricular preload and cardiac output can fall before pulmonary venous return has increased; delayed ventilation after clamping can therefore add low-flow ischemia to the original hypoxic insult. [22] Once the lungs aerate, pulmonary venous return increases and progressively assumes the preload previously supplied by the placenta. [23]
As PVR falls below SVR, ductal flow changes from predominantly right-to-left to predominantly left-to-right. This sends more right-ventricular output through the lungs for oxygenation and permits the left ventricle to contribute to pulmonary blood flow. [25] The rise in pulmonary venous return increases left-atrial pressure, while loss of directed ductus-venosus flow reduces right-atrial pressure; the resulting reversal of the atrial pressure gradient functionally closes the . [25] A small bidirectional or left-to-right shunt may be physiologic early after birth, whereas persistent exclusive right-to-left atrial shunting suggests failure of the expected pressure transition or structural heart disease. [25]
The also changes its direction of flow as PVR falls. Increased oxygen tension and reduced prostaglandin exposure constrict ductal smooth muscle, producing functional closure commonly within 24-48 hours; anatomic obliteration is slower and may take 10-14 days. [31] This distinction matters clinically: the infant may have a functionally separated circulation while the ductal tissue remains anatomically patent. Prematurity, lung disease, hypoxemia, and persistent acidosis can delay the fall in PVR and prolong fetal-pattern shunting. [31]
The successful endpoint is a series circulation in which pulmonary and systemic blood flow are coupled and right- and left-ventricular outputs become approximately equal. [31] Failure of this sequence produces (PPHN): PVR remains elevated, right-to-left shunting persists across the ductus arteriosus or foramen ovale, pulmonary blood flow and pulmonary venous return remain low, and left-ventricular preload and systemic output fall. [31] The resulting hypoxemia, tissue hypoperfusion, lactate accumulation, and acidosis further increase pulmonary vasoconstriction, creating a self-reinforcing cycle. [31]
Metabolic, thermal, renal, and bilirubin adaptation
The placenta supplies continuous glucose, so cord separation abruptly removes the external glucose source. Neonatal glucose homeostasis must then be maintained by mobilizing hepatic glycogen, initiating gluconeogenesis, and coordinating insulin suppression with counter-regulatory hormones; transiently low concentrations are common during normal adaptation, but prolonged or recurrent hypoglycemia may have systemic and neurodevelopmental consequences. [39] Interpret glucose values with the infant’s gestation, clinical condition, feeding status, and trajectory rather than treating a single concentration as a universal diagnosis; the frequently used operational threshold is below 2.6 mmol/L (47 mg/dL), but the evidence supporting one universal cutoff remains contested. [39]
Thermoregulation also becomes independent of the maternal environment at delivery. Evaporative, convective, conductive, and radiative heat loss increase immediately after birth, while the preterm infant has limited insulation and immature heat production. Hypothermia increases metabolic demand and can aggravate hypoglycemia, respiratory difficulty, and acidosis; protocols for the first postnatal hour are associated with reductions in hypothermia and hypoglycemia, although the evidence concerns bundled care rather than one isolated intervention. [40]
Renal function and bilirubin handling likewise shift from placental support to neonatal organ function. Early urine output is a practical marker of effective renal perfusion and adaptation, but it must be interpreted cautiously during the first day because fetal fluid redistribution and changing glomerular filtration make a single low output value nonspecific. Bilirubin production rises after birth as fetal erythrocytes are replaced, while hepatic uptake, conjugation, and intestinal elimination mature over time; serial bilirubin assessment is therefore more informative than a single visual examination. These processes should be considered alongside respiratory, circulatory, glucose, temperature, and acid-base markers when judging whether transition is complete.
| Physiologic domain | Fetal state | Normal neonatal change | Clinical marker of successful transition | Consequence of failure |
|---|---|---|---|---|
| Pulmonary gas exchange | Liquid-filled lungs; pulmonary gas exchange is absent or minimal. [21] | Air replaces lung liquid, FRC is established, and pulmonary gas exchange begins. [21][30] | Spontaneous tidal breathing with improving oxygenation and stable chest movement. [28][30] | Respiratory distress, hypoxemia, hypercapnia, and acidosis. [33] |
| Pulmonary vascular resistance and flow | High PVR diverts most right-ventricular output away from the lungs through the ductus arteriosus. [25] | Lung aeration produces a rapid fall in PVR and a large rise in pulmonary blood flow. [25] | Increasing pulmonary venous return and falling oxygen requirement. [31] | PPHN with right-to-left shunting and impaired oxygen transport. [31][33] |
| Systemic vascular resistance | The placenta is a low-resistance vascular bed. [25] | Cord clamping removes the placental circuit and raises SVR and left-ventricular afterload. [24] | Rising systemic arterial pressure with preserved peripheral perfusion. [24][31] | Low cardiac output, hypotension, tissue hypoperfusion, and acidosis. [22][31] |
| Cardiac preload and output | Left-ventricular preload is supplied chiefly by umbilical venous return; the ventricles function in parallel. [25] | Pulmonary venous return replaces placental venous return, and ventricular outputs become coupled in series. [23][31] | Stable heart rate, pulses, blood pressure, capillary perfusion, and lactate trajectory. [31] | A transient or sustained fall in cardiac output, especially when cord clamping precedes ventilation. [22] |
| Foramen ovale | Right-atrial pressure exceeds left-atrial pressure, maintaining right-to-left atrial flow. [25] | Increased pulmonary venous return raises left-atrial pressure and produces functional closure. [25] | No persistent exclusive right-to-left atrial shunt. [25] | Persistent fetal-pattern shunting and systemic desaturation. [31] |
| Ductus arteriosus | High PVR and low SVR favor right-to-left ductal flow. [25] | Flow becomes predominantly left-to-right; functional closure occurs within 24-48 hours, while anatomic closure takes 10-14 days. [31] | Progressive reduction in ductal shunting with improving pulmonary and systemic separation. [31][36] | Persistent fetal-pattern shunting, pulmonary overcirculation, or systemic hypoperfusion depending on resistance and shunt direction. [31] |
| Oxygen transport and acid-base balance | Oxygen is obtained through the placenta; fetal lungs do not serve as the gas-exchange organ. [25] | Pulmonary oxygen uptake begins and oxygenated pulmonary venous blood supports systemic delivery. [23][25] | Improving preductal oxygenation, perfusion, and acid-base status. [33][37] | Hypoxemia, lactate accumulation, metabolic acidosis, and worsening PVR. [31] |
| Glucose homeostasis | Continuous maternal-placental glucose delivery. [39] | Endogenous glycogenolysis and gluconeogenesis assume glucose supply after cord separation. [39] | Glucose remains stable with feeding and without symptoms of hypoglycemia. [39][40] | Symptomatic, prolonged, or recurrent hypoglycemia with potential neurologic injury. [39] |
| Temperature control | Maternal environment provides thermal stability. [40] | The newborn must generate and conserve heat after delivery. [40] | Normothermia during the first postnatal hour. [40] | Hypothermia, increased metabolic demand, hypoglycemia, and impaired adaptation. [40] |
| Renal function and bilirubin metabolism | Placental clearance and maternal homeostasis supplement immature fetal organs. | Renal excretion and hepatic bilirubin processing become independent neonatal functions. | Appropriate urine output and serial bilirubin assessment interpreted by postnatal age. | Fluid or electrolyte disturbance and unconjugated hyperbilirubinemia requiring surveillance. |
Pearl: Successful transition is demonstrated by a linked sequence, air-filled lungs, falling PVR, rising pulmonary blood flow and pulmonary venous return, increasing SVR, functional closure of fetal shunts, stable cardiac output, adequate oxygen and glucose delivery, and normothermia. When one link fails, respiratory distress, PPHN, hypoglycemia, hypothermia, low systemic flow, and acidosis commonly reinforce one another rather than appearing as isolated abnormalities.
Antenatal Risk Assessment and Perinatal Preparation
- ▸For threatened or established preterm birth, give antenatal corticosteroids when birth is sufficiently likely for benefit, use magnesium sulfate for neuroprotection when locally adopted gestational-age and timing criteria are met, and use PPROM antibiotics and GBS prophylaxis according to local protocol.
- ▸Assess suspected fetal growth restriction with serial biometry plus fluid volume, umbilical-artery and middle-cerebral-artery Dopplers, fetal movement, and cardiotocography or biophysical profile; worsening Dopplers or abnormal testing may require expedited birth with neonatal notification.
- ▸Assess hypertensive disease using blood pressure, proteinuria, symptoms, platelet count, renal and hepatic function, fetal growth, fluid, and Doppler studies rather than relying on a single biomarker to determine severity.
Antenatal risk assessment is a delivery-planning exercise, not merely a prediction of birth weight or gestational age. Review the maternal record, fetal anatomy and growth, placental function, fetal testing, expected mode and timing of birth, and the resources available at the proposed birth site. The purpose is to identify problems that require treatment before birth, move the mother to a facility capable of caring for the anticipated newborn, and assemble the people and equipment before they are needed. Evidence for several antenatal interventions remains context-dependent: the recent synthesis retained consensus-derived estimates for hypertensive-disorder management and diabetes because robust experimental data were limited, and cautioned that effects may differ across health systems. [41]
Maternal and fetal assessment
Confirm gestational age from the best available dating method and reassess whether the expected site of birth can provide the level of neonatal care required. For threatened or established preterm birth, determine whether delivery is imminent, whether transfer can occur safely, and whether maternal treatment can be completed without delaying a medically necessary birth. Give antenatal when preterm birth is sufficiently likely for benefit; randomized-trial evidence summarized for low- and middle-income settings found a 36% reduction in neonatal mortality, although the regimen and timing must follow the local obstetric protocol. [41] Warn the neonatal team that recent corticosteroid exposure may increase early neonatal , particularly when a complete course was given within 7 days of birth. [45]
Give for fetal neuroprotection when imminent early preterm birth meets the locally adopted gestational-age and timing criteria. Explain to the family that this treatment is intended to reduce neurologic injury risk, not to mature the lungs or treat neonatal respiratory disease. Use antibiotics for preterm prelabor rupture of membranes (PPROM) according to obstetric protocol; pooled randomized evidence found reductions in neonatal mortality from sepsis and from prematurity, while evidence comparing individual antibiotic regimens remains limited. [41] Provide intrapartum antibiotic prophylaxis for (GBS) according to the screening- or risk-based policy in use locally. Risk factors include GBS bacteriuria, PPROM lasting more than 18 hours, preterm labor, maternal fever, and a previous infant with GBS disease. [44] When antenatal culture is unavailable or birth is too early for scheduled screening, an intrapartum point-of-care test may provide a result in less than 60 minutes, but assay performance differs among platforms. [43]
Assess hypertensive disease by blood pressure, symptoms, urine protein assessment, platelet count, renal and hepatic function, fetal growth, amniotic fluid, and umbilical-artery and middle-cerebral-artery Doppler studies when indicated. Do not use a single biomarker to determine severity: a retrospective study found that a combined model had limited discrimination for severe preeclampsia and concluded that severity still requires assessment of blood pressure, proteinuria, symptoms, and organ dysfunction. [56] Expect higher respiratory morbidity in very preterm infants exposed to pregnancy-specific hypertension or superimposed preeclampsia, and arrange neonatal respiratory expertise accordingly. [51]
Screen and manage diabetes during pregnancy, document the type of diabetes and degree of glycemic control, and plan surveillance for excessive or restricted growth. Diabetes increases the likelihood that the newborn will require assessment for , respiratory distress, low , and hypoglycemia; in a prospective cohort of women with diabetes in pregnancy, these complications were common and the authors recommended strengthened glycemic monitoring and delivery planning. [17]
Review fetal growth serially rather than relying on a single estimated fetal weight. In suspected , interpret biometry with fluid volume, umbilical-artery Doppler, middle-cerebral-artery Doppler, cerebroplacental ratio, fetal movement, and cardiotocography or biophysical profile as clinically indicated. Late-onset growth restriction studies associate estimated fetal weight and Doppler findings with neonatal outcomes, but the available predictive models have only moderate performance and lack external validation. [48] A fetus with worsening Doppler abnormalities or abnormal testing may require expedited birth; notify neonatology before delivery because growth restriction increases the likelihood of respiratory, metabolic, hematologic, and thermoregulatory problems.
For maternal red-cell , document antibody specificity and titre, determine fetal antigen risk where available, and arrange serial assessment for fetal anemia with specialist-directed Doppler surveillance. Plan for neonatal blood typing, direct antiglobulin testing, hemoglobin and bilirubin assessment, and compatible blood products when fetal or neonatal is plausible. Prediction of severity remains imperfect, and a recent scoping review found that few obstetric biobanks capture standardized immunohematology data. [53]
Identify multiple gestation early and record chorionicity and amnionicity. Assess each fetus separately for growth, fluid, presentation, structural anomaly, and placental function; the delivery plan must account for the possibility that the infants will differ substantially in gestational age-related or disease-related needs. Obtain a fetal echocardiogram when the anatomy scan, family history, maternal disease, or genetic findings indicate increased risk of congenital heart disease. For suspected congenital heart disease or fetal arrhythmia, define whether the newborn may need immediate cardiorespiratory support, pacing, pulmonary vasodilator therapy, prostaglandin infusion, or urgent transfer. In a tertiary-center series of congenital complete heart block, most affected newborns were diagnosed prenatally, many were premature, and selected unstable infants required transcutaneous pacing and isoproterenol; the authors emphasized disease-specific multidisciplinary planning. [42]
Review all structural anomalies for consequences at birth rather than waiting for postnatal deterioration. Anticipated airway obstruction, a neck or thoracic mass, severe micrognathia, congenital diaphragmatic hernia, esophageal atresia, or a lesion likely to impair ventilation warrants antenatal consultation with neonatology, obstetrics, anesthesia, and pediatric surgery. For congenital diaphragmatic hernia, plan stabilization before repair; a systematic review and meta-analysis found higher mortality when repair occurred within the first 24 hours than after at least 24 hours, although these data should not be interpreted as a delivery-room management protocol. [55]
Abnormal fetal testing, reduced fetal movement, oligohydramnios or polyhydramnios, placental abnormalities, and suspected fetal compromise should trigger a joint decision about timing and location of birth. Breech presentation requires explicit discussion of mode of delivery, gestational age, fetal size, head position, operator skill, and the availability of personnel able to manage an unexpected difficult birth. Maternal counseling should describe the anticipated neonatal problems, the limits of prenatal prediction, the likely need for admission or transfer, possible separation from the infant, and the effect of delivery decisions on maternal as well as neonatal risk. At periviable gestations, counseling must include maternal consequences of cesarean delivery: a large cross-sectional study found higher adjusted odds of severe maternal morbidity, transfusion, critical-care complications, and venous thromboembolism compared with vaginal delivery. [54]
Perinatal preparation
Call a multidisciplinary briefing before delivery whenever the fetus may need more than routine newborn care. Include obstetrics, neonatology, anesthesia, nursing, respiratory therapy, and, when indicated, pediatric cardiology, pediatric surgery, transfusion medicine, genetics, and maternal-fetal medicine. Assign a team leader, define who will communicate with the family, confirm the delivery room and operating-room location, and document the plan for maternal transfer, neonatal transfer, and escalation if the infant is more ill than predicted.
Prepare personnel and equipment for the highest credible level of need rather than the most likely uncomplicated course. Confirm availability of appropriately sized airway and respiratory equipment, vascular-access supplies, cardiorespiratory monitoring, temperature-control equipment, emergency medications, and disease-specific items such as prostaglandin, pacing capability, or surgical airway expertise. For alloimmunization or anticipated hemorrhage, notify the blood bank early and verify compatible red cells, plasma, and platelet support. For anticipated airway or cardiac disease, place the birth where pediatric anesthesia, cardiology or surgery, advanced imaging, and intensive care are immediately accessible; maternal transfer before labor or fetal compromise is preferable to postnatal transfer when safe.
| Antenatal risk | Expected neonatal problem | Prenatal assessment | Preventive intervention | Personnel or equipment required | Delivery plan |
|---|---|---|---|---|---|
| Spontaneous preterm labor or PPROM | Respiratory immaturity, sepsis risk, temperature instability, hypoglycemia, and complications of prematurity | Confirm gestational age, cervical and membrane status, infection assessment, fetal testing, and estimated time to birth | Antenatal corticosteroids; magnesium sulfate for neuroprotection when criteria are met; antibiotics for PPROM; GBS prophylaxis when indicated [41] | Neonatal team experienced in prematurity, respiratory support, incubator or radiant warmer, monitoring, intravenous-access supplies, and transport capability | Deliver in a facility with the required neonatal intensive-care level; transfer the mother before birth when safe |
| Suspected chorioamnionitis or maternal fever | Early-onset sepsis, respiratory disease, hemodynamic instability, and preterm birth | Maternal temperature, symptoms, laboratory findings, fetal heart-rate pattern, membrane duration, and placental assessment when available; PPROM and chorioamnionitis are associated with neonatal acute respiratory distress syndrome [49] | Maternal antibiotics and expedited delivery when obstetrically indicated; alert neonatology before birth | Neonatal clinician able to assess and support a potentially infected or unstable newborn; blood-culture and antibiotic resources | Birth where neonatal assessment and treatment can begin without delay; avoid remote or inadequately staffed delivery locations |
| Hypertensive disease or superimposed preeclampsia | Fetal growth restriction, prematurity, respiratory morbidity, thrombocytopenia, and neonatal instability | Blood pressure, symptoms, proteinuria, maternal organ function, serial growth, fluid, Doppler studies, and fetal testing [56] | Maternal disease control, corticosteroids when preterm birth is likely, magnesium sulfate when indicated for maternal or fetal neuroprotection, and planned delivery for deterioration | Neonatology, obstetric anesthesia, blood bank if severe disease or operative birth is likely, and respiratory support | Tertiary hospital when severe disease, very preterm birth, or fetal compromise is possible; coordinate maternal and neonatal teams |
| Diabetes in pregnancy | Macrosomia or growth restriction, hypoglycemia, respiratory distress, low Apgar score, and possible early death [17] | Diabetes type and control, glucose records, fetal growth, fluid, and antenatal testing | Optimize glycemia and plan timing and mode of birth; anticipate early glucose surveillance | Neonatal clinician, glucose-testing capability, respiratory support, and appropriately sized vascular-access equipment | Deliver where neonatal metabolic and respiratory assessment is immediately available |
| Red-cell alloimmunization | Fetal anemia, hydrops, hemolytic disease, hyperbilirubinemia, and need for transfusion | Antibody identification and titre, paternal or fetal antigen status when available, serial fetal-anemia surveillance, hydrops assessment, and fetal-medicine consultation [53] | Intrauterine treatment when indicated; arrange compatible blood before birth | Neonatology, transfusion medicine, compatible irradiated or otherwise specified blood products, intensive phototherapy, and exchange-transfusion capability | Tertiary center with maternal-fetal medicine, neonatal intensive care, and blood bank support |
| Fetal growth restriction or abnormal placental Doppler | Hypoglycemia, hypothermia, polycythemia, respiratory difficulty, feeding difficulty, and stillbirth risk | Serial biometry, fluid volume, umbilical-artery and cerebral Doppler, fetal movement, and cardiotocography or biophysical profile [48] | Treat maternal contributors, administer corticosteroids if preterm birth is likely, and deliver for worsening fetal testing or Doppler findings | Neonatology, glucose and hematocrit testing, thermal support, and capacity for respiratory support | Plan birth in a unit able to manage a small or compromised infant; avoid unplanned delivery away from neonatal expertise |
| Multiple gestation | Prematurity, discordant growth, respiratory disease, and need for more than one neonatal team | Chorionicity, amnionicity, individual fetal growth and Doppler studies, presentations, and anomaly assessment | Antenatal corticosteroids and magnesium sulfate when criteria are met; establish a delivery sequence and neonatal allocation | Two or more appropriately trained neonatal teams when simultaneous support may be required, multiple warmers and monitors, and transport capacity | Operating or delivery room large enough for parallel maternal, obstetric, anesthesia, and neonatal care |
| Suspected congenital anomaly or anticipated airway disease | Airway obstruction, respiratory failure, impaired ventilation, or need for urgent surgery | Detailed ultrasound, fetal MRI when useful, fetal echocardiography when indicated, genetic evaluation, and multidisciplinary review | Plan airway and surgical strategy before birth; avoid delivery at a facility lacking the required expertise | Neonatology, pediatric anesthesia, pediatric surgery or otolaryngology, difficult-airway equipment, and blood products when anticipated | Deliver where the airway can be secured and definitive specialist care can begin; consider an ex utero intrapartum treatment plan for selected lesions |
| Suspected congenital heart disease or fetal arrhythmia | Ductal-dependent circulation, heart failure, bradycardia, hypoxemia, or need for pacing | Fetal echocardiography, rhythm assessment, ventricular function, hydrops evaluation, and cardiology consultation [42] | Disease-specific planning; arrange prostaglandin or pacing capability when indicated | Neonatology, pediatric cardiology, ECG, echocardiography, prostaglandin, vascular-access supplies, and transcutaneous pacing capability [42] | Deliver at a cardiac center or a linked facility with immediate stabilization and rapid transfer capability |
| Abnormal fetal testing, breech presentation, or anticipated urgent birth | Birth depression, traumatic delivery, hypoxic injury, airway difficulty, and unplanned prematurity | Repeat fetal assessment, presentation and head-position assessment, placental location, maternal pelvis and delivery history, and review of the indication for urgent birth | Correct reversible maternal factors, corticosteroids or magnesium sulfate when eligible, and documented mode-of-delivery plan | Senior obstetrician, anesthesia, neonatology, blood bank when operative birth is likely, and equipment for difficult airway or unexpected compromise | Use a staffed operating or delivery room with neonatal personnel present; do not schedule birth at a site unable to manage the predicted risk |
Pearl: The safest delivery plan is specific: identify the anticipated neonatal problem, treat what can be treated before birth, move the mother before an emergency develops, and place the right people, blood products, and equipment in the room before delivery begins.
Delivery-Room Stabilization and Neonatal Resuscitation
- ▸Apnea, gasping, or a heart rate below 100/min requires positive-pressure ventilation within approximately 60 seconds of birth, whereas a heart rate of at least 100/min with respiratory distress or persistent cyanosis calls for pulse oximetry and consideration of titrated oxygen or CPAP.
- ▸If the heart rate remains below 60/min after at least 30 seconds of effective positive-pressure ventilation, begin chest compressions with ventilation at a 3:1 ratio; if it remains below 60/min after at least 60 seconds, give epinephrine and reassess reversible causes.
- ▸Do not use intact umbilical cord milking in infants below 28 weeks because of concern about intraventricular hemorrhage, and do not allow stimulation or suctioning to delay ventilation.
Preparation and the first assessment
Every birth requires a system capable of immediate neonatal resuscitation because compromise may be unexpected. Before a high-risk delivery, assign a team leader, allocate airway, ventilation, circulation, and documentation roles, check equipment, and brief the team on the anticipated problem. [60] The initial assessment uses three questions: Is the infant preterm? Is muscle tone poor? Is the infant breathing or crying effectively? A vigorous term or late-preterm infant remains skin-to-skin with the mother; any “yes” answer moves the infant to a radiant warmer for resuscitation. [60]
For a vigorous infant who does not need resuscitation, maintain warmth and defer cord clamping for at least 60 seconds. This is recommended for preterm infants below 37 weeks who do not need immediate positive-pressure ventilation and suggested for vigorous term and late-preterm infants. [60] If a nonvigorous term or late-preterm infant cannot receive delayed cord clamping, intact umbilical cord milking may be considered; one described technique is to milk approximately 20 cm of intact cord toward the infant over 2 seconds, repeating the maneuver four times in total. [60] Intact cord milking may also be considered in infants born at 28+0 to 36+6 weeks when delayed clamping is not performed, but do not use it in infants below 28 weeks because of concern about intraventricular hemorrhage. [60] Individualize cord management when there is placental abruption or previa, major anomaly, significant fetal compromise, multiple gestation, growth restriction, maternal hypertensive or diabetic disease, cord abnormality, or meconium-stained fluid. [60]
Initial steps and respiratory assessment
Under the radiant warmer, provide warmth, place the head and neck in a neutral or slightly extended “sniffing” position, dry the infant, remove wet linen, and provide brief tactile stimulation for apnea, intermittent breathing, or shallow respirations. Do not allow stimulation or suctioning to delay ventilation. Routine suctioning of the mouth and nose is not indicated in clear fluid; suction only when obstruction is suspected. [60] For infants below 34 weeks, combine a delivery-room temperature of at least 23°C with a plastic wrap or bag, hat, and careful temperature monitoring; warmed, humidified respiratory gases may be used when available. [60]
Assess breathing and heart rate together. An increasing heart rate is the most useful immediate sign that a resuscitative intervention is working. Use a three-lead when available because it provides faster and more accurate heart-rate assessment than auscultation or pulse oximetry, but retain to guide oxygen therapy. [60] Apply the oximeter sensor to the right hand or wrist to obtain preductal saturation and begin monitoring when respiratory support or supplemental oxygen is required. Titrate oxygen to the evolving preductal saturation rather than treating cyanosis by appearance alone. [61]
A heart rate of at least 100/min with respiratory distress or persistent cyanosis calls for pulse oximetry and consideration of supplemental oxygen or (CPAP). A heart rate below 100/min, apnea, or gasping requires immediate (PPV), with respiratory support started within approximately 60 seconds of birth, the “golden minute.” [60] Begin PPV in term and late-preterm infants with 21% oxygen. Starting with at least 30% oxygen is reasonable below 32 weeks; evidence does not establish a single initial concentration for infants at 32+0 to 34+6 weeks, so use a blender and titrate continuously. [60]
For a spontaneously breathing preterm infant who needs respiratory support, begin CPAP rather than proceeding directly to intubation and mechanical ventilation. A reasonable initial CPAP pressure is 5-6 cm H₂O; the precise pressure should be adjusted to chest excursion, oxygenation, respiratory effort, and the risk of air leak. [60][61] Evidence is insufficient to recommend routine delivery-room CPAP for every term or late-preterm infant with distress, but a monitored CPAP trial is reasonable when spontaneous breathing and heart rate are preserved. [60]
Effective ventilation and corrective steps
Give PPV at 30-60 inflations/min, with initial inflation times of 0.5-1 second and an initial peak inspiratory pressure (PIP) of 20-30 cm H₂O. In preterm infants, use at least 5 cm H₂O of positive end-expiratory pressure (PEEP) when equipment permits; routine PEEP in term infants has less certain evidence. Adjust pressure only enough to achieve visible chest movement and a rising heart rate, avoiding excessive pressure because overdistension can cause lung injury and may increase intraventricular hemorrhage risk. [60]
If the chest does not move or the heart rate remains below 100/min, perform the NRP corrective ventilation sequence, commonly remembered as MR SOPA: improve the Mask seal, Reposition the head and airway, Suction only if obstruction is suspected, Open the mouth and airway, Pressure-increase gradually, and use an Alternative airway. The evidence supports the individual maneuvers but does not establish that the original mnemonic sequence is superior to another order. [62] Reassess chest movement and heart rate after each corrective intervention rather than continuing ineffective mask ventilation.
Proceed to when mask ventilation remains ineffective, when prolonged PPV is anticipated, or when chest compressions are required and a secure airway is feasible. For infants at least 34 weeks’ gestation, a (supraglottic airway) is an acceptable alternative when face-mask ventilation fails or intubation is not feasible, provided an appropriately trained operator and suitable device are available. [60] A laryngeal mask can also serve as the primary ventilation interface in selected term and late-preterm infants, but it does not replace intubation when tracheal suction is required for suspected obstruction or when a definitive airway is needed. [60][66]
Bradycardia, circulation, and drugs
If the heart rate remains below 60/min after at least 30 seconds of effective PPV, preferably through an endotracheal tube, start coordinated with ventilation at a 3:1 ratio, delivering 90 compressions and 30 ventilations per minute. Increase oxygen up to 100% when the response to lower concentrations is inadequate, then reduce it promptly once circulation and oxygenation improve. [60] Continue coordinated ventilation and compressions for at least 60 seconds before judging the response and giving epinephrine.
Obtain emergency during advanced resuscitation when feasible; the umbilical vein is the preferred rapid vascular route for epinephrine and volume. If umbilical venous access cannot be established promptly, is a rescue option when expertise and equipment are available. Evidence comparing these routes is very limited, and reported complications have been more frequent with intraosseous devices; neither route should interrupt effective ventilation and compressions. [63]
For persistent heart rate below 60/min despite at least 60 seconds of effective PPV and coordinated compressions, give epinephrine 0.01-0.03 mg/kg intravenously or intraosseously using 1:10,000 solution (0.1 mg/mL), equivalent to 0.1-0.3 mL/kg, and repeat every 3-5 minutes if required. [60] Consider hypovolemia, acute blood loss, and pneumothorax when there is no response. If acute blood loss is confirmed or strongly suspected, give 0.9% saline or emergency-release blood at 10 mL/kg intravenously or intraosseously over 5-10 minutes, then reassess perfusion and heart rate. Volume expansion is not a routine treatment for unexplained bradycardia because most delivery-room collapse is primarily respiratory. [60]
NRP sequence at a glance
| Assessment finding | Intervention | Dose or setting | Reassessment interval | Escalation criterion |
|---|---|---|---|---|
| Vigorous term or late-preterm infant; effective breathing or crying; good tone | Skin-to-skin care, warmth, routine observation; delayed cord clamping | Delay clamping ≥60 s | Continuous clinical observation | Move to warmer if breathing, tone, or heart rate becomes abnormal |
| Preterm, poor tone, or ineffective breathing/crying | Radiant warmer; warmth, position, drying, stimulation; clear obstruction only | Preterm <34 wk: room ≥23°C, plastic wrap/bag, hat | Immediately after initial steps | Apnea/gasping or HR <100/min: start PPV within 60 s |
| HR ≥100/min with spontaneous breathing but distress or persistent cyanosis | Pulse oximetry; titrated oxygen and/or CPAP | Term/late preterm: start oxygen at 21%; CPAP about 5-6 cm H₂O when indicated | Continuous SpO₂ and clinical assessment | Persistent distress, apnea, or HR <100/min: PPV |
| Apnea, gasping, or HR <100/min | Face-mask PPV | 30-60/min; PIP 20-30 cm H₂O; preterm PEEP ≥5 cm H₂O when available | Reassess chest movement and HR after corrective actions and at least every 30 s | No chest movement or persistent HR <100/min: MR SOPA, then alternative airway |
| Ineffective mask PPV after corrective steps | Intubate or use laryngeal mask | Laryngeal mask generally for ≥34 wk when trained and available | Reassess immediately after airway placement and after 30 s effective ventilation | HR <60/min after ≥30 s effective PPV: compressions |
| HR <60/min after ≥30 s effective PPV | Chest compressions with PPV | 3:1 ratio; increase oxygen up to 100% if needed | Reassess HR after 60 s of coordinated compressions and ventilation | HR remains <60/min: vascular access and epinephrine |
| HR <60/min after ≥60 s effective PPV plus compressions | Epinephrine | 1:10,000 IV/IO, 0.01-0.03 mg/kg; repeat every 3-5 min | Reassess HR after each cycle | No response: check ventilation, pneumothorax, hypovolemia, and blood loss |
| Confirmed or strongly suspected acute blood loss with persistent compromise | Volume expansion | 0.9% saline or blood 10 mL/kg IV/IO over 5-10 min | Reassess HR, perfusion, and response after bolus | Persistent compromise: continue NRP evaluation and consider reversible causes |
Meconium-stained fluid and special circumstances
Meconium-stained fluid does not change the initial priority: establish effective ventilation. Do not perform routine laryngoscopy or tracheal suctioning in a nonvigorous infant before PPV. If ventilation produces poor chest movement or obstruction is suspected, intubate and suction the trachea under direct visualization, then resume ventilation without avoidable delay. [60][61]
For extreme prematurity, anticipate rapid heat loss, fragile lungs, and a higher likelihood of respiratory support. Use the thermal bundle, avoid routine sustained inflations lasting at least 5 seconds, begin CPAP for spontaneous breathing when support is needed, and use gentle PPV with the lowest effective pressure. [60] Decisions at the margins of viability require antenatal discussion, a team familiar with local policy, and equipment capable of immediate respiratory and vascular support; evidence from randomized resuscitation trials is limited in periviable infants. [61]
For suspected , avoid mask ventilation because gastric insufflation further compromises the hypoplastic lungs. Intubate early, insert an orogastric tube to continuous or intermittent decompression, and use gentle ventilation with limited PIP while accepting a strategy that avoids ventilator-induced lung injury. The condition is characterized by pulmonary hypoplasia and pulmonary hypertension, so delivery-room stabilization requires disease-specific respiratory planning rather than routine escalation of mask pressure. [65]
When antenatal or clinical findings suggest ductal-dependent congenital heart disease, alert the neonatal and cardiology teams, obtain pre- and postductal saturation measurements when possible, avoid interpreting cyanosis from a single saturation value, and maintain ventilation and perfusion while arranging echocardiography and transport. If systemic or pulmonary blood flow is failing and a ductal-dependent lesion is strongly suspected, start (prostaglandin E₁) according to the local congenital-heart protocol, commonly 0.01 microgram/kg/min by continuous intravenous infusion, and prepare for apnea, hypotension, and assisted ventilation. Disease-specific delivery-room education and simulation are needed because standard resuscitation algorithms may not address all critical congenital heart lesions. [76]
Maternal opioid exposure does not justify waiting for when the newborn is apneic or gasping. Apply the initial steps, assess heart rate, and provide PPV within the golden minute when indicated; effective ventilation, not pharmacologic reversal, is the immediate treatment for opioid-associated respiratory depression. [60] Reserve naloxone decisions for subsequent care under local neonatal and toxicology protocols, particularly when chronic maternal opioid use may produce withdrawal.
Perinatal asphyxia is managed first by restoring lung aeration and circulation: prevent hypothermia, begin effective PPV promptly, escalate through the NRP sequence for persistent bradycardia, and investigate hypovolemia or pneumothorax when the response is poor. Document the duration and quality of ventilation, compressions, epinephrine, vascular access, oxygen exposure, and heart-rate response; these data guide post-resuscitation stabilization and neurologic assessment. [60]
Pearl: In neonatal resuscitation, a rising heart rate is the immediate measure of success: when it is not rising, correct ventilation before escalating circulation support.
Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care
- ▸Use the best obstetric estimate for gestational age, and perform the New Ballard Score when dating is uncertain or the clinical appearance is discordant; classify birth weight as small-for-gestational-age below the 10th percentile, appropriate-for-gestational-age between the 10th and 90th percentiles, or large-for-gestational-age above the 90th percentile.
- ▸Maintain a stable newborn’s axillary temperature at 36.5-37.5°C, correct environmental heat loss first, and investigate persistent hypothermia, recurrent instability, or fever rather than repeatedly warming alone.
- ▸Reassess feeding, vital signs, perfusion, and focused examination after the first substantial feed, before transfer or discharge, and whenever the infant becomes difficult to feed, lethargic, tachypneic, poorly perfused, jaundiced, or cold.
Examine every newborn systematically after transition, then repeat the examination when the infant’s condition, feeding, temperature, or examination changes. The purpose is not merely to document normality: the first examination establishes a physiologic baseline, identifies findings that require observation or investigation, and tests whether the infant can maintain cardiorespiratory stability outside the delivery room.
Comprehensive newborn examination
Begin with the general impression. Record alertness, spontaneous movement, posture, tone, color, respiratory effort, cry, dysmorphic features, and interaction with the examiner and caregiver. Inspect the skin for pallor, central cyanosis, jaundice, bruising, petechiae, birth trauma, congenital lesions, and signs of impaired perfusion. A peripheral bluish discoloration of the hands and feet may accompany normal transition, whereas persistent central cyanosis requires prompt cardiorespiratory assessment.
Measure weight, length, and head circumference using calibrated equipment, and plot each measurement against gestational-age-specific standards. Assess the head for molding, caput succedaneum, cephalohematoma, cranial sutures, fontanelles, and scalp defects. Examine the face, palate, tongue, neck, clavicles, and airway; inspect the eyes for red reflexes and discharge, and the ears for position and structural abnormalities. Palpate the clavicles and examine each limb for symmetry, movement, digits, hip stability, and pulses. Auscultate the heart for rate, rhythm, murmurs, and femoral pulse transmission; examine the lungs for air entry, symmetry, grunting, nasal flaring, and retractions. Inspect the abdomen for distension, masses, umbilical vessels, and hernia, and confirm a patent anus. Examine the external genitalia, document sex development and any ambiguity, and assess the spine from the occiput to the sacrum for curvature, dimples, hair tufts, or masses.
A neurologic examination should include level of alertness, spontaneous and elicited movement, flexor tone, symmetry, suck, rooting, Moro, grasp, and stepping responses when appropriate. Interpret primitive reflexes in relation to gestational age: an absent or markedly asymmetric response is more concerning than a weak response in an immature infant. Compare tone and movement serially rather than relying on a single observation, because illness, medication exposure, hypothermia, and recent birth trauma can transiently alter behavior.
Cardiorespiratory observation and perfusion
Observe the infant undisturbed before handling. Count respirations for a full minute and look for tachypnea, apnea, periodic breathing, grunting, nasal flaring, intercostal or sternal recession, and paradoxical breathing. Record heart rate after the infant is calm; persistent tachycardia, bradycardia, an irregular rhythm, or a difference between central and peripheral color warrants reassessment and escalation. Measure oxygen saturation when cyanosis, respiratory difficulty, abnormal pulses, poor perfusion, or cardiac disease is suspected; use right-hand saturation when preductal measurement is clinically relevant and document the limb used.
Assess perfusion through skin color and temperature, capillary refill, peripheral and femoral pulses, pulse quality, urine output, mental state, and feeding vigor. Cool extremities alone are nonspecific; cool extremities accompanied by pallor, weak pulses, prolonged capillary refill, lethargy, tachypnea, or metabolic instability indicate possible circulatory compromise. Do not dismiss a murmur because the infant appears well: repeat cardiac examination after transition and compare brachial and femoral pulses.
Gestational-age and size classification
Use the best obstetric estimate as the primary gestational-age assignment. Prefer a reliable last menstrual period corroborated by a first-trimester ultrasound; when these disagree, use the locally accepted dating hierarchy and document the method rather than silently changing the estimated date. A later ultrasound is useful when early dating is unavailable but is less precise for assigning gestational age. The postnatal examination should validate, not routinely replace, a well-established obstetric estimate.
When obstetric dating is uncertain or the clinical appearance is discordant, perform the . This score estimates maturity from neuromuscular findings, such as posture, square window, arm recoil, popliteal angle, scarf sign, and heel-to-ear, and physical findings including skin, lanugo, plantar creases, breast tissue, eyes, ears, and genitalia. Perform it as early as practical when the result will change classification or monitoring, and interpret it cautiously in infants affected by severe illness, neuromuscular disease, edema, or birth trauma.
Classify birth weight for gestational age using a sex- and gestational-age-specific growth chart. An appropriate-for-gestational-age infant lies between the 10th and 90th percentiles, a small-for-gestational-age infant is below the 10th percentile, and a large-for-gestational-age infant is above the 90th percentile. Do not equate small size with fetal growth restriction: the latter implies a pathologic failure to reach growth potential and requires clinical context, serial growth information, placental assessment, and, when indicated, fetal Doppler data. Record both gestational age and size category because each predicts different risks and determines the intensity of observation, feeding assessment, glucose surveillance, and temperature care.
Feeding, elimination, and serial reassessment
Assess feeding directly rather than recording only whether a feed was offered. Observe arousal, rooting, latch, positioning, suck strength, suck-swallow-breathe coordination, work of breathing during feeding, duration, volume when measured, emesis, and caregiver technique. Examine the mouth and palate when latch is poor. Reassess an infant who is difficult to wake, repeatedly fatigues, coughs or chokes, becomes cyanotic, breathes rapidly during feeds, vomits persistently, or cannot maintain intake; these findings may precede deterioration.
Document the first void and stool and their timing. Urine output during the first day is an imprecise marker of well-being, so interpret it alongside hydration, weight, perfusion, feeding, and renal examination. Record passage of meconium and then the transition toward lighter stools as enteral intake increases. Failure to pass urine or meconium within the expected period, abdominal distension, bilious vomiting, or worsening feeding requires examination for obstruction, dehydration, renal disease, or other pathology rather than simple continued observation.
Repeat vital signs and focused examination after the initial assessment, after the first substantial feed, before transfer or discharge, and whenever the infant becomes cold, lethargic, tachypneic, poorly perfused, jaundiced, or difficult to feed. Trend weight, temperature, intake, output, respiratory effort, color, tone, and bilirubin risk rather than interpreting isolated values. A normal first examination is a baseline, not a clearance from further assessment.
Routine care and preventive screening
Maintain a warm environment, dry the infant promptly, use skin-to-skin contact when clinically appropriate, cover the head, and postpone bathing until thermal stability is secure. Measure axillary temperature; a practical target for a stable newborn is 36.5-37.5°C. Correct environmental heat loss first, then reassess temperature and respiratory status. Persistent hypothermia, recurrent temperature instability, or fever requires clinical evaluation rather than repeated warming alone.
Use hand hygiene before and after contact, clean technique for cord and skin care, dedicated or disinfected equipment, and respiratory etiquette. Limit unnecessary handling and separate infants with suspected transmissible infection according to local policy. Keep the umbilical cord clean and dry, and inspect it for bleeding, erythema, discharge, or malodor.
Give intramuscular vitamin K according to local protocol, commonly 1 mg for infants weighing more than 1.5 kg and 0.5 mg for infants weighing 1.5 kg or less. Apply ocular erythromycin where required by local law or policy and where prophylaxis is indicated. Offer hepatitis B vaccine before discharge according to national immunization guidance; infants born to a hepatitis B surface-antigen-positive mother require immediate vaccine and hepatitis B immunoglobulin according to the relevant protocol.
Obtain the dried-blood-spot sample at the jurisdictionally specified time, commonly after the infant has received adequate enteral intake and at least 24 hours of life, and arrange repeat collection when the sample is early, inadequate, or obtained after transfusion or other circumstances that compromise interpretation. Screening is intended to detect serious congenital disorders before symptoms appear so that intervention can reduce disability and death.[79] Record consent or refusal, collection time, transfusion status, and the responsible clinician for follow-up; a screen-positive result is not a diagnosis and requires timely confirmatory testing.
Complete universal before discharge when feasible, using automated otoacoustic emissions or automated auditory brainstem response according to local protocol. Explain that a passed screen does not exclude mild, unilateral, delayed-onset, progressive, or neural hearing loss, and ensure diagnostic follow-up for a refer result or for infants with recognized risk factors.[85]
Perform with pulse oximetry at the locally specified postnatal age, usually after 24 hours or shortly before discharge if earlier discharge is unavoidable. Measure right-hand and foot saturations and follow the local algorithm for a failed screen. A failed result requires repeat measurement when the algorithm permits and clinical assessment for hypoxemia, respiratory disease, sepsis, or congenital heart disease; do not discharge an infant with an unexplained abnormal result.
Assess an infant who will travel home in the family’s rear-facing car seat when local policy requires a car-seat challenge, particularly when prematurity, low weight, cardiorespiratory instability, or oxygen use raises concern. Observe for apnea, bradycardia, or desaturation during the prescribed test; an abnormal result requires continued monitored care and a revised transport plan.
Before discharge, teach caregivers to place the infant supine for every sleep in a firm, flat, separate sleep space without pillows, loose bedding, bumpers, or soft objects. Recommend room-sharing without bed-sharing, avoidance of smoke and intoxicant exposure, and avoidance of overheating. Teach caregivers how to recognize poor feeding, abnormal breathing, cyanosis, fever or hypothermia, lethargy, seizures, worsening jaundice, and reduced urine output, and provide a clear route for urgent review.
| Assessment or preventive intervention | Timing | Method | Abnormal result | Required response |
|---|---|---|---|---|
| Initial general and physical examination | After transition and before routine transfer; repeat before discharge | Head-to-toe examination, anthropometry, cardiorespiratory and neurologic assessment | Abnormal color, tone, pulses, breathing, anatomy, feeding behavior, or perfusion | Stabilize, repeat focused examination, obtain targeted tests, and escalate to neonatal care when instability persists |
| Temperature | At admission, after warming or bathing, with routine observations, and when unwell | Axillary measurement; target 36.5-37.5°C | <36.5°C or ≥37.5°C | Adjust environmental temperature, recheck, assess glucose and illness risk when persistent, and escalate for fever or recurrent instability |
| Heart rate and respiratory rate | At initial assessment and serially while observed | Count for a full minute when calm; inspect work of breathing | Persistent heart-rate or respiratory-rate abnormality, apnea, grunting, flaring, or recession | Repeat assessment, measure oxygen saturation, evaluate perfusion and glucose, and provide monitored neonatal review |
| Perfusion and pulses | Initial examination and whenever color, feeding, or behavior changes | Color, capillary refill, skin temperature, brachial and femoral pulses, mental state, urine output | Pallor, weak or unequal pulses, prolonged refill, lethargy, or worsening tachypnea | Treat as possible circulatory compromise; obtain urgent cardiorespiratory assessment and escalate |
| Feeding assessment | First feed and each shift or clinically concerning feed | Observe latch, suck-swallow-breathe coordination, intake, emesis, and fatigue | Choking, cyanosis, repeated emesis, poor arousal, fatigue, or inadequate intake | Stop unsafe oral feeding, reassess airway and cardiorespiratory status, support intake, and seek neonatal or feeding evaluation |
| Urine and stool transition | Document first void and meconium; review at every assessment | Caregiver and nursing record with abdominal and hydration examination | No expected transition, abdominal distension, bilious emesis, or dehydration signs | Repeat examination and investigate obstruction, renal dysfunction, dehydration, or other illness |
| Gestational-age assignment and size classification | At birth and during the first examination | Obstetric dating; first-trimester ultrasound when available; New Ballard Score if dating is uncertain; growth chart for size | Discordant dates, uncertain maturity, <10th or >90th percentile | Document the method, use the best estimate for care, and tailor temperature, feeding, glucose, and observation plans |
| Vitamin K prophylaxis | Shortly after birth according to local protocol | Intramuscular administration; commonly 1 mg if >1.5 kg and 0.5 mg if ≤1.5 kg | Declined, omitted, or uncertain administration | Counsel caregivers, document refusal or administration, and arrange protocol-based follow-up |
| Newborn bloodspot screening | At the jurisdictionally specified age, commonly after 24 hours and adequate feeding | Heel-prick dried-blood-spot collection with documented timing and transfusion status | Inadequate, early, missing, or screen-positive sample | Repeat an unsatisfactory sample promptly; arrange confirmatory testing and tracked follow-up for a positive screen |
| Hearing screening | Before discharge when feasible | Automated otoacoustic emissions or automated auditory brainstem response | Refer or incomplete test | Repeat or arrange diagnostic audiology within the local pathway; continue surveillance when risk factors remain |
| Critical congenital heart disease screening | Usually after 24 hours or before early discharge | Right-hand and foot pulse oximetry using the local algorithm | Failed screen or unexplained low saturation | Repeat only as permitted by protocol, assess clinically, and do not discharge until the abnormality is explained or an appropriate plan is in place |
| Car-seat assessment | Before discharge when required by local policy | Monitored observation in the family’s rear-facing seat | Apnea, bradycardia, or desaturation | Continue monitored care, reassess readiness, and revise the transport plan |
| Safe-sleep counseling | Before discharge and reinforced at follow-up | Teach-back about supine sleep, firm flat surface, separate sleep space, and avoidance of soft bedding or smoke | Caregiver uncertainty or unsafe planned arrangement | Re-teach, involve the care team, and document a safe discharge plan |
Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care
- ▸Classify gestational age and birth weight independently: preterm is <37+0 weeks, ELBW is <1,000 g, and SGA is <10th percentile; the combination of these labels determines risk more accurately than any single label.
- ▸Do not diagnose fetal growth restriction from a single low birth weight; review growth trajectory, proportionality, parental size when relevant, placental findings, and antenatal Dopplers, while anticipating hypoglycemia, hypothermia, polycythemia or anemia, feeding intolerance, and NEC risk.
- ▸In very preterm or unstable infants, maintain an axillary temperature of 36.5-37.5°C, trend weight, length, and head circumference at least weekly, and use scheduled cranial ultrasonography and ROP examinations according to gestational age and risk.
Gestational age and birth weight answer different clinical questions. Classify gestational age from the best obstetric estimate: preterm is <37+0 weeks, subdivided into extremely preterm (<28+0), very preterm (28+0-31+6), moderate preterm (32+0-33+6), and late preterm (34+0-36+6); term is 37+0-41+6 weeks, and post-term is ≥42+0 weeks. Classify birth weight independently as low birth weight (<2,500 g), very-low birth weight (<1,500 g), or extremely-low birth weight (ELBW, <1,000 g). Size for gestational age is appropriate (10th-90th percentile), small (SGA, <10th percentile), or large (LGA, >90th percentile). A preterm infant may be SGA, appropriate, or LGA; the combination determines risk more accurately than any single label. In a cohort of preterm SGA infants born at 23-34 weeks, gestational age altered the pattern of respiratory, neurologic, gastrointestinal, and mortality outcomes, and mortality was 3.13-fold higher than in non-SGA infants. [102]
The clinical phenotype of abnormal growth
(FGR) is a prenatal diagnosis of inadequate growth potential, usually supported by abnormal placental, fluid, or Doppler findings; SGA is a postnatal size descriptor and may reflect constitutional smallness. FGR infants have reduced glycogen and fat stores, impaired thermogenesis, and limited physiologic reserve. Expect hypoglycemia, hypothermia, polycythemia or anemia, feeding intolerance, hypoxic-ischemic stress, and postnatal growth failure. Placental insufficiency also raises the risk of intestinal ischemia and (NEC), particularly when combined with prematurity. Do not interpret a single low weight as proof of FGR; examine the trajectory, proportionality, parental size when relevant, placental findings, and antenatal Dopplers.
LGA infants, including infants of mothers with diabetes, are vulnerable to birth trauma, respiratory disease despite term gestation, hypoglycemia from persistent fetal hyperinsulinism, hypocalcemia, polycythemia, and hyperbilirubinemia. Check glucose early and serially according to local protocol, assess perfusion and hematocrit when clinically indicated, and examine carefully for clavicular injury, brachial plexus dysfunction, and respiratory distress. In both SGA and LGA infants, growth status changes surveillance; it does not replace assessment of gestational age or clinical condition.
Extreme prematurity combines developmental immaturity with exposure to extrauterine injury. The immature lung has incomplete alveolar and pulmonary vascular development; oxygen, inflammation, and invasive ventilation can interrupt alveolarization and angiogenesis, producing the developmental form of (BPD). [99] The immature cerebral circulation is pressure-sensitive, predisposing to (IVH), while immature intestinal perfusion and host defense predispose to NEC. Immature respiratory control causes (AOP), and low iron stores, phlebotomy, rapid growth, and shortened red-cell survival contribute to . Reduced mineral accretion and limited enteral mineral delivery cause (osteopenia); serum mineral surveillance remains standard, while quantitative ultrasound is a promising radiation-free adjunct whose reliability has been demonstrated in ELBW infants. [114]
Environment and developmental care
Use a servo-controlled incubator for very preterm or unstable infants and a radiant warmer for procedures, resuscitation, or infants who cannot remain enclosed. Set the environment to maintain an axillary temperature of 36.5-37.5°C, measure temperature after admission and after changes in support, and prevent both cold stress and iatrogenic overheating. Extreme prematurity increases transepidermal water loss, particularly in the most immature infants and after intrauterine inflammation; humidification, minimal exposure, a plastic barrier when indicated, and gentle skin care reduce evaporative heat and fluid loss. [117]
Provide skin-to-skin care whenever cardiorespiratory status, vascular access, and staffing permit. Use a written eligibility and transfer plan: secure airway and lines, maintain thermal control, monitor continuously, and return the infant promptly if apnea, bradycardia, desaturation, temperature instability, or perfusion deteriorates. Skin-to-skin contact supports parent participation and may facilitate oral-feeding progression; observational studies associate contact with reduced stress and better growth, but non-randomized designs cannot establish causality. [110][111] Developmental care is not passive handling. Cluster necessary procedures, preserve uninterrupted sleep, support flexion and midline posture, use containment during procedures, reduce unnecessary adhesive removal, and coordinate care so that repeated stimulation is avoided.
Reduce incubator opening, alarms, conversation, and equipment noise. Shield the eyes from unnecessary light, use day-night cycling appropriate to developmental age, and avoid prolonged direct light exposure. Explain the plan to parents and invite them to provide voice, touch, containment, and skin-to-skin contact. These measures limit autonomic stress and conserve energy without withholding examination or urgent treatment.
Surveillance and prevention of linked complications
Trend weight, length, and head circumference at least weekly during hospitalization, plot each measurement by sex and postmenstrual age, and assess velocity rather than reacting to a single value. Use the Fenton preterm charts until approximately 50 weeks postmenstrual age or the locally adopted INTERGROWTH-21st standards; thereafter use the jurisdiction’s term-infant standard. Plot birth measurements, nadir weight, weekly change, and discharge values. Falling weight or head-circumference z scores requires review of illness burden, fluid status, nutrient delivery, malabsorption, and chronic lung disease rather than automatic concentration of feeds or escalation of prescriptions.
Minimize phlebotomy, use micro-sampling, and investigate disproportionate pallor, tachycardia, increasing oxygen requirement, apnea, poor weight gain, or reduced activity for anemia. Monitor alkaline phosphatase, phosphate, calcium, and vitamin D according to local ELBW protocol, especially in infants with prolonged parenteral nutrition, cholestasis, diuretic exposure, or poor growth. Handle the infant with the head and trunk aligned, avoid abrupt changes in blood pressure or carbon dioxide, and use gentle, coordinated procedures to reduce IVH risk. Cranial ultrasonography is generally performed in the first 7-10 days, repeated at 4-6 weeks of age, and repeated near term-equivalent age or sooner after clinical deterioration; abnormal findings require serial imaging and neurologic follow-up. Lower gestational age and birth weight are major IVH risk markers, and severe IVH has been associated with perinatal instability and inflammatory exposure. [106][115][116]
Assess for a clinically significant (PDA) when there is persistent respiratory or hemodynamic instability, widened pulse pressure, bounding pulses, an active precordial impulse, oliguria, or unexplained pulmonary edema. Confirm the diagnosis and its physiologic significance by echocardiography rather than treating an echocardiographic ductus in isolation. Conservative management is appropriate for many infants; escalation requires evidence of systemic hypoperfusion, pulmonary overcirculation, worsening respiratory status, or failure of conservative care. Avoid routine closure solely because a ductus remains patent.
Treat recurrent or clinically important AOP after excluding hypothermia, hypoglycemia, infection, anemia, airway obstruction, and excessive respiratory depression. Caffeine citrate is commonly given at a loading dose of 20 mg/kg intravenously or orally, followed by 5-10 mg/kg once daily; the drug reduces apnea by antagonizing adenosine receptors and has a long half-life that permits daily administration. [100] Persistent events require review of dose relative to current weight, respiratory support, anemia, sepsis, and seizure mimics; escalation should follow local protocol because evidence comparing routes, frequencies, and dose-adjustment strategies remains very uncertain. [100]
Prevent NEC by avoiding unnecessary hemodynamic instability, protecting human milk feeding when available, advancing enteral nutrition cautiously in high-risk infants, and examining promptly for feeding intolerance, abdominal discoloration, distension, tenderness, bilious emesis, bloody stool, apnea, or metabolic acidosis. Stop feeds and obtain urgent abdominal and laboratory assessment when NEC is suspected. In growth-restricted infants with abnormal umbilical-artery Dopplers, a randomized trial found that carefully monitored earlier feeding achieved full feeds sooner without a statistically significant increase in NEC, but the result should not override the infant’s perfusion, abdominal examination, or local feeding protocol. [107]
Prevent BPD by protecting the developing lung: use the least injurious effective respiratory support, avoid unnecessary oxygen exposure, treat infection and fluid overload promptly, and reassess the need for respiratory support at every change in condition. BPD is assessed at 36 weeks postmenstrual age using the infant’s oxygen and respiratory-support requirement; contemporary definitions and changing respiratory practice influence the apparent incidence and severity, so document the support level and oxygen requirement precisely. [99][103][104] Do not promise that an experimental anti-inflammatory, cell, extracellular-vesicle, or growth-factor therapy prevents long-term lung disease; available studies remain early-phase or preclinical, and durable benefit has not been established. [99]
Screen every infant who meets national retinopathy criteria for (ROP), with particular attention to infants born at <31 weeks, weighing <1,500 g, or with an unstable course requiring prolonged oxygen or ventilation. Perform the first examination at 31 weeks postmenstrual age or 4 weeks chronological age, whichever is later; examine infants born before 27 weeks at 31 weeks postmenstrual age, and repeat examinations at intervals determined by retinal findings until vascularization is complete or treatment criteria are reached. Lower gestational age and birth weight increase risk, and PDA and invasive ventilation were associated with ROP in a cohort study. [101][105] Maintain stable, carefully titrated oxygenation rather than pursuing either indiscriminate oxygen restriction or liberal oxygen exposure.
| Neonatal subgroup | Dominant risks | Surveillance | Preventive measures | Escalation criteria |
|---|---|---|---|---|
| Extremely preterm or ELBW | AOP, respiratory failure and BPD, IVH, NEC, anemia, osteopenia, ROP, hypothermia | Continuous cardiorespiratory and oxygen monitoring; serial growth; early and scheduled cranial ultrasound; ROP examinations; CBC and mineral surveillance | Servo-controlled thermal care, developmental handling, minimal phlebotomy, lung-protective support, human milk when available, caffeine, coordinated procedures | Recurrent apnea or bradycardia, rising oxygen/support requirement, shock or oliguria, abdominal signs, symptomatic anemia, seizures, abnormal ultrasound, or treatment-requiring ROP |
| FGR or SGA preterm | Hypoglycemia, hypothermia, polycythemia, placental-insufficiency injury, NEC, poor postnatal growth, IVH and mortality | Serial glucose and temperature; perfusion and hematocrit assessment when indicated; Doppler-informed feeding risk; weekly weight, length, and head circumference | Thermal protection, early recognition of glucose disturbance, cautious feeding advancement, minimized handling, careful blood-pressure and carbon-dioxide control | Persistent hypoglycemia, respiratory or circulatory instability, feeding intolerance, abdominal distension or bloody stool, worsening growth trajectory, or abnormal neurologic examination |
| LGA or infant of a diabetic mother | Hypoglycemia, respiratory disease, birth trauma, polycythemia, hypocalcemia, jaundice | Early serial glucose; examination for trauma and brachial plexus injury; respiratory and perfusion assessment; bilirubin surveillance | Early feeding when safe, thermal stability, glucose protocol, meticulous delivery examination | Symptomatic or persistent hypoglycemia, respiratory distress, poor perfusion, symptomatic hyperviscosity, seizure, or significant birth injury |
| Very or moderate preterm infant | Feeding immaturity, apnea, temperature instability, anemia, ROP or IVH according to gestational age and illness | Growth and feeding-skill assessment; cardiorespiratory monitoring while events persist; targeted cranial and retinal screening | Cue-based developmental care, skin-to-skin contact, noise/light reduction, caffeine when indicated, and avoidance of unnecessary oxygen | Increasing apnea, feeding-associated desaturation, failure to gain weight, temperature instability, suspected sepsis, or inability to maintain safe feeding |
Pearl: In the extremely preterm or growth-abnormal infant, growth, temperature, oxygen exposure, perfusion, feeding tolerance, retinal vascularization, and brain imaging are linked surveillance domains; a deterioration in one should trigger review of the others rather than isolated treatment of a single monitor value.
Neonatal Respiratory Disease and Escalation of Respiratory Support
- ▸Start CPAP at 5-6 cmH₂O for a spontaneously breathing infant with respiratory distress and adequate effort, targeting SpO₂ 90-95% in most preterm infants while titrating FiO₂ to the lowest concentration that achieves the target.
- ▸In probable preterm RDS with increasing distress and FiO₂ >0.30 on CPAP pressure ≥6 cmH₂O, administer early surfactant; LISA/MIST with poractant alfa 200 mg/kg is preferred when feasible.
- ▸Intubate for ineffective spontaneous ventilation, recurrent apnea with bradycardia, severe or worsening respiratory acidosis, refractory hypoxemia despite optimized non-invasive support, exhaustion, or shock attributable to respiratory failure.
Respiratory failure in a newborn is a syndrome, not a diagnosis. Begin by identifying whether the dominant problem is inadequate lung aeration, surfactant deficiency, airway obstruction, parenchymal inflammation or aspiration, air leak, pulmonary vascular maladaptation, pulmonary hypoplasia, or central/obstructive apnea. The same infant may have more than one mechanism, for example, a preterm infant with respiratory distress syndrome (RDS) may develop pneumothorax, pulmonary hemorrhage, or evolving bronchopulmonary dysplasia (BPD). Treatment should therefore be escalated according to work of breathing, gas exchange, lung mechanics, and hemodynamic effect rather than respiratory rate alone.
Clinical assessment and diagnostic strategy
Assess respiratory rate and pattern, grunting, nasal flaring, retractions, chest excursion, breath-sound symmetry, color, tone, apnea, perfusion, temperature, and the trajectory of oxygen and pressure requirements. A rising oxygen requirement, recurrent desaturation, worsening retractions, fatigue, apnea, or reduced air entry suggests failure of the current support. In a preterm infant, tachypnea and retractions with early oxygen need favor RDS; in a term or late-preterm infant, tachypnea beginning soon after birth with relatively mild distress favors transient tachypnea of the newborn (TTN), which usually resolves within 24-72 hours.[120] Meconium aspiration syndrome (MAS), pneumonia, pulmonary hemorrhage, and congenital diaphragmatic hernia (CDH) require a lower threshold for imaging and echocardiography because clinical appearances overlap.
Obtain a blood gas when distress is moderate or worsening, oxygen or pressure needs are rising, apnea is recurrent, invasive ventilation is being considered, or pulmonary hypertension is suspected. Interpret the result with the clinical examination. A low pH with rising PaCO₂ indicates inadequate alveolar ventilation; a low PaO₂ or low oxygen saturation despite increasing inspired oxygen indicates impaired oxygen transfer, shunt, or both. Metabolic acidosis with an increasing lactate suggests systemic hypoperfusion or severe pulmonary vascular disease rather than isolated mild parenchymal disease. Do not intubate solely for a single abnormal gas if the infant is clinically improving, but do not allow a compensating respiratory alkalosis to conceal deteriorating perfusion or fatigue. In one contemporary MIST cohort, prespecified criteria for invasive ventilation included pH <7.25 with PaCO₂ >60 mmHg, recurrent apnea, persistent FiO₂ >0.40, or failure despite escalating non-invasive pressure; these are reasonable reference points, not universal rules.[122]
Use right-hand preductal and either-foot postductal pulse oximetry when hypoxemia is disproportionate to the radiograph, cyanosis is persistent, or (PPHN) is suspected. A pre- to postductal saturation difference supports right-to-left ductal shunting, but a small or absent difference does not exclude pulmonary hypertension or cardiac disease. Confirm signal quality, perfusion, probe position, and a stable plethysmographic waveform before acting on a discrepant value. For most preterm infants receiving respiratory support, a practical oxygen target is SpO₂ 90-95%; titrate FiO₂ to the lowest concentration that achieves the target and avoid prolonged hyperoxia.[122]
Obtain a chest radiograph when the diagnosis is uncertain, distress is severe, invasive ventilation is being considered, there is asymmetric air entry, sudden deterioration, suspected air leak, pulmonary hemorrhage, CDH, or failure to respond as expected. TTN classically produces hyperinflation, prominent perihilar interstitial markings, and fluid in the fissures; RDS produces low lung volumes with diffuse reticulogranular opacity and air bronchograms; MAS produces patchy bilateral opacities with hyperinflation; pneumonia may produce focal or diffuse air-space opacity; pulmonary hemorrhage can cause rapidly developing bilateral alveolar opacification; and pneumothorax may show hyperlucency, absent peripheral vascular markings, or a deep-sulcus sign on a supine film. Radiography is a snapshot and may not distinguish infection, aspiration, edema, or hemorrhage reliably; correlate with the time course and gas exchange.
provides bedside assessment of aeration without ionizing radiation and can be repeated during changes in support.[119] Pleural sliding argues against a significant pneumothorax at the examined location; absent sliding, a lung point, or a barcode pattern supports pneumothorax. Diffuse compact B-lines and a thickened or irregular pleural line support interstitial or alveolar disease, whereas consolidations with dynamic air bronchograms favor pneumonia or atelectasis. LUS scores have shown good discrimination for surfactant requirement in preterm RDS, with reported area under the curve values of 0.800-0.831 across four scoring protocols, but acquisition and interpretation remain operator-dependent and protocols are heterogeneous.[127] Use LUS to complement, not replace, clinical assessment, radiography, and echocardiography.
Perform echocardiography early when there is a pre- or postductal saturation difference, refractory hypoxemia, disproportionate oxygen need, a murmur, abnormal pulses, cardiomegaly, suspected CDH-associated pulmonary hypertension, or failure to improve after lung recruitment. Distinguish PPHN from structural heart disease by assessing cardiac anatomy, ventricular size and function, ductal and atrial shunt direction, tricuspid-regurgitation velocity when measurable, septal flattening, pulmonary venous return, and systemic output. Right-to-left or bidirectional ductal shunting with right-ventricular pressure overload and structurally normal great arteries supports PPHN; ductal-dependent lesions, transposition, anomalous pulmonary venous return, coarctation, and severe left-sided obstruction require disease-specific management rather than pulmonary vasodilation alone. Echocardiographic estimates can be misleading when atrial, ventricular, or ductal shunts create high pulmonary blood flow; invasive testing in reported cases showed that shunt flow, rather than pulmonary vascular resistance, was the principal driver of the apparent pulmonary hypertension.[131]
Initial support and escalation
Provide non-invasive support to a spontaneously breathing infant with respiratory distress who has adequate respiratory effort and no immediate indication for intubation. (CPAP) maintains functional residual capacity, limits alveolar collapse, supports the upper airway, and reduces work of breathing.[120] Start CPAP at 5-6 cmH₂O and adjust according to retractions, oxygen requirement, chest expansion, and gas exchange. Use an occlusive short-binasal-prong or nasal-mask interface when accurate pressure delivery is critical, particularly in very immature infants with moderate-to-severe RDS. Occlusive interfaces transmit pressure within approximately 0.5-1.0 cmH₂O of the set value, whereas non-occlusive cannula systems may underdeliver by 2-3 cmH₂O and can deliver less than 2 cmH₂O when the mouth is open.[120] Inspect the nares and septum frequently; occlusive interfaces can cause nasal injury, while loose interfaces may provide inadequate distending pressure.[120]
can be useful for selected, spontaneously breathing, more mature infants with mild disease or during weaning, but it should not delay CPAP or intubation when pressure delivery is inadequate. In an internally validated retrospective cohort, escalation from high flow to CPAP occurred in 39.8% of preterm infants, compared with CPAP failure requiring invasive ventilation in 17.4%; the models were not externally validated and cannot define bedside thresholds.[124] Treat rising FiO₂, recurrent apnea, increasing work of breathing, or hypercapnia on high flow as evidence that the infant needs more reliable distending pressure.
Use bilevel CPAP or nasal intermittent positive-pressure ventilation (NIPPV) when CPAP provides inadequate ventilatory assistance, apnea recurs, or hypercapnia develops despite preserved spontaneous breathing. NIPPV adds inflations above baseline PEEP and may reduce work of breathing and apnea; synchronization may improve physiologic outcomes, although evidence for long-term benefit remains limited.[122][123] During minimally invasive surfactant therapy, a retrospective cohort found no statistically significant difference in invasive ventilation within 72 hours between initial NIPPV and CPAP after adjustment for gestational age and birth weight; this observational result does not establish equivalence.[122]
Administer surfactant early to a preterm infant with probable RDS whose oxygen requirement and distress are increasing despite effective CPAP. A commonly used trigger is FiO₂ >0.30 on CPAP pressure ≥6 cmH₂O, interpreted alongside work of breathing, blood gas, radiograph, and LUS findings.[122] Prefer less-invasive surfactant administration (LISA/MIST) through a thin catheter while the infant remains spontaneously breathing on CPAP when an experienced operator and appropriate rescue airway capability are available. Poractant alfa is commonly given at 200 mg/kg; a repeat dose may be considered when FiO₂ remains >0.30 at approximately 6 hours or radiography shows persistent or worsening RDS, according to local protocol.[122] INSURE, intubation, surfactant administration, and rapid extubation, remains an alternative when thin-catheter administration is not feasible or the infant requires controlled ventilation. A small randomized trial in infants of 28-34 weeks suggested fewer pneumothoraces, repeat doses, and episodes of mechanical ventilation with MIST than INSURE, but the comparisons were not statistically conclusive.[121]
Intubate for ineffective spontaneous ventilation, recurrent apnea with bradycardia, severe or worsening respiratory acidosis, refractory hypoxemia despite optimized non-invasive support, exhaustion, shock attributable to respiratory failure, or a need for controlled ventilation during transport or surgery. Before intubation, correct mask or interface leak, obstruction, malposition, inadequate pressure, and poor synchrony. After intubation, confirm tube position clinically and radiographically, use a pressure-limited or volume-targeted strategy, and reassess gas exchange and hemodynamics after every major change. Avoid excessive tidal volume, high oxygen exposure, and unnecessarily prolonged ventilation because ventilator-induced injury and oxygen toxicity contribute to BPD.
Use conventional mechanical ventilation when non-invasive support fails or when airway protection and precise control of ventilation are required. Start with the lowest effective mean airway pressure and tidal volume, provide adequate PEEP to prevent derecruitment, and adjust inspiratory pressure or delivered volume to achieve acceptable pH and PaCO₂ rather than normalizing PaCO₂ aggressively. Consider volume-targeted ventilation when available; monitor for air leak, atelectasis, overdistension, hypotension, and rising oxygen requirement. Extubate as soon as respiratory drive, gas exchange, secretions, and cardiovascular stability permit, usually to CPAP or NIPPV rather than directly to low-flow oxygen in very preterm infants. Extubation failure is particularly common at lower gestational ages and identifies infants at higher risk of prolonged ventilation and BPD, although it may primarily reflect underlying disease severity rather than cause those outcomes.[2]
Use (HFOV) in selected infants with severe oxygenation failure, diffuse atelectasis, pulmonary hemorrhage, air leak, or failure of conventional ventilation despite optimized lung recruitment. Set the mean airway pressure to maintain recruitment without excessive overdistension, use a frequency appropriate to size and disease, and titrate amplitude to visible chest vibration and PaCO₂. HFOV requires close monitoring of blood pressure, lung volume, oxygenation, and carbon dioxide because excessive mean airway pressure can impair venous return and cardiac output.
Disease-directed priorities
TTN generally requires supportive oxygen and, when needed, CPAP; avoid routine intubation and repeated invasive testing when the infant is improving. CPAP may facilitate fluid clearance and reduce work of breathing, while persistent or worsening distress should prompt reconsideration of RDS, pneumonia, MAS, pneumothorax, or PPHN.[120] MAS requires careful assessment for air trapping and pulmonary hypertension; CPAP is reasonable for a spontaneously breathing infant with mild-to-moderate disease, but severe obstruction, hyperinflation, acidosis, or exhaustion warrants intubation and controlled ventilation. Do not routinely suction the trachea solely because meconium was present; ventilate according to the infant’s physiology.
For suspected pneumonia, obtain blood cultures and relevant microbiology while providing respiratory support, but do not allow diagnostic sampling to delay oxygenation or ventilation. Consolidation, air bronchograms, temperature instability, apnea, and worsening gas exchange support the diagnosis, but radiography cannot reliably distinguish pneumonia from aspiration or atelectasis. Pulmonary hemorrhage presents with abrupt oxygenation failure, falling hemoglobin, bloody airway secretions, and new diffuse opacities; stabilize the airway, increase PEEP cautiously to tamponade alveolar bleeding, correct coagulopathy when present, and use ventilation that avoids high shear and overdistension.
Treat pneumothorax according to physiology, not radiographic size. A stable infant may be observed with close monitoring and serial imaging; tension physiology, rapidly worsening oxygenation, hypotension, or severe respiratory distress requires immediate needle aspiration followed by chest drainage when ongoing air leak is likely. Reduce excessive distending pressure and reassess tube position and unilateral ventilation after every acute deterioration.
In CDH, avoid mask ventilation because gastric and intestinal inflation further compresses the hypoplastic lung. Intubate early, insert an orogastric tube for continuous decompression, and use gentle ventilation with permissive hypercapnia and the lowest pressures that achieve adequate oxygenation. Echocardiography is required to characterize pulmonary hypertension, ventricular function, and associated cardiac lesions; CDH physiology is dynamic, and pulmonary hypoplasia, pulmonary vascular disease, and cardiac dysfunction may coexist.[132]
BPD is an evolving disorder of immature lung structure, inflammation, ventilator injury, and abnormal pulmonary vascular development. Minimize invasive ventilation, use effective non-invasive distending pressure, avoid both hypoxemia and hyperoxemia, and investigate a new oxygen increase for atelectasis, infection, airway obstruction, pulmonary edema, or pulmonary hypertension. BPD-associated pulmonary hypertension reflects impaired angiogenesis, reduced pulmonary vascular surface area, alveolar simplification, and possible right-ventricular-pulmonary-artery uncoupling; sildenafil may improve short-term hemodynamics in selected infants, but neonatal evidence does not establish durable vascular remodeling or survival benefit.[135]
Apnea requires immediate assessment of airway patency, respiratory effort, oxygenation, temperature, glucose, infection risk, anemia, seizures, and intracranial disease. Caffeine citrate is commonly loaded at 20 mg/kg intravenously or orally, followed by 5-10 mg/kg once daily; the optimal route and frequency remain uncertain in the available trial evidence.[100] Escalate from low-flow oxygen to CPAP or NIPPV when obstruction, recurrent desaturation, or apnea persists. Intubate when apnea causes repeated bradycardia or cannot be controlled with stimulation, caffeine, and non-invasive support.
PPHN presenting as respiratory failure requires correction of hypoxemia, acidosis, hypothermia, atelectasis, and excessive intrathoracic pressure while the underlying lung disease is treated. Optimize lung recruitment with CPAP or ventilation, maintain preductal oxygenation in the locally accepted target range, and confirm the diagnosis and ventricular function by echocardiography before pulmonary vasodilator therapy. Inhaled nitric oxide is most useful for hypoxemic respiratory failure with echocardiographic evidence of significant pulmonary hypertension and adequate lung recruitment; reassess response and avoid indiscriminate use when structural heart disease or severe left-ventricular dysfunction is present. Magnesium sulfate is not routine therapy: a 2026 scoping review found insufficient evidence, with small studies reporting hypotension, bradycardia, and increased inotropic requirements.[133] Consider transfer for extracorporeal membrane oxygenation (ECMO) when severe, potentially reversible respiratory or pulmonary vascular failure persists despite optimized ventilation, oxygenation, pulmonary vasodilation, and hemodynamic support, provided the infant meets the receiving center’s gestational-age, weight, reversibility, and bleeding-risk criteria.
| disorder | characteristic findings | diagnostic tests | initial support | escalation or rescue therapy | major complication |
|---|---|---|---|---|---|
| TTN | Early tachypnea, mild retractions, usually modest oxygen need; commonly resolves within 24-72 h | Chest radiography; LUS; blood gas if worsening | Oxygen; CPAP 5-6 cmH₂O if distress persists | Bilevel CPAP/NIPPV or intubation if worsening, hypercapnia, apnea, or an alternative diagnosis emerges | Pneumothorax; misdiagnosed RDS, pneumonia, MAS, or PPHN |
| RDS | Preterm infant with progressive retractions, grunting, oxygen need, low-volume reticulogranular lungs | Blood gas; chest radiography; LUS; echocardiography if hypoxemia is disproportionate | CPAP 5-6 cmH₂O; titrated oxygen | LISA/MIST with poractant alfa 200 mg/kg; NIPPV; intubation and lung-protective ventilation | Air leak; pulmonary hemorrhage; BPD |
| MAS | Term or post-term infant, meconium exposure, patchy opacities, hyperinflation, air trapping | Chest radiography; blood gas; LUS; echocardiography for PPHN | Oxygen or CPAP if spontaneous breathing is adequate | NIPPV or conventional ventilation; HFOV for severe oxygenation failure; inhaled nitric oxide when PPHN is confirmed | PPHN; pneumothorax; air trapping |
| Pneumonia | Respiratory distress with focal or diffuse opacity, apnea, temperature instability, or progressive oxygen need | Blood culture and microbiology; chest radiography; blood gas; LUS | Oxygen, CPAP, or NIPPV according to work of breathing | Intubation and ventilation for acidosis, apnea, or refractory hypoxemia | Sepsis; air leak; pulmonary hypertension |
| Pneumothorax | Sudden deterioration, asymmetric air entry, increased oxygen need, hypotension if tension physiology | Transillumination or LUS; chest radiography if stable enough | Observation only if clinically stable; reduce excessive distending pressure | Immediate needle aspiration for tension physiology; chest drainage for ongoing or recurrent air leak | Tension physiology; cardiovascular collapse |
| Pulmonary hemorrhage | Abrupt hypoxemia, bloody airway secretions, falling hemoglobin, new diffuse opacities | Hemoglobin and coagulation studies; chest radiography; blood gas | Airway stabilization; CPAP or ventilation with cautious PEEP | Intubation, increased PEEP when appropriate, HFOV for refractory failure, correction of coagulopathy | Severe hypoxemia; airway obstruction; shock |
| BPD | Persistent oxygen or respiratory-support requirement in a very preterm infant; recurrent atelectasis or oxygen lability | Serial clinical assessment; chest radiography or LUS; echocardiography for pulmonary hypertension | Lung-protective ventilation; CPAP/NIPPV; carefully titrated oxygen | Reassess for airway disease, edema, atelectasis, or PPHN; selected pulmonary vasodilator therapy | BPD-associated pulmonary hypertension; prolonged ventilation |
| CDH | Scaphoid abdomen, asymmetric breath sounds, bowel in thorax, severe hypoxemia, pulmonary hypoplasia | Prenatal/postnatal radiography; echocardiography; blood gas | Immediate intubation, gastric decompression, gentle ventilation | HFOV, inhaled nitric oxide for selected PPHN physiology, ECMO in selected centers | Pulmonary hypertension; ventricular dysfunction; air leak |
| Apnea of prematurity | Recurrent pauses with bradycardia or desaturation in a preterm infant after exclusion of other causes | Continuous cardiorespiratory monitoring; blood gas and targeted evaluation for infection, glucose, anemia, seizures, or airway obstruction | Stimulation, airway positioning, caffeine; CPAP if obstruction or desaturation persists | NIPPV for recurrent events; intubation for uncontrolled apnea with bradycardia | Hypoxemic injury; aspiration; missed infection or neurologic disease |
| PPHN | Labile hypoxemia, pre- to postductal saturation difference, right-to-left shunting, respiratory failure disproportionate to radiography | Pre- and postductal SpO₂; echocardiography; blood gas; chest radiography/LUS | Optimize lung recruitment, oxygenation, ventilation, temperature, and acid-base status | Inhaled nitric oxide after echocardiographic assessment; HFOV; ECMO in selected centers | Right-ventricular failure; systemic hypoperfusion; neurologic injury |
Pearl: Escalate respiratory support when the infant’s work of breathing, oxygen requirement, PaCO₂, acidosis, apnea, or hemodynamics worsen despite an adequately fitted interface and optimized lung recruitment; never substitute a higher device setting for a reassessment of the diagnosis.
Neonatal Cardiovascular Disease, Ductal Circulation, and Shock
- ▸When ductal-dependent congenital heart disease is plausible in a deteriorating neonate, start intravenous alprostadil at 0.01 microgram/kg/min and titrate to oxygenation or systemic perfusion without waiting for definitive echocardiographic labeling.
- ▸Obtain urgent transthoracic echocardiography for persistent cyanosis, shock, differential pulses, unexplained acidosis, or disproportionate oxygen need to define anatomy, ductal flow, mixing, ventricular function, outflow obstruction, and pulmonary venous drainage.
- ▸A preductal-postductal saturation gradient or an arm-leg blood-pressure difference is only a clue: a small or absent gradient does not exclude PPHN or structural heart disease, and a normal arm-leg difference does not exclude neonatal coarctation while the ductus remains open.
Central cyanosis, weak pulses, prolonged capillary refill, hypotension, metabolic acidosis, or an unexpected oxygen-saturation pattern should be treated as possible cardiovascular failure until circulation has been defined. A normal chest examination does not exclude critical congenital heart disease (CHD), and a murmur may be absent when pulmonary or systemic blood flow is severely reduced. Assess color, respiratory effort, mental state, temperature, capillary refill, urine output, liver size, precordial activity, heart sounds, femoral and brachial pulses, and blood pressure repeatedly; compare the right-hand (preductal) saturation with a foot (postductal) saturation. A saturation gradient is a clue to differential ductal shunting, not a diagnosis: a small or absent gradient does not exclude (PPHN) or structural heart disease.
Recognizing the circulation that is failing
The central question is whether the ductus arteriosus is supplying the lungs, the systemic circulation, or neither. In ductal-dependent pulmonary circulation, pulmonary blood flow falls when the ductus constricts; cyanosis is prominent, the cardiac examination may be quiet, and the lungs may be relatively clear. In ductal-dependent systemic circulation, left-sided obstruction limits output to the descending aorta; the infant develops poor perfusion, metabolic acidosis, oliguria, and often shock as the ductus closes. Femoral pulses may be weak or absent, but they can remain palpable early, particularly when ductal flow is still present. A right-arm-to-leg pressure difference supports arch obstruction, but a normal difference does not exclude coarctation in a neonate whose ductus remains open.
PPHN produces right-to-left shunting across the ductus and/or foramen ovale. The usual bedside pattern is labile hypoxemia, a preductal saturation higher than the postductal saturation, and hypoxemia disproportionate to the radiographic lung disease. The gradient may fluctuate or disappear when shunting is predominantly atrial, when right- and left-sided pressures are similar, or when pulmonary venous obstruction or mixing physiology is present. In preterm infants, pulmonary hypertension is heterogeneous and treatment should be guided by serial functional echocardiography and the underlying physiologic phenotype; randomized trials have not shown that inhaled nitric oxide reduces mortality or bronchopulmonary dysplasia in this population, and concern remains about severe intraventricular hemorrhage [140].
A loud murmur suggests turbulent flow but does not measure cardiac output. A harsh systolic murmur may accompany critical ; a continuous murmur may reflect a patent ductus; a single loud second heart sound raises concern for pulmonary hypertension; and a gallop, hepatomegaly, or poor pulses suggests ventricular failure or obstruction. Transposition of the great arteries may have little or no murmur because the principal lesion is parallel rather than obstructed flow. In a retrospective cohort of prenatally diagnosed d-transposition, restrictive interatrial communication identified neonates requiring balloon atrial septostomy for inadequate intercirculatory mixing [141].
Immediate evaluation
Obtain simultaneous right-hand and foot pulse oximetry, an electrocardiogram, four-limb blood pressures, bedside glucose, blood gas with lactate, and cross-matched blood when shock is severe. Trend lactate rather than interpreting a single value: persistent or rising lactate indicates inadequate oxygen delivery despite an apparently acceptable blood pressure. Lactate can support recognition of hypoxic-ischemic injury, but it is not specific for cardiac shock; early postnatal lactate showed high discriminative performance for hypoxic-ischemic encephalopathy in one retrospective term-neonate case-control study, a finding that should not be extrapolated as a cardiac diagnostic threshold [148].
Perform urgent transthoracic whenever cyanosis, shock, differential pulses, unexplained acidosis, or disproportionate oxygen need persists. Define cardiac anatomy, ductal patency and direction of flow, atrial-level mixing, ventricular function, outflow obstruction, arch continuity, pulmonary venous drainage, estimated pulmonary pressure, and pericardial effusion. Bedside functional echocardiography can answer the immediate hemodynamic questions, ventricular filling, contractility, shunt direction, and systemic blood-flow surrogates, but it does not replace a comprehensive study by pediatric cardiology. Pulmonary-artery acceleration time has some association with catheterization-derived pulmonary pressure and pulmonary vascular resistance in infants, although agreement for severity was only fair; use it as an adjunct, not as a stand-alone diagnosis [143].
Use four-limb blood pressure as a screening maneuver, not as a rule-out test. A lower leg pressure than the arm, diminished femoral pulses, or a delayed femoral upstroke supports or another arch obstruction. Reassess after stabilization because low cardiac output, cuff size, crying, and an open ductus can obscure the gradient. Prenatal arch predictors remain imperfect: in one multicenter diagnostic cohort of fetuses with suspected coarctation, a multiparametric model had an area under the ROC curve of 0.749, with sensitivity 84.1% and specificity 54.2% at a predicted-probability cutoff of 0.45 [142].
An electrocardiogram helps identify tachyarrhythmia, bradyarrhythmia, atrioventricular block, ventricular hypertrophy, ischemia, and electrolyte-related abnormalities, but a normal neonatal ECG does not exclude critical CHD. Obtain chest radiography when lung disease, pulmonary edema, pneumothorax, or abnormal cardiac position is part of the differential; do not delay prostaglandin or echocardiography for imaging.
Distinguishing urgent cardiac diagnoses
The practical differential is summarized below. These are physiologic categories: one anatomical lesion may occupy more than one category, and mixed lesions can produce misleading findings.
| Presentation | Likely mechanism | Urgent test | Immediate stabilization | Definitive intervention | Danger of delay |
|---|---|---|---|---|---|
| Profound cyanosis with relatively clear lungs, weak response to oxygen, or progressive cyanosis as the ductus closes | Ductal-dependent pulmonary circulation from pulmonary atresia, critical pulmonary stenosis, or severe right-sided obstruction | Echocardiography defining pulmonary blood flow, ductal patency, and atrial mixing | Start infusion; secure airway if apnea or exhaustion develops; avoid unnecessary reduction in pulmonary vascular resistance before anatomy is known | Catheter or surgical restoration of pulmonary blood flow, tailored to anatomy | Rapid loss of pulmonary blood flow, severe hypoxemia, acidosis, and arrest |
| Shock, metabolic acidosis, weak femoral pulses, oliguria, or differential arm-leg pressure | Ductal-dependent systemic circulation from critical left-sided obstruction, arch obstruction, or hypoplastic left heart physiology | Echocardiography of the left ventricle, aortic valve, arch, ductus, and coronary perfusion; four-limb pressure comparison | Start ; support ventilation without excessive mean airway pressure; correct hypoglycemia, hypothermia, and significant hypovolemia; use vasoactive support guided by ventricular function | Catheter intervention, surgical arch repair, balloon aortic valvuloplasty, or staged palliation | Ductal closure causes sudden systemic hypoperfusion, coronary ischemia, acidosis, and death |
| Severe cyanosis with pulmonary edema, respiratory distress, or shock; postductal and preductal saturations may be similar | Obstructed total anomalous pulmonary venous return, causing pulmonary venous hypertension and restricted systemic output | Immediate echocardiography focused on pulmonary venous confluence, drainage, and obstruction | Intubate and ventilate if necessary; avoid indiscriminate fluid loading; maintain systemic perfusion and obtain emergent cardiac surgical review | Urgent surgical relief of pulmonary venous obstruction | Pulmonary edema, profound hypoxemia, pulmonary hypertensive crisis, and cardiovascular collapse |
| Marked cyanosis with little murmur and relatively preserved pulses; severe deterioration when atrial mixing is restrictive | d- with parallel circulations and inadequate mixing | Echocardiography of atrial communication, ductus, ventricular function, and coronary anatomy | Start to support ductal mixing; correct hypoxemia and acidosis; urgent balloon atrial septostomy when atrial communication is restrictive | Arterial switch operation after stabilization | Inadequate mixing causes profound hypoxemia, acidosis, myocardial injury, and death |
| Shock after apparent early stability, weak femoral pulses, arm-leg pressure difference, or unexplained acidosis | or interrupted arch with progressive ductal closure | Echocardiography of the arch and ductus; four-limb blood pressures | Start ; support systemic perfusion and avoid treating the pressure number alone | Surgical arch repair, with catheter treatment reserved for selected circumstances | Renal, intestinal, myocardial, and cerebral ischemia as ductal flow falls |
| Labile hypoxemia, preductal saturation higher than postductal, loud second heart sound, and relatively normal cardiac anatomy | PPHN with right-to-left ductal or atrial shunting | Echocardiography confirming pulmonary pressure, shunt direction, ventricular function, and exclusion of structural CHD | Optimize lung recruitment and ventilation, oxygenation, temperature, glucose, analgesia, and systemic perfusion; consider inhaled nitric oxide after echocardiographic confirmation in an appropriate infant | Treat the underlying pulmonary or systemic disease; escalate pulmonary vasodilator and cardiac support according to phenotype | Persistent hypoxemia, right-ventricular failure, low left-ventricular preload, acidosis, and multiorgan injury |
Start intravenous alprostadil when ductal-dependent CHD is plausible; do not wait for a definitive echocardiographic label if the infant is deteriorating. A practical initial infusion is 0.01 microgram/kg/min, titrated to oxygenation or systemic perfusion while watching for apnea, fever, flushing, and hypotension. Higher doses may be required in severe ductal constriction; a retrospective cohort of critical aortic stenosis used 0.05-0.1 microgram/kg/min until balloon valvuloplasty [144]. Establish reliable venous access, but do not delay infusion while pursuing central access. Bolus alprostadil is a rescue treatment for acute ductal spasm during catheterization rather than routine neonatal therapy; a three-patient case series reported improved ductal flow but transient hypotension in two infants [138].
Circulatory support
Give a fluid bolus only when clinical examination, ultrasound, blood loss, or preload assessment supports hypovolemia. Use 10 mL/kg of isotonic crystalloid over 20-30 minutes, then reassess capillary refill, pulses, hepatomegaly, lung findings, urine output, lactate, and ventricular filling. Repeat cautiously; excessive volume worsens pulmonary edema, atrioventricular valve regurgitation, and ventricular failure, especially in obstructed pulmonary venous return or myocardial dysfunction. If blood loss is suspected, use appropriately cross-matched blood rather than repeated crystalloid.
Use vasoactive drugs to correct a defined physiologic deficit, not simply to normalize a blood-pressure reading. Dopamine increases vascular tone and may raise blood pressure when vasoplegia predominates, but tachycardia and increased afterload can worsen ventricular dysfunction. Dobutamine is more useful when contractility and forward flow are low with adequate vascular tone, although hypotension may follow. Epinephrine provides inotropy and vasoconstriction for severe low-output shock or impending arrest; norepinephrine is most useful when profound vasodilation and low systemic vascular resistance limit coronary and systemic perfusion. Milrinone reduces afterload and provides inodilator and lusitropic effects, but can worsen hypotension; reserve it for selected ventricular dysfunction or pulmonary-vascular phenotypes after adequate systemic pressure is established. Neonatal dosing and outcome evidence remain limited: cardiotonic drugs continue to be used without sufficient evidence about dosing, safety, efficacy, and long-term effects [137].
Begin with one agent at a low dose, reassess within minutes, and titrate against perfusion, lactate clearance, urine output, echocardiographic function, and the suspected lesion. Avoid escalating several agents without repeating echocardiography; a high vasoactive requirement may signify unrecognized obstruction, inadequate mixing, ventricular failure, pulmonary hypertension, or excessive shunt. In a retrospective cohort of preterm infants with early pulmonary hypertension, a maximum vasoactive-inotropic score of at least 20 was associated with higher mortality, but this is a prognostic association rather than a treatment threshold [146].
Treat arrhythmias according to mechanism and hemodynamic effect. For unstable supraventricular tachycardia, provide synchronized cardioversion; for stable narrow-complex tachycardia, vagal maneuvers are followed by rapid intravenous when appropriate. Correct hypoxemia, acidosis, hypoglycemia, hypocalcemia, and electrolyte abnormalities. Obtain specialist advice before administering amiodarone, procainamide, or beta-blockade because ventricular function, accessory pathways, and ductal physiology alter risk. Symptomatic bradycardia or high-grade atrioventricular block requires urgent pediatric cardiology involvement and may require temporary pacing.
Oxygen, ventilation, and escalation
Use the minimum oxygen concentration that corrects clinically significant hypoxemia while avoiding hyperoxia. In PPHN, oxygen lowers pulmonary vascular resistance, but excessive oxygen and injurious ventilation can worsen lung injury and systemic hemodynamics. Ventilate to correct severe acidosis and hypoxemia while preserving venous return; excessive mean airway pressure can reduce preload and worsen systemic output in ductal-dependent lesions. Inhaled nitric oxide should follow echocardiographic confirmation of significant PPHN and adequate lung recruitment; its benefit is established in selected term infants, whereas evidence in preterm pulmonary hypertension remains controversial [139][140]. Do not use nitric oxide as a substitute for identifying obstructed pulmonary venous return, transposition with restrictive mixing, or ductal-dependent systemic obstruction.
Call pediatric cardiology immediately for persistent central cyanosis, shock, differential pulses, unexplained acidosis, abnormal ECG, suspected ductal-dependent circulation, or an abnormal echocardiographic screening study. Transfer to a cardiac center with neonatal intensive care, echocardiography, catheterization, surgery, and mechanical circulatory support when the required intervention cannot be provided locally. Discuss extracorporeal membrane oxygenation (ECMO) early when shock or hypoxemic failure remains refractory despite correction of anatomy-dependent physiology, ventilation, oxygenation, preload, and vasoactive support. ECMO is a bridge, not definitive treatment; it is particularly time-sensitive when pulmonary venous obstruction, transposition with inadequate mixing, or severe ventricular failure is suspected. In lethal neonatal pulmonary vascular disorders such as alveolar capillary dysplasia with misaligned pulmonary veins, ECMO may support selected infants toward lung transplantation, but medical therapy alone is not curative [155].
Pearl: In a deteriorating neonate with cyanosis or shock, start by asking which circuit the ductus is supporting, begin alprostadil when that answer is uncertain, and obtain echocardiography before escalating treatment that could worsen the physiology.
Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders
- ▸A plasma glucose below 2.6 mmol/L (47 mg/dL) is a commonly used operational threshold; treat symptomatic, unable-to-feed, or persistent hypoglycemia with intravenous 10% dextrose, using 2 mL/kg (200 mg/kg) as a practical rescue dose.
- ▸Use total serum bilirubin, plotted by postnatal age, gestational age, and neurotoxicity risk factors, for phototherapy and exchange-transfusion decisions; transcutaneous measurements should not replace TSB during phototherapy.
- ▸Conjugated hyperbilirubinemia warrants evaluation when direct bilirubin is above 1 mg/dL with TSB 5 mg/dL or less, or above 20% of TSB when TSB exceeds 5 mg/dL.],
Glucose, electrolyte, renal, hematologic, and bilirubin abnormalities often arise from the same physiology: prematurity limits glycogen and mineral stores, illness alters perfusion and hormone responses, and feeding failure changes both substrate delivery and free-water balance. Interpret each result against gestational age, postnatal age, weight trajectory, intake, urine output, perfusion, and the clinical examination rather than treating an isolated laboratory value.
Glucose disorders
Screen infants who are small or large for gestational age, infants of diabetic mothers, late-preterm infants, those with perinatal stress or hypothermia, and newborns who are poorly feeding, tremulous, apnoeic, lethargic, hypotonic, or seizing. A plasma glucose concentration below 2.6 mmol/L (47 mg/dL) is a commonly used operational threshold, although no single concentration reliably separates injury from safety. Antenatal corticosteroids increase the risk of neonatal hypoglycemia, particularly during the first 24 hours and when delivery occurs within 7 days of treatment [45].
Confirm a low bedside result with a laboratory plasma glucose when feasible, but do not delay treatment for a symptomatic infant. Feed promptly if the infant is alert and able to feed; buccal 40% dextrose gel, 0.5 mL/kg (200 mg/kg), is useful for selected asymptomatic infants who can safely receive enteral treatment. Give intravenous 10% dextrose for symptoms, inability to feed, or persistent/recurrent hypoglycemia. A practical rescue dose is 2 mL/kg of 10% dextrose (200 mg/kg), followed by a continuous infusion; the cited neonatal protocol used this bolus for glucose below 25 mg/dL [45]. Recheck glucose after treatment and adjust the glucose infusion rate in small increments, commonly 0.5-1 mg/kg/min, while investigating ongoing hypoglycemia for excess insulin, inadequate substrate delivery, endocrine disease, or metabolic disease.
Avoid both untreated hypoglycemia and reflexive overcorrection. Hyperglycemia is frequent in very preterm or critically ill infants because insulin secretion and tissue sensitivity are immature, while exogenous glucose, stress hormones, and reduced renal glucose handling increase plasma glucose. Review the glucose infusion rate, eliminate unnecessary glucose-containing infusions, and treat the underlying stress before using insulin. The available neonatal cohort used an alarm threshold above 180 mg/dL, reduced the glucose infusion rate first, and reserved insulin for persistent hyperglycemia [45]. Continuous glucose monitoring can detect silent excursions, but interstitial values require confirmation before major therapeutic changes; formal NICU-wide recommendations remain absent [45].
Electrolyte and acid-base disorders
Measure sodium, potassium, chloride, bicarbonate, calcium, magnesium, phosphate, glucose, urea, and creatinine when an infant has poor intake, abnormal weight change, oliguria, seizures, arrhythmia, respiratory deterioration, shock, or unexplained lethargy. Obtain an ionized calcium when symptoms are acute or albumin is abnormal. Correct calcium, sodium, and potassium abnormalities gradually unless there is a life-threatening arrhythmia or seizure, because rapid shifts can cause neurologic or cardiac injury.
Hypocalcemia is common in preterm infants, infants of diabetic mothers, growth-restricted infants, and newborns with birth asphyxia or severe illness. Treat symptomatic hypocalcemia, seizures, tetany, laryngospasm, or arrhythmia, with 10% calcium gluconate 100 mg/kg (1 mL/kg, providing approximately 0.22 mmol/kg of elemental calcium) intravenously over 10 minutes with continuous cardiac monitoring. Do not give calcium through an arterial line, and stop immediately if extravasation occurs. For persistent or asymptomatic hypocalcemia, provide enteral or intravenous replacement according to the measured ionized calcium and local protocol, and check magnesium because hypomagnesemia can make hypocalcemia refractory.
Hypomagnesemia may cause tremor, irritability, weakness, seizures, or arrhythmia and may accompany hypocalcemia. Give magnesium sulfate only after confirming the concentration and assessing renal function; a commonly used symptomatic dose is 25-50 mg/kg intravenously, with repeat dosing guided by magnesium concentration and the electrocardiogram. Phototherapy may lower measured magnesium and calcium, but the evidence is a single-center prospective before-after study of 100 infants, so routine supplementation solely because phototherapy has started is not justified [157].
Treat hyperkalemia as an emergency when there are electrocardiographic changes, rapidly rising potassium, or a markedly elevated confirmed serum value. Repeat a non-haemolysed sample, stop potassium administration, place the infant on continuous ECG monitoring, and stabilize the myocardium with intravenous calcium gluconate when ECG changes are present. Shift potassium intracellularly with insulin plus glucose or nebulized beta-agonist according to local protocol; remove potassium with diuresis, exchange therapy, or dialysis when renal failure or refractory hyperkalemia persists. For hyponatremia, distinguish excess free water from sodium loss before replacing sodium. For hypernatremia, restore circulating volume first if perfusion is poor, then replace free-water deficit slowly with frequent sodium checks.
Metabolic acidosis reflects excess acid generation, impaired renal excretion, bicarbonate loss, or inadequate perfusion. Obtain a blood gas, lactate, glucose, electrolytes, renal indices, and, when indicated, ammonia and ketones. Correct ventilation, oxygen delivery, perfusion, temperature, and the cause of bicarbonate loss before giving sodium bicarbonate. Reserve bicarbonate for selected severe metabolic acidosis after adequate ventilation and perfusion have been restored; indiscriminate administration increases sodium load and carbon dioxide generation.
Renal function, oliguria, and fluid balance
Assess fluid balance from serial weight, prescribed and delivered intake, urine output, stool and gastric losses, insensible losses, serum sodium, urea, creatinine, bicarbonate, perfusion, and examination for edema or dehydration. Record urine output hourly in unstable infants and use the same weighing method each day. Urine output during the first 24 hours is variable and does not by itself establish renal failure; oliguria must be interpreted alongside perfusion, creatinine trajectory, and fluid exposure.
Suspect after hypotension, hypoxemia, nephrotoxic exposure, major surgery, renal or urinary tract obstruction, or a rising creatinine. The neonatal Kidney Disease: Improving Global Outcomes framework classifies injury by changes in serum creatinine and urine output, but creatinine is delayed and influenced by maternal creatinine, gestational age, muscle mass, and fluid dilution. Urinary neutrophil gelatinase-associated lipocalin is promising, yet its baseline concentration varies with gestational age, birth weight, and sex; it should not be interpreted without population-appropriate reference ranges [168].
Investigate persistent oliguria with examination of perfusion and bladder, a catheter assessment when appropriate, renal and bladder ultrasonography, urinalysis, urine sodium and creatinine, and review of all medications and infusions. Relieve obstruction promptly. A distended abdomen, respiratory deterioration, ascites, and falling urine output should raise concern for urinary extravasation or bladder perforation in an extremely preterm infant, particularly after umbilical arterial catheterization or repeated catheterization [169]. Consult neonatology-nephrology or urology for persistent oliguria, progressive creatinine rise, refractory electrolyte or acid-base disturbance, suspected obstruction, or anticipated dialysis.
Use isotonic fluid boluses only when hypovolemia is supported by the clinical picture; 10 mL/kg over 20-30 minutes with reassessment is a practical neonatal approach [context]. Do not treat oliguria with repeated fluid loading when the infant is edematous or pulmonary function is worsening. Restrict fluid when there is clinically significant overload, adjust all drug doses to renal function, and involve a renal replacement service for refractory hyperkalemia, severe acidosis, symptomatic uremia, or fluid overload that prevents adequate respiratory or nutritional care.
Hematologic disorders
Interpret haemoglobin and haematocrit against gestational and postnatal age, sampling site, hydration, and transfusion history. Anaemia may result from phlebotomy, haemolysis, blood loss, reduced erythropoiesis, or prematurity. Investigate with reticulocyte count, smear, bilirubin fractions, lactate dehydrogenase, haptoglobin when interpretable, blood group, and direct antiglobulin testing. Transfuse packed red cells when anaemia is accompanied by hypoxemia, tachycardia, poor perfusion, recurrent apnoea, inadequate growth, or significant respiratory support, not solely to normalize a number. Use irradiated, leukoreduced, cytomegalovirus-safe, antigen-compatible blood according to institutional policy, and give the smallest volume that achieves the clinical goal, commonly 10-15 mL/kg, with reassessment.
Packed-cell transfusion decisions in very-low-birth-weight infants remain individualized. A retrospective cohort found no independent association between transfusion and necrotizing enterocolitis after adjustment, while sepsis was the significant associated variable; this observational result does not prove that transfusion is risk-free [12]. Minimize phlebotomy, coordinate blood sampling, and consider aliquoted donor units. Transfusion may accelerate the postnatal fall in fetal haemoglobin in infants born before 30 weeks, although the clinical consequences and optimal fetal-haemoglobin-preserving strategy remain uncertain [166].
Polycythemia is usually defined by a venous haematocrit of at least 65%. Confirm a high capillary result with venous blood because capillary haematocrit overestimates venous values. Assess hydration, glucose, calcium, bilirubin, perfusion, respiratory status, and neurologic findings. Treat symptomatic hyperviscosity with partial exchange using isotonic saline under specialist supervision; avoid routine exchange for an asymptomatic infant without substantial venous haematocrit elevation.
Thrombocytopenia requires confirmation on a smear and assessment of bleeding, sepsis or inflammation, placental insufficiency, necrotizing enterocolitis, congenital infection, maternal immune thrombocytopenia, and fetal/neonatal alloimmune thrombocytopenia. Give platelet transfusion for active bleeding, urgent invasive procedures, or a very low count according to local threshold and clinical context; prophylactic transfusion thresholds are lower in stable infants than in those with bleeding or major intracranial risk. A before-after study found a statistically significant platelet decline after phototherapy, but its single-center design does not establish that phototherapy causes clinically important bleeding [157].
Prolonged bleeding, bruising, pulmonary or gastrointestinal haemorrhage, shock, or abnormal coagulation tests require urgent evaluation with prothrombin time, activated partial thromboplastin time, fibrinogen, platelet count, blood film, and liver assessment. Suspect when thrombocytopenia, prolonged clotting times, low fibrinogen, elevated fibrin degradation products, and clinical bleeding accompany shock, severe hypoxia, infection, liver injury, or tissue necrosis. Treat the cause and replace red cells, platelets, fibrinogen, or plasma only for bleeding or an invasive procedure; laboratory correction alone is not an indication for plasma.
Haemolysis and bilirubin disorders
Unconjugated hyperbilirubinemia results from bilirubin production exceeding hepatic uptake and conjugation. Haemolysis from Rh or ABO incompatibility, glucose-6-phosphate dehydrogenase deficiency, hereditary red-cell disorders, bruising, or occult blood loss increases production; prematurity and poor feeding reduce clearance and enterohepatic elimination. Obtain maternal and infant blood groups, direct antiglobulin testing, total serum bilirubin (TSB), haemoglobin, reticulocytes, and smear when jaundice is early, rapidly rising, severe, or accompanied by anaemia. G6PD deficiency is an oxidant-protection defect that causes episodic haemolysis, sometimes triggered by infection, and female heterozygotes may be missed [161]. Avoid oxidant drugs and substances when deficiency is known or strongly suspected; a normal test during acute haemolysis may require later confirmation.
Measure bilirubin with a transcutaneous device for screening when validated locally, but use TSB for treatment decisions and whenever the level is near a treatment threshold, the infant is receiving phototherapy, or jaundice is early or rapidly progressive. Total serum bilirubin remains the reference standard for guiding phototherapy, whereas smartphone tools have mainly been validated before phototherapy [158]. During phototherapy, non-invasive readings may track direction of change but should not replace TSB because correlation weakens during treatment [158].
Plot TSB against postnatal age in hours, gestational age, and neurotoxicity risk factors, particularly haemolysis, sepsis, albumin deficiency, clinical instability, and prematurity, using the current local hour-specific treatment nomogram. Start intensive when TSB reaches the applicable threshold; maximize exposed skin, use a measured irradiance device, protect the eyes, maintain temperature, support feeding, and monitor hydration. Recheck TSB according to the starting distance from the threshold and rate of rise, with earlier measurement when haemolysis is suspected. Phototherapy converts unconjugated bilirubin into water-soluble photoisomers that can be excreted in bile and urine [157].
Escalate urgently for a TSB approaching the exchange-transfusion threshold, rapid rise despite intensive phototherapy, acute bilirubin encephalopathy, or haemolysis with anaemia. Prepare compatible blood, intensive phototherapy, cardiorespiratory monitoring, and a neonatal transfusion team. Perform double-volume exchange transfusion when the age-specific threshold is reached or when clinical encephalopathy demands it. In isoimmune haemolysis, intravenous immunoglobulin 0.5-1 g/kg may be considered when bilirubin continues to rise despite intensive phototherapy and is approaching the exchange threshold; evidence is limited and potential benefit must be weighed against adverse effects and the need not to delay exchange transfusion.
Conjugated hyperbilirubinemia is never physiologic. Measure direct or conjugated bilirubin in any infant with jaundice persisting beyond 2 weeks, pale stools, dark urine, hepatomegaly, poor growth, or illness; investigate sooner when jaundice appears in the first day or the infant is unwell. A direct bilirubin above 1 mg/dL when TSB is 5 mg/dL or less, or above 20% of TSB when TSB exceeds 5 mg/dL, warrants evaluation for cholestasis. Check liver enzymes, gamma-glutamyl transferase, albumin, glucose, coagulation, urine culture, infection testing when indicated, abdominal ultrasonography, and metabolic testing; examine stool colour directly. Promptly consult paediatric gastroenterology or hepatobiliary surgery for acholic stools, rising conjugated bilirubin, suspected biliary atresia, or unexplained persistent cholestasis. Early recognition matters because Kasai portoenterostomy before 60 days is associated with better outcomes in biliary atresia, although evidence for the rare combination with intestinal atresia comes from case reports and retrospective series [167].
| disorder | high-risk population | diagnostic threshold or test | immediate treatment | monitoring | consultation criterion |
|---|---|---|---|---|---|
| Hypoglycemia | SGA, LGA, infant of diabetic mother, late-preterm, stressed or poorly feeding infant | Operational threshold commonly <2.6 mmol/L (47 mg/dL); confirm with plasma glucose | Feed or give buccal dextrose gel if safe; symptomatic, severe, or persistent cases require IV 10% dextrose; 2 mL/kg was used for <25 mg/dL in one neonatal protocol [45] | Repeat glucose after intervention; monitor intake, temperature, neurologic status, and glucose infusion rate | Recurrent episodes, need for high glucose delivery, seizures, or suspected hyperinsulinism/metabolic disease |
| Hyperglycemia | Very preterm or critically ill infant, recent corticosteroid exposure, high glucose infusion | Confirm persistent elevation; one neonatal protocol used >180 mg/dL as an alarm threshold [45] | Reduce excessive glucose delivery; treat stress; reserve insulin for persistent hyperglycemia | Serial plasma or confirmed bedside glucose; electrolytes and fluid balance | Persistent hyperglycemia despite appropriate glucose reduction or suspected endocrine/metabolic disease |
| Hypocalcemia or hypomagnesemia | Preterm, SGA, infant of diabetic mother, asphyxia, severe illness, phototherapy exposure | Ionized calcium, total calcium with albumin, magnesium, ECG; phototherapy study found lower calcium and magnesium after 24 hours [157] | Symptomatic hypocalcemia: 10% calcium gluconate 100 mg/kg IV with ECG monitoring; replace magnesium when deficient | ECG, calcium, magnesium, phosphate, symptoms, and infusion site | Seizure, arrhythmia, refractory hypocalcemia, or severe persistent deficiency |
| Sodium or potassium disorder | Fluid loss or excess, renal dysfunction, extreme prematurity, critical illness | Repeat non-haemolysed electrolyte sample; assess sodium trend, ECG, renal function, and volume status | Restore perfusion before slow sodium correction; for hyperkalemia stop potassium, monitor ECG, give calcium for ECG changes, and shift potassium intracellularly | Electrolytes, glucose, urine output, weight, perfusion, ECG | Severe or rapidly changing sodium, ECG changes, refractory hyperkalemia, or suspected obstruction/renal failure |
| Metabolic acidosis | Shock, hypoxemia, renal failure, bicarbonate loss, severe respiratory disease | Blood gas, lactate, electrolytes, glucose, renal indices; add ketones or ammonia when indicated | Correct oxygen delivery, ventilation, perfusion, temperature, and cause; reserve bicarbonate for selected severe cases | Serial gas, lactate, perfusion, urine output, and electrolytes | Persistent acidosis, rising lactate, shock, or suspected inborn metabolic disease |
| Acute kidney injury or oliguria | Hypotension, hypoxemia, nephrotoxin exposure, surgery, obstruction, extreme prematurity | Rising creatinine and/or reduced urine output; interpret creatinine with gestational age and fluid balance; uNGAL requires gestation-specific interpretation [168] | Optimize perfusion without fluid overload; stop nephrotoxins, relieve obstruction, and adjust drug doses | Hourly urine output when unstable, daily weight, creatinine, urea, electrolytes, acid-base status | Progressive creatinine rise, persistent oliguria, refractory electrolyte/acid-base disorder, obstruction, or dialysis need |
| Anemia or polycythemia | Extreme prematurity, blood loss or haemolysis; infants of diabetic mothers or growth-restricted infants for polycythemia | CBC, reticulocytes, smear; confirm high capillary haematocrit with venous sample; venous haematocrit ≥65% suggests polycythemia | Treat symptomatic anemia with packed cells; symptomatic hyperviscosity may require partial exchange | Perfusion, oxygen requirement, apnoea, bilirubin, glucose, haematocrit, and transfusion response | Symptomatic anemia, suspected haemolysis, symptomatic hyperviscosity, or major blood loss |
| Thrombocytopenia or DIC | Placental insufficiency, sepsis/inflammation, NEC, maternal immune thrombocytopenia, alloimmune disease, shock | Confirm platelet count on smear; PT, aPTT, fibrinogen, and clinical bleeding for DIC | Treat cause; transfuse platelets or plasma for bleeding or procedure rather than an isolated abnormal test | Bleeding examination, serial CBC, coagulation, fibrinogen, organ function | Active bleeding, very low or falling platelets, abnormal coagulation with shock, or suspected alloimmune disease |
| Unconjugated hyperbilirubinemia | Prematurity, haemolysis, poor feeding, bruising, Rh/ABO incompatibility, G6PD deficiency | TSB plotted by hour of life, gestation, and neurotoxicity risk; direct antiglobulin test and haemolysis studies when indicated | Intensive phototherapy at the age-specific threshold; IVIG may be considered for selected immune haemolysis; exchange transfusion at the age-specific threshold or for encephalopathy | TSB trend, haemoglobin, hydration, temperature, feeding, irradiance, and neurologic examination | Rapid rise, haemolysis, TSB near exchange threshold, acute bilirubin encephalopathy, or poor response to phototherapy |
| Conjugated hyperbilirubinemia | Persistent jaundice, pale stools, dark urine, hepatomegaly, poor growth, or illness | Direct bilirubin >1 mg/dL when TSB ≤5 mg/dL or >20% of TSB when TSB >5 mg/dL | Stop hepatotoxic exposures, support glucose and coagulation, and begin directed evaluation; do not treat with phototherapy alone | Fractionated bilirubin, liver tests, coagulation, glucose, stool colour, weight, and abdominal examination | Any cholestasis, acholic stool, rising direct bilirubin, or suspected biliary atresia |
Pearl: In a sick newborn, falling glucose, worsening acidosis, oliguria, thrombocytopenia, anaemia, and rising unconjugated bilirubin may be manifestations of one process, poor perfusion, haemolysis, illness, or inadequate intake. Treat the physiology while confirming each laboratory abnormality.
Neonatal Infection, Sepsis, and Perinatal Viral Disease
- ▸Treat a clinically unstable newborn immediately after obtaining cultures, do not wait for a normal CBC, CRP, procalcitonin, or other screening biomarker to exclude sepsis.
- ▸Start empiric ampicillin 50 mg/kg IV plus gentamicin 4-5 mg/kg IV or IM, with gestation-, postnatal-age-, renal-function-, and local-protocol-adjusted intervals, then tailor promptly to cultures and susceptibilities.
- ▸When neonatal HSV is suspected, start acyclovir 20 mg/kg IV every 8 hours immediately while obtaining surface swabs, blood PCR, CSF HSV PCR, hepatic enzymes, bilirubin, coagulation studies, and renal function; absence of skin lesions does not exclude disseminated or CNS disease.
is a clinical diagnosis before it is a laboratory diagnosis. Newborns may deteriorate with apnea, temperature instability, feeding intolerance, tachypnea, grunting, lethargy, poor perfusion, hypotension, irritability, seizures, or unexplained respiratory failure; fever may be absent, particularly in preterm infants. [44][179] Treat a clinically unstable infant immediately after obtaining cultures; do not wait for a screening biomarker to become abnormal.
Clinical syndromes and timing
Early-onset sepsis (EOS) usually presents within the first 72 hours, although studies and surveillance systems sometimes extend the definition to 7 days. Infection is acquired from maternal rectovaginal flora or ascending infection of the membranes and amniotic fluid. (GBS; Streptococcus agalactiae) and Escherichia coli predominate, with E. coli relatively more common in preterm infants and GBS more common in term infants. [44] Maternal GBS colonization, GBS bacteriuria, clinical , maternal fever, preterm labor, prolonged rupture of membranes (PROM), and PPROM increase concern for vertical transmission. In extremely preterm infants, prelabor PPROM and acute chorioamnionitis on placental pathology were more common among infants with proven EOS; none of the proven EOS cases met a low-risk profile defined by cesarean delivery without labor, rupture of membranes at delivery, and no chorioamnionitis. [182]
Prevent EOS by following the local GBS strategy: antenatal rectovaginal culture-based screening or a validated risk-based protocol, and intrapartum penicillin or ampicillin when indicated. Risk indications include GBS bacteriuria, PROM longer than 18 hours, preterm labor, maternal fever, or a previous infant with GBS disease. [44] Intrapartum prophylaxis reduces GBS EOS but does not prevent late-onset disease, so a well-appearing infant still requires observation appropriate to gestational age and risk. [44]
Late-onset sepsis (LOS) occurs after 72 hours and is usually healthcare-associated, although community and household transmission also occur. Prematurity, prolonged hospitalization, invasive procedures, parenteral nutrition, mechanical ventilation, and central venous access increase exposure to skin flora and hospital pathogens. In a contemporary cohort of very preterm infants, coagulase-negative staphylococci, Staphylococcus aureus, E. coli, and Klebsiella species were the leading isolates; fungi accounted for 7.0% of pathogens. [175] Rising LOS after 2017 was driven by non-coagulase-negative staphylococci and Gram-negative organisms, so the empiric regimen must follow the unit antibiogram rather than a fixed national recipe. [175]
Meningitis may accompany either EOS or LOS, but it is more frequent with LOS. [44] Suspect it with seizures, abnormal tone, bulging fontanelle, marked irritability or lethargy, apnea, temperature instability, unexplained shock, or bacteremia. Do not perform lumbar puncture in an unstable infant until airway, breathing, circulation, and intracranial-pressure concerns have been addressed; once safe, obtain cerebrospinal fluid (CSF) cell count and differential, protein, glucose, Gram stain, bacterial culture, and pathogen-directed molecular testing. A negative blood culture does not exclude meningitis, and a positive blood culture does not establish the absence of CNS disease.
Pneumonia may be part of EOS after aspiration or ascending infection, or part of LOS after prolonged respiratory support. Tachypnea, grunting, oxygen need, apnea, temperature instability, and worsening ventilator requirements overlap with respiratory distress syndrome and pulmonary hypertension. Obtain blood culture and chest radiography when respiratory findings are persistent, focal, or accompanied by systemic illness; tracheal aspirate culture is interpretable only in an intubated infant and should not replace blood culture. Treat the infant's physiology, oxygenation, ventilation, perfusion, and glucose, while cultures are pending.
Urinary infection is an important bacterial source after the first days of life and may present only with fever, poor feeding, lethargy, apnea, jaundice, or temperature instability. Obtain urinalysis and urine culture by catheterization or suprapubic aspiration before antibiotics; a bag specimen is unsuitable for establishing bacteriuria. Pyuria and a properly collected positive culture are complementary components of diagnosis, and contamination is common when collection is inadequate. [186] Because bacteremic UTI and meningitis require different treatment durations, perform CSF evaluation when clinically indicated before shortening parenteral therapy or switching to oral treatment; exclusion of meningitis is particularly important in neonates 28 days of age or younger. [187]
Central-line-associated bloodstream infection (CLABSI) should be considered with new apnea, feeding intolerance, temperature instability, perfusion change, thrombocytopenia, metabolic acidosis, or escalating respiratory support in an infant with a central line. Obtain cultures from a peripheral vein and, when feasible, from each catheter lumen before antibiotics; interpret coagulase-negative staphylococci alongside the clinical course, number of positive cultures, time to positivity, inflammatory response, and catheter status. In one NICU study, 63.4% of late-onset coagulase-negative-staphylococcal episodes were attributed to infection, whereas all early-onset episodes were attributed to contamination, illustrating why a single positive result cannot be interpreted in isolation. [180] Remove or exchange the catheter when it is infected, malfunctioning, no longer needed, or associated with a pathogen for which source control is required. Prevent CLABSI with hand hygiene, aseptic insertion, hub disinfection, sterile dressing care, daily line-necessity review, and prompt removal; a multimodal bundle reduced CLABSI from 6.4 to 1.1 per 1000 central-line days in one prospective quality-improvement study. [185]
NEC-associated infection presents with feeding intolerance, abdominal distension or tenderness, bilious gastric residuals or emesis, bloody stool, apnea, temperature instability, lethargy, metabolic acidosis, thrombocytopenia, or shock. Obtain blood cultures, CBC with platelets, blood gas and lactate, glucose, electrolytes, and serial abdominal radiographs; use abdominal ultrasonography when radiographs are equivocal or bowel perfusion and fluid collections require assessment. Stop enteral feeds, decompress the stomach, provide cardiorespiratory support, and begin broad antibacterial therapy when systemic illness or advanced NEC is suspected; involve pediatric surgery for pneumoperitoneum, perforation, or progressive deterioration. Do not label every feeding intolerance episode as NEC, but do not delay treatment when systemic instability accompanies abdominal findings.
Investigation and empiric treatment
Obtain at least one adequately filled peripheral blood culture before antibiotics; obtain a second culture when blood volume and clinical circumstances permit. A positive culture must be interpreted with the organism, number of positive bottles or sites, time to positivity, clinical trajectory, and inflammatory response because contaminants, especially coagulase-negative staphylococci, are common. [180] Draw CSF studies when meningitis is suspected and the infant is stable enough for lumbar puncture. Obtain catheter and peripheral cultures for suspected CLABSI, catheterized urine culture for suspected UTI, and chest imaging for persistent respiratory disease. In suspected NEC, repeat abdominal examination, radiography, blood gas, platelet count, and lactate according to severity.
Start empiric ampicillin 50 mg/kg IV plus gentamicin 4-5 mg/kg IV or IM, using gestation-, postnatal-age-, renal-function-, and local-protocol-adjusted intervals. This combination covers GBS, Listeria monocytogenes, enterococci, and common Gram-negative EOS pathogens; adjust promptly to culture and susceptibility results. The evidence supporting maternal GBS prophylaxis is observational rather than based on randomized trials, and local resistance patterns matter. [44] In a setting with substantial resistance, recent broad-spectrum antibiotic exposure, severe LOS, or suspected CLABSI, use the unit's validated alternative, commonly vancomycin plus an antipseudomonal beta-lactam such as cefepime, ceftazidime, or piperacillin-tazobactam, and involve infectious-diseases and microbiology specialists. High resistance to gentamicin and third-generation cephalosporins, including frequent extended-spectrum beta-lactamase production, has been reported in an EOS cohort, demonstrating why local surveillance must determine escalation. [174]
Do not use a normal CBC, CRP, procalcitonin, or other screening result to rule out sepsis in a symptomatic newborn. Biomarkers are adjuncts: CRP may remain low early, and leukocyte indices are altered by gestational age, labor, stress, and noninfectious disease. Serial trajectories may be more informative than isolated values, but available studies remain retrospective; in one cohort, the rate of CRP change correlated with progression more strongly than the maximum CRP value. [181] Interleukin-6 showed an AUROC of 0.86 for neonatal sepsis in one retrospective cohort, but sensitivity was 67.6%, so it cannot safely replace clinical assessment and cultures. [189]
Perinatal viral and congenital infection
Start acyclovir 20 mg/kg IV every 8 hours immediately when neonatal (HSV) is suspected, especially with vesicles, seizures, focal neurologic signs, CSF pleocytosis, hepatitis, thrombocytopenia, shock, or maternal genital HSV, while obtaining HSV surface swabs, blood PCR, CSF cell count and HSV PCR, hepatic enzymes, bilirubin, coagulation studies, and renal function. Absence of skin lesions does not exclude disseminated or CNS HSV. A neonatal HSV-2 encephalitis case initially failed antibacterial treatment and improved after acyclovir and immunoglobulin therapy; this illustrates why antiviral treatment must not await skin findings or bacterial culture results. [177] Continue for the syndrome and CSF-PCR response according to specialist guidance, and provide suppressive oral acyclovir after CNS or disseminated disease when indicated.
Evaluate (CMV) when there is microcephaly, growth restriction, thrombocytopenia, petechiae, jaundice or hepatosplenomegaly, abnormal cranial imaging, ventriculomegaly, seizures, or failed hearing screening. Confirm congenital infection with CMV PCR from saliva or urine obtained within the first 21 days; confirm a positive saliva result with urine because breast milk contamination can produce a false-positive result. Perform CBC, liver tests, renal assessment, ophthalmologic examination, auditory brainstem response, and neuroimaging. Congenital CMV may be clinically silent initially yet cause later hearing loss; in a prospective cohort, hepatosplenomegaly and hypotonia independently predicted late-onset sensorineural hearing loss. [178] Discuss valganciclovir or intravenous ganciclovir with infectious-diseases specialists for symptomatic disease, particularly CNS, ocular, or significant multisystem disease, while monitoring neutropenia, thrombocytopenia, renal function, and liver tests. [178]
For suspected congenital , obtain maternal serology and treatment history, neonatal quantitative nontreponemal serology, examination of the skin, mucosa, bones, liver, spleen, and neurologic system, and CSF studies when criteria indicate. Treat confirmed or high-probability disease with aqueous crystalline penicillin G IV for 10 days; use the jurisdictional neonatal protocol for dose and interval, and do not substitute a short course when the infant is symptomatic or evaluation is incomplete. Evaluate for with parasite-specific serology and targeted eye, neurologic, and imaging assessment; test for congenital when the phenotype includes cataracts, congenital heart disease, hearing loss, or characteristic rash. These diagnoses require public-health and infectious-diseases coordination because maternal serology, timing of infection, and confirmatory testing determine interpretation.
For maternal HIV exposure, obtain neonatal virologic testing rather than antibody testing alone, start risk-stratified antiretroviral prophylaxis as soon as possible, and coordinate infant feeding and follow-up with an HIV specialist. For maternal hepatitis B surface antigen positivity, give hepatitis B vaccine and hepatitis B immunoglobulin promptly according to the neonatal immunization protocol; verify post-vaccination serologic response. Consider enterovirus when fever, lethargy, apnea, poor feeding, diarrhea, meningitis, myocarditis, hepatitis, coagulopathy, or shock occurs, particularly with maternal or household viral illness. Test CSF, blood, and, when clinically appropriate, stool or respiratory specimens with reverse-transcription PCR; CSF PCR confirmed CNS infection in a recent neonatal series, but severe disease included myocarditis and meningoencephalitis. [176] There is no established specific antiviral treatment for neonatal enterovirus; provide intensive supportive care, isolate or cohort according to infection-control policy, and involve infectious diseases. Intravenous immunoglobulin has been used, but efficacy has not been established in controlled trials. [176]
| Infection or pathogen | Transmission risk | Clinical presentation | Diagnostic specimens | Empiric or definitive therapy | Prevention |
|---|---|---|---|---|---|
| GBS EOS | Maternal rectovaginal colonization, ascending infection, chorioamnionitis, prolonged ROM, intrapartum exposure | Respiratory distress, apnea, poor perfusion, temperature instability, poor feeding, meningitis | Blood culture; CSF when meningitis is suspected; placental studies when available | Ampicillin plus gentamicin; narrow to penicillin or ampicillin when susceptible | Antenatal screening or risk-based strategy; intrapartum penicillin or ampicillin when indicated [44] |
| Gram-negative EOS, especially E. coli | PPROM, chorioamnionitis, prematurity, maternal or hospital-resistant flora | Sepsis, pneumonia, meningitis, shock; fever may be absent in preterm infants | Blood culture; CSF when safe; chest imaging for respiratory disease | Ampicillin plus gentamicin where local susceptibility supports it; escalate to a locally active agent for resistant disease [174] | PPROM and chorioamnionitis management; hand hygiene; local resistance surveillance |
| LOS: CoNS, S. aureus, Enterobacterales, fungi | Prematurity, prolonged hospitalization, central lines, ventilation, procedures, hospital or household transmission | Apnea, feeding intolerance, temperature instability, perfusion change, respiratory deterioration | Peripheral and line blood cultures; CSF and urine as indicated | Vancomycin plus locally active Gram-negative coverage for severe or line-associated disease; remove infected line when required; tailor to cultures [175][180] | Hand hygiene, line bundles, environmental cleaning, cohorting during outbreaks [185] |
| Bacterial meningitis | Hematogenous spread in EOS or LOS; GBS and Gram-negative organisms are important | Seizures, abnormal tone, lethargy, apnea, bulging fontanelle, shock | CSF cell count, glucose, protein, Gram stain, culture, PCR; blood culture | Treat with meningitic-dose antibiotics guided by age, pathogen, and susceptibility; do not shorten therapy before meningitis is excluded [187] | Prevent EOS and CLABSI; prompt evaluation of bacteremia |
| Pneumonia | Ascending/perinatal infection, aspiration, ventilation, hospital transmission | Tachypnea, grunting, oxygen need, apnea, focal or diffuse infiltrates | Blood culture; chest radiograph; tracheal aspirate if intubated | EOS regimen initially; broaden for LOS or resistant hospital pathogens | Hand hygiene, respiratory-equipment asepsis, minimize unnecessary ventilation |
| UTI, usually E. coli | Ascending infection; urinary tract anomaly; healthcare exposure | Fever or hypothermia, poor feeding, lethargy, apnea, jaundice, sepsis | Catheterized or suprapubic urine urinalysis and culture; blood culture; CSF when indicated | Parenteral therapy initially; tailor to susceptibility and exclude meningitis before oral step-down [187] | Catheter asepsis; investigate recurrent infection for urinary abnormality |
| NEC-associated infection | Prematurity, intestinal barrier injury, enteral feeding vulnerability, hospital flora | Distension, bloody stool, bilious emesis, apnea, acidosis, thrombocytopenia, shock | Blood culture, CBC, gas/lactate, serial abdominal radiographs, ultrasound when needed | Stop feeds, decompress, support circulation, and give broad antibacterial therapy for systemic or advanced disease; surgical consultation for perforation | Human milk when feasible, cautious feeding advancement, hand hygiene, prompt abdominal evaluation |
| HSV-1/2 | Maternal genital shedding at delivery; postnatal contact | Vesicles, seizures, encephalitis, hepatitis, coagulopathy, shock; lesions may be absent | Surface swabs, blood PCR, CSF HSV PCR, liver and coagulation tests | Acyclovir 20 mg/kg IV every 8 h immediately when suspected; specialist-guided prolonged treatment [177] | Maternal lesion assessment, delivery planning, contact precautions, avoid exposure to active lesions |
| Congenital CMV | Primary or recurrent maternal infection with transplacental transmission | Microcephaly, growth restriction, petechiae, thrombocytopenia, hepatosplenomegaly, abnormal imaging, hearing loss | Saliva and confirmatory urine CMV PCR within 21 days; CBC, liver tests, hearing, eye and brain assessment | Specialist-guided ganciclovir or valganciclovir for symptomatic disease; monitor cytopenias and renal function [178] | Maternal hygiene and testing strategies; targeted neonatal testing and hearing surveillance |
| Congenital syphilis | Transplacental Treponema pallidum infection | Rash, hepatosplenomegaly, jaundice, cytopenias, bone or neurologic disease; may be asymptomatic | Maternal and neonatal quantitative serology; CSF and other studies when indicated | Ten-day penicillin regimen for confirmed or high-probability disease | Maternal screening and treatment during pregnancy; serologic follow-up |
| Toxoplasmosis or rubella | Transplacental infection | Toxoplasmosis: CNS, ocular, growth and intracranial abnormalities; rubella: cataracts, heart disease, hearing loss, rash | Pathogen-specific serology or PCR; eye, hearing, cardiac, neurologic and imaging assessment | Specialist-directed antiparasitic therapy for toxoplasmosis; supportive and specialist management for congenital rubella | Maternal prevention, antenatal testing, and rubella immunization before pregnancy |
| HIV or hepatitis B exposure | Transplacental, intrapartum, or postnatal transmission | Often clinically silent initially; later virologic, hepatic, or immunologic disease | HIV neonatal virologic testing; maternal and infant hepatitis B serology according to protocol | Risk-stratified neonatal antiretroviral prophylaxis; hepatitis B vaccine plus immunoglobulin for exposed infants | Maternal testing, antiretroviral suppression, safe feeding plan; immediate hepatitis B prophylaxis |
| Enterovirus | Intrapartum maternal infection or postnatal household/hospital transmission | Fever, meningitis, myocarditis, hepatitis, coagulopathy, shock, meningoencephalitis | CSF, blood, stool or respiratory RT-PCR as clinically indicated | Intensive supportive care; no established specific antiviral; consider specialist-guided IVIG, whose efficacy remains unproven [176] | Hand hygiene, contact precautions, maternal and household exposure control, outbreak surveillance |
Pearl: In a newborn with unexplained apnea, shock, respiratory deterioration, seizures, or feeding failure, obtain cultures promptly and treat bacterial sepsis while simultaneously asking whether the pattern requires CSF testing, acyclovir, or pathogen-specific congenital-infection evaluation.
Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection
- ▸In an infant at least 35 weeks’ gestation with a significant perinatal hypoxic-ischaemic event and moderate or severe encephalopathy, urgently assess eligibility for whole-body therapeutic hypothermia, starting as soon as possible, ideally within 6 hours of birth, for 72 hours.
- ▸Use continuous amplitude-integrated EEG as an early screen but obtain conventional multichannel EEG because aEEG can miss brief, focal, or low-amplitude seizures; confirm seizure control on EEG rather than relying on cessation of visible movements.
- ▸For a confirmed electrographic seizure, give phenobarbital 20 mg/kg IV over at least 20 minutes, then additional 10 mg/kg IV doses to a cumulative loading dose of 40 mg/kg if seizures continue, with respiratory and blood-pressure monitoring.
Begin with a structured neurologic examination and repeat it after any deterioration, seizure, cardiorespiratory instability, or major intervention. Record level of alertness, spontaneous activity, posture, tone, symmetry of movement, primitive reflexes, suck and gag, cranial-nerve responses, pupils, autonomic signs, and the presence of abnormal movements. Distinguish jitteriness, stimulus-sensitive, suppressible movement without ocular deviation, from a seizure, which is usually stereotyped, may include ocular or autonomic change, and is not reliably excluded by a normal examination. Serial examinations are more informative than a single score because sedation, analgesia, hypothermia, hypoglycemia, and anticonvulsants can obscure evolving injury. [193]
For suspected , apply the before sedating drugs whenever possible and document the findings by domain rather than recording only the stage. Moderate encephalopathy is characterized by lethargy, hypotonia, a weak suck, incomplete Moro reflexes, and seizures; severe encephalopathy is characterized by stupor or coma, flaccidity, absent suck and Moro reflexes, and abnormal pupils or autonomic function. In an infant at least 35 weeks’ gestation with evidence of a significant perinatal hypoxic-ischaemic event and moderate or severe encephalopathy, urgently assess eligibility for whole-body . Start cooling as soon as possible, ideally within 6 hours of birth, maintain the protocol-defined target temperature for 72 hours, and rewarm slowly under continuous cardiorespiratory and neurologic monitoring. Do not delay treatment while awaiting MRI; correct reversible contributors such as hypoglycemia, hypoxemia, hyperoxia, hypocarbia, hypercarbia, hypotension, and seizures. The evidence base for prognostication described here concerns infants at least 35 weeks’ gestation treated with whole-body therapeutic hypothermia. [193]
Use continuous when available as an early bedside screen, but obtain conventional multichannel because aEEG can miss brief, focal, or low-amplitude seizures and cannot reliably distinguish electrographic seizures from artifact. Start conventional EEG promptly when abnormal movements recur, the infant is encephalopathic, or aEEG is abnormal, and continue monitoring after treatment because electroclinical dissociation is common during anticonvulsant therapy. An abnormal aEEG background at 36 hours is a useful prognostic marker, but never use it alone to withdraw intensive care: in a systematic review of 37 studies including 2721 cooled infants, abnormal background at 36 hours predicted adverse 2-year outcome with sensitivity 0.83 and specificity 0.88, while absent sleep-wake cycling had specificity 0.93. [193]
Treat a confirmed electrographic seizure after checking glucose, calcium, magnesium, sodium, temperature, oxygenation, perfusion, and medication exposure. Give 20 mg/kg IV over at least 20 minutes; if seizures continue, give additional 10 mg/kg IV doses to a cumulative loading dose of 40 mg/kg, with respiratory and blood-pressure monitoring. For persistent electrographic seizures, or when phenobarbital is ineffective or contraindicated, use 40-60 mg/kg IV or 20 mg phenytoin equivalents/kg IV, guided by local protocol and cardiac monitoring. Treat the cause in parallel: give IV dextrose for symptomatic or persistent hypoglycemia, calcium for symptomatic hypocalcemia, magnesium for symptomatic hypomagnesemia, and antibiotics after cultures when infection or meningitis is possible. Do not equate cessation of visible movements with seizure control; confirm response on EEG. [193]
Maintain cerebral perfusion by correcting oxygen delivery and systemic circulation rather than treating a blood-pressure number in isolation. Reassess ventilation, hemoglobin, preload, myocardial function, lactate, urine output, temperature, and glucose; give a cautious isotonic fluid bolus only when hypovolemia is supported, and use vasoactive support when myocardial dysfunction or distributive shock persists. Avoid abrupt changes in carbon dioxide, oxygenation, blood pressure, or hematocrit because impaired autoregulation makes the injured brain vulnerable to both ischemia and hemorrhage. In preterm infants, use midline head positioning, minimal handling, stable ventilation, and carefully controlled infusions to reduce fluctuations in cerebral blood flow; IVH is strongly associated with neurodevelopmental impairment and occurs in approximately 20-40% of the highest-risk extremely preterm infants. [116]
Perform through the anterior fontanelle in a preterm infant at risk of or with unexplained neurologic change. Obtain an early study after stabilization and repeat it during the first week; repeat imaging after new apnea, seizures, anemia, hemodynamic instability, or a falling hematocrit. Describe germinal-matrix hemorrhage, ventricular blood, ventricular size, periventricular echogenicity, cystic change, and parenchymal hemorrhagic infarction, and trend ventricular measurements rather than relying on a qualitative impression. In a retrospective cohort of transported infants born before 32 weeks, day-1 ultrasound identified IVH in 19.9%, while grade III or IV hemorrhage occurred in 8.7%; these observational data support surveillance but do not establish treatment effects. [116]
Obtain when the infant is clinically stable, usually after the acute treatment window, using diffusion-weighted and apparent-diffusion-coefficient sequences for acute ischemia, T1- and T2-weighted sequences for regional and maturational injury, and susceptibility-weighted or T2*-weighted sequences for blood products. MRI is the principal study for , neonatal arterial , , and injury not adequately characterized by ultrasound. Add venography for suspected sinovenous thrombosis and angiography when arterial occlusion or malformation is suspected. In HIE, consider proton magnetic resonance spectroscopy when available: in a single-centre retrospective cohort of 91 cooled infants, the lactate/N-acetylaspartate ratio measured on days 4-6 was associated with adverse school-age outcome, but this result requires cautious interpretation because the study was retrospective and single-centre. [194]
Target laboratory testing to the phenotype rather than ordering an undirected panel. For seizures or encephalopathy, obtain bedside glucose, blood gas with lactate, electrolytes including calcium and magnesium, renal and hepatic indices, complete blood count, and coagulation studies; add blood culture and lumbar puncture when meningitis is suspected and the infant is stable enough for the procedure. Consider ammonia, plasma amino acids, urine organic acids, acylcarnitine profile, and targeted genetic or metabolic testing for unexplained, recurrent, refractory, or familial seizures, persistent hypotonia, dysmorphism, or progressive encephalopathy. In a hypotonic infant, separate central hypotonia, reduced tone with relatively preserved reflexes and an encephalopathic state, from peripheral hypotonia with weakness, diminished reflexes, fasciculations, or respiratory failure; tailor creatine kinase, thyroid studies, metabolic testing, neuromuscular genetics, and specialist assessment accordingly. [193]
Recognize the characteristic patterns of major neonatal neurologic syndromes and link each pattern to an urgent action:
| Neurologic syndrome | Defining findings | Diagnostic test | Urgent treatment | Prognostic markers | Follow-up need |
|---|---|---|---|---|---|
| Hypoxic-ischemic encephalopathy | Altered consciousness, abnormal tone or reflexes, weak suck, seizures, and multiorgan evidence of perinatal hypoxia | Serial modified Sarnat examination, conventional EEG, MRI with diffusion and susceptibility sequences | Assess therapeutic-hypothermia eligibility immediately; correct glucose, oxygenation, ventilation, perfusion, and seizures | EEG background and sleep-wake cycling; MRI pattern; lactate/N-acetylaspartate ratio when obtained | Serial neurologic and developmental assessment, with early recognition of motor, cognitive, language, hearing, and visual impairment |
| Neonatal seizures | Stereotyped clonic, tonic, or subtle ocular/autonomic events; electrographic seizures may occur without visible movements | Conventional EEG with aEEG adjunct; glucose, calcium, magnesium, sodium, infection and metabolic studies | Phenobarbital 20 mg/kg IV, additional 10 mg/kg doses to 40 mg/kg if needed; use levetiracetam or fosphenytoin for persistent seizures | Seizure burden, background activity, etiology, and MRI injury pattern | Neurology review, seizure-risk assessment, hearing and vision surveillance, and developmental monitoring |
| Intraventricular or periventricular hemorrhage | Preterm infant with apnea, altered consciousness, seizures, anemia, or a rapidly enlarging head circumference; severe disease may include parenchymal hemorrhagic infarction | Serial cranial ultrasonography; MRI when stable | Stabilize ventilation and perfusion, correct clinically important anemia or coagulopathy, and involve neurosurgery for progressive posthaemorrhagic ventricular dilatation | Hemorrhage grade, parenchymal injury, ventricular trajectory, and posthaemorrhagic hydrocephalus | Serial head circumference, ventricular measurements, neurologic examination, and developmental surveillance |
| Periventricular leukomalacia | Evolving spasticity, abnormal tone, feeding dysfunction, or later motor asymmetry in a preterm infant | MRI with T1/T2 and diffusion sequences; serial ultrasound may show cystic evolution | Prevent secondary hypoxemia, hypocarbia, hypotension, and glucose disturbance; treat seizures | Cystic or diffuse white-matter injury, corticospinal tract involvement, and associated IVH | Repeated motor, vision, hearing, and developmental assessment |
| Cerebral sinovenous thrombosis | Seizures, encephalopathy, focal signs, apnea, or unexplained thrombocytopenia/dehydration | MRI with diffusion plus MR venography and susceptibility sequences | Correct dehydration, hypoxemia, infection, and seizures; involve hematology and neurology urgently regarding anticoagulation | Venous infarction, hemorrhage, clot extension, and neurologic examination | Neurology follow-up, thrombosis review, seizure surveillance, and developmental assessment |
| Neonatal arterial stroke | Focal clonic seizures, asymmetric tone or movement, or persistent encephalopathy | MRI with diffusion and arterial angiography when indicated | Treat seizures and systemic contributors; obtain neurology and hematology input rather than empirically anticoagulating | Lesion size and location, corticospinal involvement, and early asymmetry | Early motor, language, vision, and seizure follow-up |
| Meningitis-related injury | Seizures, lethargy, temperature instability, poor feeding, apnea, or shock | Blood culture, lumbar puncture when safe, CSF culture/PCR, EEG, and MRI for complications | Start empiric meningitis-dose antimicrobials after cultures without delaying treatment; control seizures and shock | CSF organism and inflammation, seizures, infarction, ventriculitis, and MRI injury | Hearing assessment, neurologic review, seizure surveillance, and developmental monitoring |
| Central neonatal hypotonia or encephalopathy | Reduced tone with altered alertness, weak feeding, abnormal reflex integration, or respiratory dysregulation | Serial examination, glucose/electrolytes, blood gas/lactate, infection studies, MRI, and targeted metabolic/genetic testing | Stabilize airway, breathing, glucose, temperature, and perfusion; treat infection, seizures, and metabolic derangement | Evolution of tone, reflexes, consciousness, MRI, and metabolic results | Neurology, feeding, hearing, vision, and developmental follow-up |
| Withdrawal-related neurologic dysfunction | Irritability, tremor, hypertonia, poor sleep, feeding difficulty, vomiting, autonomic instability, or seizures after prenatal drug exposure | Exposure history, serial functional assessment, glucose/electrolytes, and EEG for atypical or persistent events | Reduce environmental stimulation, support feeding and hydration, treat hypoglycemia, and use protocolized opioid therapy for severe opioid withdrawal | Exposure, severity and duration of symptoms, seizures, growth, and feeding course | Developmental and behavioral surveillance, with attention to language, regulation, sleep, and motor development |
For every infant with brain injury, document the suspected mechanism, timing, examination trajectory, seizure burden, imaging pattern, and family history in a single longitudinal neurologic record. Prognosis must be multimodal: combine serial examination, EEG, MRI, laboratory evolution, and clinical course rather than assigning outcome from one early sign. In cooled HIE cohorts, abnormal aEEG at 36 hours provided reliable bedside prognostic information, whereas targeted neonatal echocardiography alone had limited evidence as a prognostic test; MRI spectroscopy was associated with school-age outcome in a retrospective cohort but should complement, not replace, clinical assessment. [193][194]
Pearl: Treat the newborn with seizures or encephalopathy as a time-critical neurologic emergency: confirm the electrical event, correct reversible physiology, identify the lesion, protect cerebral perfusion, and defer definitive prognostic conclusions until examination, EEG, and imaging have converged. [193]
Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease
- ▸Advance enteral feeds according to hemodynamic and respiratory stability, abdominal examination, stooling, and weight trajectory rather than gestational age alone, and interrupt feeds for bilious emesis, progressive distension, abdominal discoloration, bloody stool, tenderness, absent bowel sounds, or systemic instability.
- ▸Begin oral feeds only when the infant is alert and physiologically stable with respiratory reserve, coordinated non-nutritive sucking, rooting, and maintained oxygenation without frequent apnea or bradycardia; stop for desaturation, bradycardia, coughing, choking, stress signals, fatigue, or loss of coordination.
- ▸When parenteral nutrition is required, begin amino acids at approximately 2-3 g/kg/day, glucose at a glucose infusion rate of 4-6 mg/kg/min, and intravenous lipid emulsion at 1-2 g/kg/day, advancing toward 3.5-4 g/kg/day amino acids, 8-10 mg/kg/min glucose, and 3 g/kg/day lipids as monitoring permits.
is the preferred enteral substrate for most neonates. Give colostrum as early as possible, including small oropharyngeal applications when direct feeding is not yet safe, then use freshly expressed maternal milk whenever available. Maternal expressed milk supplies immunologic and trophic factors that are not reproduced by formula; however, production may be inadequate after preterm birth, and expressing for a hospitalized infant is physically and emotionally demanding. Provide a hospital-grade pump, hands-on instruction, comfortable and private pumping space, access to skin-to-skin care, and lactation review at each clinical change rather than framing milk volume as a measure of maternal performance. Evidence comparing expression techniques is heterogeneous: no method is consistently superior, whereas early practical assistance, equipment access, individualized support, and continuity across maternity and neonatal services repeatedly appear useful. [214]
Use when maternal milk is unavailable or insufficient, particularly for very preterm or very-low-birth-weight infants at high risk of . Explain that pasteurization improves microbiologic safety but reduces some biologically active components, and that donor milk has variable nutrient content; in contrast, preterm formula has more consistent composition. The optimal supplement and the value of routine fortification remain unsettled: the COLLABORATE study is a protocol for a large adaptive randomized trial, not outcome evidence, and explicitly describes limited high-quality evidence and conditional professional-society support for donor milk. [210] A retrospective study of 359 preterm infants found no significant difference among maternal milk, donor milk, or both in time to fortification, full enteral nutrition, or duration of parenteral nutrition; this association cannot establish equivalence because feed selection was not randomized. [209]
Enteral nutrition and feeding development
Advance enteral feeds according to gestational age, hemodynamic stability, respiratory support, abdominal examination, stooling, and weight trajectory rather than by gestational age alone. Provide trophic feeds when perfusion is adequate and there is no suspected intestinal catastrophe; increase cautiously when the infant has stable vital signs, a soft nondistended abdomen, reassuring stools, and no recurrent emesis. Do not use gastric residual volume alone to diagnose intolerance. Bilious emesis, progressive distension, abdominal discoloration, bloody stool, tenderness, absent bowel sounds, temperature or perfusion instability, apnea, or sudden thrombocytopenia requires immediate reassessment and usually feed interruption.
Suck-swallow-breathe coordination usually becomes reliable around 33-34 weeks postmenstrual age, but readiness is individual. [210] Before offering oral feeds, confirm sufficient alertness, physiologic stability, respiratory reserve, coordinated non-nutritive sucking, rooting, and the ability to maintain oxygenation without frequent apnea or bradycardia. Begin at breast or with a slow-flow teat when the infant is awake and cueing; use a supported, semi-upright or side-lying position, external pacing, and brief pauses. Stop for desaturation, bradycardia, coughing, choking, stress signals, fatigue, or loss of coordination. A feed is successful when the infant remains physiologically organized, not merely when a prescribed volume is completed.
Use : offer feeds for early hunger cues such as waking, rooting, hand-to-mouth activity, and coordinated sucking, and defer or stop for sleep, finger splay, grimacing, arching, color change, coughing, or respiratory deterioration. Cue-based feeding is an observable form of responsive caregiving and is associated with improved feeding outcomes in neonatal settings, although much of the supporting literature is qualitative or observational. [213] Teach parents to read the infant rather than to force completion of a target volume. Feeding is a learned dyadic skill; parental anxiety, exhaustion, and pressure to produce milk can undermine both milk expression and oral feeding. [213]
Use by an orogastric or nasogastric tube when oral coordination, endurance, respiratory status, or safety is inadequate. Confirm tube position according to local policy before the first feed and after clinically important displacement; do not rely on insertion depth alone. A 2026 observational study found that an anthropometric model predicted radiographic tube position better than the conventional nose-ear-xiphoid method, but prospective external validation is still required before routine implementation. [217] Combine gavage feeds with non-nutritive sucking, skin-to-skin contact, containment, and oral care with maternal milk to preserve oral experience. Gradually replace gavage volume with breast or bottle feeds as oral intake becomes safe and consistent, while retaining tube supplementation until hydration, weight gain, and intake remain adequate without cardiorespiratory events.
Nutritional prescription
Calculate fluids from current weight, gestational age, postnatal age, urine output, insensible losses, sodium balance, respiratory support, and serum chemistry. A practical starting range for a stable preterm infant is 70-100 mL/kg/day, advancing toward 150-180 mL/kg/day when clinically tolerated; term infants commonly begin around 60-80 mL/kg/day and advance toward 150 mL/kg/day. These are prescriptions to individualize, not automatic targets. Restrict or expand volume for pulmonary edema, renal dysfunction, high-output stoma, phototherapy, fever, or excessive insensible loss. Track daily weight, cumulative fluid balance, urine output, sodium, potassium, bicarbonate, glucose, urea, creatinine, calcium, phosphate, magnesium, and triglycerides when lipids are being advanced.
For growing preterm infants, aim for approximately 100-130 kcal/kg/day and 3.5-4.5 g protein/kg/day, with protein prioritized when growth is poor. Human milk requires individualized fortification because unfortified milk may not meet protein, calcium, phosphate, sodium, iron, and vitamin requirements at achievable volumes. Start fortifier once enteral volume is established according to local protocol, commonly at 40-80 mL/kg/day, and increase stepwise while monitoring abdominal tolerance, weight, length, head circumference, blood urea, electrolytes, calcium, phosphate, and alkaline phosphatase. Falling urea in an infant with poor growth may suggest inadequate protein, but interpret it with renal function, illness, and sodium balance; do not escalate protein solely because weight gain is slow. Routine fortification remains an area of active uncertainty, and the major randomized comparison is still being conducted. [210]
Provide vitamin D, iron, phosphate, calcium, and other micronutrients according to gestational age, milk intake, biochemical results, and local policy. Monitor for metabolic bone disease with serial calcium, phosphate, alkaline phosphatase, and vitamin D in high-risk infants; add urinary indices or radiography when biochemical or clinical findings warrant. Standard milk-bank processing preserves most measured macronutrients, but a 2026 analysis found stage-dependent reductions in copper and iodine, supporting attention to micronutrient adequacy in very preterm infants. [212]
Parenteral nutrition
Start when enteral intake cannot safely provide adequate energy and protein, particularly in extremely preterm infants, shock, severe respiratory failure, postoperative ileus, intestinal obstruction, , , or evolving short bowel syndrome. Use a peripheral line only for solutions whose osmolarity and glucose concentration remain within local policy; place a peripherally inserted central catheter or other central access when prolonged nutrition or higher dextrose and amino-acid concentrations are required. Verify catheter position radiographically or with an approved bedside method before use and after clinically significant migration.
Begin amino acids at approximately 2-3 g/kg/day and advance toward 3.5-4 g/kg/day. Start glucose at a glucose infusion rate of 4-6 mg/kg/min and titrate, commonly toward 8-10 mg/kg/min, against serial blood glucose; reduce glucose delivery and assess sepsis, stress, medications, and excess caloric intake when hyperglycemia develops. Begin intravenous lipid emulsion at 1-2 g/kg/day and advance toward 3 g/kg/day as triglycerides and clinical status permit. Use a contemporary mixed-oil emulsion when available; no lipid formulation has eliminated the need to monitor triglycerides, direct bilirubin, infection risk, and line complications.
Add sodium, potassium, acetate or chloride, calcium, phosphate, magnesium, trace elements, and vitamins only after reviewing renal function, serum values, urine output, and current enteral intake. Avoid simultaneous calcium and phosphate precipitation by using pharmacy-validated concentrations and compatibility procedures. Recheck glucose and electrolytes after initiation or major changes, triglycerides after lipid escalation and during instability, and direct bilirubin, liver enzymes, alkaline phosphatase, and coagulation indices during prolonged therapy. Taper PN when enteral intake is reliably increasing; do not stop abruptly in an infant receiving substantial glucose without checking for hypoglycemia.
associated with intestinal failure is diagnosed by serial direct bilirubin and liver tests, not by a single mildly abnormal result. Exclude sepsis, biliary obstruction, metabolic disease, hemolysis, and medication toxicity; maximize tolerated enteral milk, avoid unnecessary lipid excess, prevent catheter infection, and maintain cycling of PN when clinically appropriate. A large retrospective cohort found no independent association between neonatal PN exposure and later food allergy after adjustment for illness severity; the unadjusted association was explained by confounding, although a small residual risk could not be excluded. [216]
Gastrointestinal disease
Examine the abdomen at baseline and before feeds in infants at risk. Inspect color, contour, venous pattern, umbilical and groin regions, and stoma; auscultate bowel sounds; palpate for distension, tenderness, guarding, mass, or a doughy feel; assess anus and stool passage; and correlate findings with perfusion, temperature, respiratory status, urine output, platelets, blood gas, lactate, and inflammatory markers. A normal abdominal examination does not exclude early disease. Repeat it after any feeding deterioration or systemic change.
For suspected , stop feeds, decompress the stomach, obtain blood cultures, start broad-spectrum intravenous antibiotics according to the unit antibiogram, provide appropriate analgesia, and obtain abdominal radiographs. Repeat radiography according to clinical severity and at once for deterioration; use abdominal ultrasound when radiographs are equivocal or when portal venous gas, bowel-wall perfusion, free fluid, or focal necrosis would alter management. Involve pediatric surgery early for pneumoperitoneum, peritonitis, persistent shock or acidosis, fixed dilated bowel, abdominal wall erythema, or progressive radiographic disease. A regional epidemiologic study reported a median nil-per-os duration of 8 days after NEC and a median of 25 days to full feeds, but these figures describe one population and should not become fixed prescriptions. [218]
usually presents as sudden abdominal discoloration or distension, systemic instability, and free intraperitoneal air, often without the preceding radiographic pattern of NEC. Stop enteral feeds, decompress, begin antibiotics, obtain urgent imaging, and consult surgery. Peritoneal drainage may provide temporary source control in an unstable extremely preterm infant or serve as definitive treatment in selected patients; laparotomy is favored when drainage fails, perforation persists, there is peritonitis, or the infant requires direct assessment and resection. Early prophylactic hydrocortisone was not associated with focal intestinal perforation in a propensity-matched observational study, although mortality was higher in exposed infants and the mortality finding is vulnerable to residual confounding. [220]
For or neonatal obstruction, bilious vomiting, failure to pass meconium, progressive distension, or abnormal abdominal radiography requires urgent surgical consultation. Do not give enteral feeds until obstruction and perforation have been assessed. Contrast enema can be diagnostic and therapeutic in selected uncomplicated meconium ileus, but use it only with surgical backup because perforation may already be present. Operative management is required for perforation, peritonitis, volvulus, complete obstruction, ischemia, or failure of nonoperative decompression. After resection, preserve bowel length and the ileocecal valve whenever viable; residual anatomy determines the risk of , high-output stoma, dehydration, micronutrient deficiency, and prolonged PN dependence.
In short bowel syndrome, continue trophic maternal or donor milk when the bowel is usable, replace stoma losses with an individualized electrolyte solution, provide PN through reliable central access, and advance enteral feeds slowly while monitoring stool or stoma output, weight, urine output, sodium, magnesium, zinc, fat-soluble vitamins, direct bilirubin, and liver function. Coordinate neonatology, surgery, gastroenterology, nutrition, pharmacy, nursing, and feeding therapy. Escalate for recurrent sepsis, progressive cholestasis, inability to maintain growth or hydration, worsening acidosis, or suspected intestinal failure-associated liver disease.
| Clinical situation | Preferred nutrition | Route | Monitoring | Complication | Escalation criterion |
|---|---|---|---|---|---|
| Stable very preterm infant beginning feeds | Maternal expressed milk; donor human milk if maternal supply is insufficient; fortify once volume and tolerance permit | Breast, bottle, or gavage | Daily weight; intake/output; abdominal examination; glucose and electrolytes; weekly length and head circumference | Feeding intolerance, inadequate protein or mineral delivery | Recurrent emesis, distension, bloody stool, cardiorespiratory instability, or falling growth trajectory |
| Oral-motor immaturity or fatigue | Full prescribed milk volume by gavage with non-nutritive sucking and skin-to-skin care | Orogastric or nasogastric tube, with supervised oral attempts | Cues, suck-swallow-breathe coordination, oxygenation, bradycardia, fatigue, and percentage taken orally | Aspiration, oral aversion, prolonged tube dependence | Recurrent desaturation or choking, unsafe swallow, or failure to progress despite therapy |
| Insufficient maternal milk in an infant at NEC risk | Pasteurized donor human milk, with individualized fortification; preterm formula when donor milk is unavailable or inappropriate | Enteral, usually gavage initially | Growth, protein adequacy, tolerance, direct bilirubin, calcium, phosphate, and alkaline phosphatase | Inadequate nutrient delivery or NEC | Inability to advance, bloody stool, systemic instability, or radiographic abnormality |
| Hemodynamic instability, obstruction, NEC, perforation, or postoperative ileus | PN with minimal enteral milk only when bowel perfusion and surgical assessment permit | Peripheral PN briefly or central PN for concentrated/prolonged therapy | Glucose, electrolytes, calcium, phosphate, magnesium, triglycerides, direct bilirubin, liver tests, line position, and cultures | Hyperglycemia, hypertriglyceridemia, catheter infection, cholestasis, precipitation | Worsening acidosis or shock, rising direct bilirubin, line sepsis, inadequate growth, or inability to meet targets |
| Suspected NEC | No enteral feeds initially; PN while bowel is rested; resume maternal milk cautiously after clinical and radiographic recovery | Gastric decompression plus central or peripheral PN; later gavage/oral reintroduction | Serial abdominal examinations, radiographs and selected ultrasound, blood gas/lactate, CBC, platelets, cultures, urine output | Perforation, stricture, sepsis, prolonged PN dependence | Pneumoperitoneum, peritonitis, persistent shock/acidosis, fixed loop, or progressive disease |
| Spontaneous intestinal perforation | Bowel rest and PN; enteral feeds only after source control and recovery | Gastric decompression; drainage or laparotomy when indicated; PN centrally | Abdominal signs, perfusion, lactate, blood gas, radiography/ultrasound, drain output, cultures | Sepsis, recurrent perforation, short bowel syndrome | Free air with deterioration, peritonitis, failed drainage, or ongoing leak |
| Meconium ileus or neonatal obstruction | PN during evaluation; restart milk after decompression or definitive repair | Gastric decompression; contrast enema in selected uncomplicated cases; operative route when required | Bilious output, abdominal girth, serial examination, radiography, electrolytes, hydration, stool passage | Perforation, volvulus, ischemia, malabsorption | Peritonitis, perforation, complete obstruction, volvulus, ischemia, or failed nonoperative treatment |
| Short bowel syndrome or high-output stoma | Maternal/donor milk as tolerated, individualized fortification, and PN until enteral autonomy | Enteral plus central PN; replace measured stoma losses | Stoma output, weight, urine output, sodium, magnesium, zinc, vitamins, direct bilirubin, liver tests | Dehydration, micronutrient deficiency, cholestasis, catheter sepsis | Persistent growth or hydration failure, recurrent sepsis, progressive cholestasis, or acidosis |
The practical endpoint is not a calendar date or a nominal feed volume. It is safe, coordinated intake that supports growth without cardiorespiratory compromise, abdominal disease, micronutrient deficiency, or preventable dependence on PN.
Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies
- ▸Avoid mask ventilation in suspected congenital diaphragmatic hernia; intubate, place an orogastric tube to suction, and use gentle ventilation because gastric and intestinal distension further compresses hypoplastic lungs.
- ▸Normal oxygen saturation does not exclude critical congenital heart disease; when ductal-dependent pulmonary or systemic blood flow is plausible, start alprostadil at commonly 0.01 microgram/kg/min through reliable IV access and arrange urgent echocardiography and transfer.
- ▸Bilious emesis with shock, peritonism, bloody stool, rising lactate, or suspected volvulus requires immediate operation rather than a prolonged contrast work-up.
Structural disease and birth injury become emergencies when they obstruct the airway or gastrointestinal tract, impair perfusion, expose viscera or neural tissue, cause hemorrhage, or threaten neurologic or renal function. At birth, establish temperature control, cardiorespiratory monitoring, preductal and postductal oxygen saturation, glucose, perfusion, and a complete external examination. Obtain umbilical or peripheral vascular access early when obstruction, shock, major anomaly, or operative transfer is likely. Do not allow diagnostic imaging to delay airway protection, gastric decompression, hemorrhage control, or transfer to a surgical center.
Use a low threshold for when upper-airway obstruction, severe facial or thoracic distortion, recurrent apnea, exhaustion, or anticipated transport is present. Avoid mask ventilation in suspected ; intubate, place an orogastric tube to continuous or intermittent suction, and use gentle ventilation because gastric and intestinal distension further compresses the hypoplastic lungs. Acyanotic lesions such as critical coarctation, interrupted aortic arch, and critical aortic stenosis may present primarily with shock rather than cyanosis, so normal oxygen saturation does not exclude critical (CHD) [238]. If ductal-dependent pulmonary or systemic blood flow is plausible, start through reliable IV access, commonly 0.01 microgram/kg/min, and arrange urgent echocardiography and pediatric cardiology transfer; monitor for apnea, hypotension, fever, and flushing. Give only a 10 mL/kg isotonic crystalloid bolus over 20-30 minutes when examination and laboratory findings support hypovolemia, then reassess perfusion, lactate, urine output, and respiratory status.
Assess bleeding after traumatic delivery or suspected internal hemorrhage with serial heart rate, blood pressure, capillary refill, mental status, abdominal examination, hematocrit or hemoglobin, platelet count, coagulation studies, blood gas, lactate, and crossmatched blood availability. A pale or mottled infant with tachycardia, weak pulses, increasing oxygen requirement, metabolic acidosis, or a tense enlarging scalp swelling requires urgent escalation even before hemoglobin falls. Use targeted radiography for suspected fracture, pneumothorax, bowel obstruction, or malpositioned tubes; for cranial, abdominal, renal, spinal, and soft-tissue assessment; for cyanosis, shock, abnormal pulses, a persistent saturation pattern, or suspected structural heart disease; and when spinal dysraphism, brain injury, complex airway or thoracic anatomy, or a stable infant’s neurologic lesion requires anatomical definition. Reserve contrast studies for a stable infant after decompression and surgical consultation when the result will distinguish obstruction or fistula anatomy and change the immediate operation.
| Anomaly or injury | Key prenatal or postnatal clue | Immediate stabilization | Diagnostic study | Specialist | Timing of intervention |
|---|---|---|---|---|---|
| Critical CHD, including ductal-dependent lesions and dextro-transposition | Fetal echocardiographic diagnosis; cyanosis, shock, weak femoral pulses, differential saturation, acidosis, or collapse as the ductus constricts | Preductal/postductal oximetry, ECG, four-limb pressures, glucose, blood gas/lactate; secure IV access; start alprostadil if ductal dependence is plausible; avoid excess oxygen and fluid | Urgent echocardiography; chest radiography and ultrasound as adjuncts | Pediatric cardiology and cardiac surgery | Immediate consultation and transfer; catheter or operative intervention as soon as anatomy and physiology require. Prenatal diagnosis of dextro-transposition supports delivery at a tertiary center with immediate prostaglandin and timely intervention [141]. |
| Neural-tube defect, especially open myelomeningocele | Prenatal spinal lesion; sac or placode at birth, neurologic deficit, abnormal lower-limb tone, bladder dysfunction, or CSF leakage | Nurse prone or lateral with the lesion protected by sterile saline-moistened nonadherent dressing; prevent drying, pressure, heat loss, and contamination; assess bladder emptying and hydrocephalus; treat exposed tissue as an urgent operative problem | Spinal ultrasound when the posterior elements permit; MRI of spine and brain when stable; cranial ultrasound for ventriculomegaly | Pediatric neurosurgery, urology, and genetics | Same-day neurosurgical discussion; repair urgently after stabilization, with CSF diversion determined by hydrocephalus and operative findings. Early presentation of myelomeningocele is associated with fewer wound and shunt complications in a prospective cohort [232]. |
| Omphalocele or gastroschisis | Prenatal abdominal-wall defect; exposed bowel without a sac in gastroschisis, or membrane-covered bowel/liver in omphalocele | Protect exposed viscera with a sterile warm transparent covering; minimize heat and fluid loss; avoid compression; insert an orogastric tube, provide IV access, analgesia, and serial perfusion/abdominal-pressure assessment; intubate for respiratory compromise | Abdominal radiography when obstruction, perforation, or malposition is suspected; abdominal ultrasound; echocardiography and renal ultrasound; genetic evaluation for omphalocele-associated syndromic disease | Pediatric surgery, genetics, and anesthesia | Immediate surgical consultation. Stage reduction with a silo when primary closure would impair ventilation or venous return; new bilious drainage, sac deterioration, increasing distension, or acidosis demands urgent reassessment for mechanical obstruction. Giant omphalocele commonly requires individualized staged reduction because forced closure can compromise cardiorespiratory function [235]. |
| Esophageal atresia with or without tracheoesophageal fistula | Excessive salivation, choking or desaturation with feeds, inability to pass an orogastric tube, prenatal polyhydramnios, abdominal distension from a distal fistula | Stop oral feeds; nurse head elevated; continuous or frequent upper-pouch suction; avoid bag-mask ventilation when possible; intubate for respiratory failure and treat aspiration; obtain IV access | Chest and abdominal radiograph with a radiopaque tube; bronchoscopy or contrast study only after surgical discussion and with aspiration precautions; renal, cardiac, vertebral, and limb assessment | Pediatric surgery, airway/anesthesia, cardiology, and genetics | Urgent surgical consultation at diagnosis; repair after stabilization, with emergency operation for respiratory deterioration, severe aspiration, or perforation. |
| Intestinal atresia, malrotation, or volvulus | Prenatal polyhydramnios or dilated bowel; bilious emesis, failure to pass meconium, progressive distension, tenderness, bloody stool, shock, or metabolic acidosis | Nil by mouth; orogastric decompression; IV fluids only for documented losses or hypovolemia; correct glucose, electrolytes, temperature, and perfusion; obtain cultures and antibiotics when ischemia, perforation, or sepsis is suspected | Serial abdominal radiographs; ultrasound with Doppler for volvulus; water-soluble contrast enema or upper gastrointestinal contrast study in a stable infant after surgical consultation | Pediatric surgery and radiology | Bilious emesis with shock, peritonism, bloody stool, rising lactate, or suspected volvulus requires immediate operation rather than a prolonged contrast work-up. Small-bowel atresia affects approximately 1 in 1,500-4,500 neonates, but comparative surgical evidence remains retrospective and does not establish routine tapering enteroplasty [233]. |
| Hirschsprung disease | Delayed meconium, abdominal distension, bilious vomiting, feeding intolerance, or explosive stool after rectal examination; enterocolitis may present with fever, lethargy, diarrhea, or shock | Decompress with rectal irrigations only by trained personnel; stop feeds if enterocolitis or obstruction is suspected; correct dehydration and electrolytes; obtain cultures and give antibiotics for systemic illness | Contrast enema can suggest the level but does not establish the diagnosis; rectal suction biopsy with ganglion-cell and nerve-fiber assessment is diagnostic; serial mapping is required for suspected total colonic aganglionosis | Pediatric surgery, gastroenterology, and pathology | Early surgical consultation; urgent treatment for complete obstruction, perforation, or Hirschsprung-associated enterocolitis. In a prospective cohort, appendix-tip biopsy was proposed only as an adjunct for suspected total colonic aganglionosis, with interpretation requiring adequate muscular tissue and experienced pathology [234]. |
| Anorectal malformation | Absent or ectopic anus, abnormal perineal anatomy, failure to pass meconium, abdominal distension, or meconium from the urethra or vagina | Keep nil by mouth if obstructed; decompress the stomach; monitor urine output and abdominal pressure; inspect for fistula; avoid traumatic probing; obtain IV access and treat sepsis or perforation | Perineal examination and cross-table lateral radiograph or prone imaging when operative planning requires it; renal and spinal ultrasound; echocardiography; MRI for spinal dysraphism; contrast study after decompression when fistula anatomy remains uncertain | Pediatric colorectal surgery, urology, neurosurgery, and genetics | Immediate surgical consultation; diversion or selected primary repair depends on anatomy and stability. Early screening for renal, spinal, and Müllerian anomalies is recommended in contemporary multidisciplinary practice [229]. |
| Congenital diaphragmatic hernia | Prenatal herniated abdominal viscera, mediastinal shift, scaphoid abdomen, severe respiratory distress, or asymmetric breath sounds | Avoid mask ventilation; intubate early; insert an orogastric tube to suction; use gentle lung-protective ventilation, monitor pre/postductal saturation and perfusion, and treat pulmonary hypertension and shock in a tertiary center | Chest radiograph confirms the intrathoracic viscera after stabilization; echocardiography defines pulmonary hypertension and cardiac anatomy; fetal ultrasound or MRI assists prenatal severity assessment | Neonatology, pediatric surgery, cardiology, and ECMO team | Repair only after cardiorespiratory stabilization, adequate perfusion, and improving gas exchange. A 2026 meta-analysis found higher mortality when repair occurred within 24 hours than at or after 24 hours, although most included studies were retrospective [55]. |
| Urinary tract obstruction or posterior urethral valves | Bilateral hydronephrosis, oligohydramnios, enlarged bladder, poor urinary stream, palpable bladder, electrolyte disturbance, or failure to void | Confirm urine output; catheterize gently if retention is suspected; monitor potassium, creatinine, acid-base status, blood pressure, and fluid balance; avoid repeated fluid boluses without evidence of hypovolemia | Renal/bladder ultrasound; serum chemistry and urinalysis; voiding cystourethrography after stabilization for suspected reflux or posterior urethral valves; renal scintigraphy or MRI for selected anatomy | Pediatric urology and nephrology | Same-day urology consultation for bilateral obstruction, rising creatinine, hyperkalemia, respiratory compromise from oligohydramnios-related pulmonary hypoplasia, or urinary retention; decompress and drain urgently when indicated. |
| Ambiguous genitalia or suspected disorder of sex development | Atypical genital phenotype, palpable gonads, hypospadias with bilateral undescended testes, salt-wasting illness, or prenatal concern | Do not assign sex hurriedly or perform circumcision; assess airway, perfusion, glucose, sodium, potassium, acid-base status, and hydration; obtain IV access; treat adrenal crisis immediately with isotonic saline, dextrose, and hydrocortisone according to local emergency protocol | Electrolytes, glucose, 17-hydroxyprogesterone, cortisol, renin/aldosterone, testosterone and related steroids; karyotype or rapid sex-chromosome testing; pelvic/abdominal ultrasound; targeted genetic testing | Pediatric endocrinology, genetics, urology, and psychology; involve the family with a coordinated team | Immediate endocrine consultation when illness or electrolyte abnormality is present; multidisciplinary diagnostic planning before irreversible surgery or definitive sex assignment. |
| Major skeletal anomaly or limb-reduction defect | Prenatal abnormal long bones, contractures, absent or malformed limb, fractures, disproportion, thoracic restriction, or a dysmorphic pattern | Assess airway, breathing, chest-wall excursion, perfusion, neurologic function, and skin integrity; position gently, splint only when instability or pain warrants it, and provide analgesia; examine for associated vertebral, cardiac, renal, and craniofacial anomalies | Targeted radiographs of affected regions and spine; ultrasound for hips, kidneys, or soft tissues; echocardiography; MRI when spinal, brain, or complex soft-tissue anatomy will change management; genetic testing | Orthopedic surgery, genetics, neurosurgery, and rehabilitation | Urgent orthopedic or neurosurgical review for unstable fracture, spinal instability, threatened skin, vascular compromise, or airway-restricting skeletal dysplasia; genetics consultation during the initial admission. |
| Caput succedaneum | Diffuse, soft scalp edema crossing suture lines after labor or vacuum extraction | Observe, measure, and reassess; check skin, neurologic state, hematocrit, and bilirubin risk; investigate if swelling enlarges or the infant becomes unstable | Clinical diagnosis; ultrasound or radiography only when the diagnosis is uncertain or fracture is suspected | Neonatology; neurosurgery if atypical or complicated | Observation when stable; urgent assessment if swelling rapidly expands, anemia or shock develops, or neurologic signs appear. |
| Cephalohematoma | Localized subperiosteal swelling that does not cross sutures, often appearing after birth | Serial head examination, hematocrit, and bilirubin surveillance; do not aspirate routinely because infection risk and recurrence outweigh benefit | Ultrasound or skull radiography for suspected fracture or atypical mass; neuroimaging for neurologic deterioration | Neonatology; neurosurgery for depressed fracture, intracranial extension, or persistent diagnostic uncertainty | Observation in most cases; urgent imaging and specialist review for neurologic signs, anemia, infection, or an associated depressed fracture. |
| Subgaleal hemorrhage | Fluctuant scalp swelling crossing sutures, increasing head circumference, pallor, tachycardia, hypotension, lethargy, or acidosis after vacuum or forceps delivery | Treat as occult hemorrhagic shock: continuous cardiorespiratory monitoring, two vascular access sites if possible, serial head circumference and hematocrit, coagulation testing, crossmatched blood, and rapid blood-product replacement when indicated; correct hypothermia and coagulopathy | Bedside ultrasound may define the collection; cranial ultrasound or MRI/CT is added for neurologic signs, but imaging must not delay resuscitation | Neonatology, transfusion medicine, and neurosurgery | Immediate senior review and urgent transfer to intensive care; operate only for selected associated lesions, while resuscitation and hemorrhage assessment come first. |
| Clavicular fracture | Crepitus, swelling, asymmetric Moro reflex, reduced arm movement, or pain after shoulder dystocia or difficult extraction | Analgesia, gentle handling, avoid traction on the arm, and assess pulses, skin, and brachial plexus function | Clavicle radiograph when the diagnosis is uncertain or another fracture is suspected | Neonatology and orthopedics if displaced, open, or diagnostically uncertain | Usually conservative care; urgent orthopedic review for neurovascular compromise or multiple fractures. |
| Brachial plexus injury | Asymmetric Moro reflex, flaccid or internally rotated arm, absent biceps function, or diaphragmatic asymmetry after shoulder dystocia | Protect the limb from traction; assess respiratory effort, diaphragm, pulses, and associated clavicular or humeral injury; provide analgesia | Clinical neurologic examination; radiography for fracture; ultrasound for diaphragm; MRI or electrodiagnostic testing later when severity and recovery remain uncertain | Neurology, orthopedics, and rehabilitation | Examine serially; urgent specialist review for complete palsy, Horner syndrome, respiratory compromise, or suspected avulsion; early rehabilitation planning. |
| Facial nerve injury | Asymmetric facial movement, incomplete eye closure, or flattened nasolabial fold after forceps delivery | Protect the cornea with lubrication and gentle eye care; assess feeding and associated skull injury; avoid unnecessary instrumentation | Clinical diagnosis; imaging only for atypical, progressive, or central neurologic findings | Neonatology, ophthalmology, and neurology | Early ophthalmology review if the eye cannot close; observe most peripheral birth palsies with serial examinations. |
| Spinal injury | Reduced movement, abnormal posture, respiratory failure, shock, or neurologic change after difficult extraction or extreme flexion/extension | Immobilize in neutral alignment, maintain oxygenation and perfusion, avoid repeated examination-induced movement, and obtain vascular access; manage neurogenic shock with specialist guidance | Radiographs for alignment and fracture; ultrasound in selected newborns; MRI of the spinal cord and soft tissues when stable | Neurosurgery, orthopedics, and neurology | Immediate immobilization and urgent neurosurgical/orthopedic consultation for neurologic deficit, deformity, or respiratory compromise. |
After stabilization, document the lesion with photographs or diagrams when appropriate, record neurologic and vascular findings before analgesia or sedation, and communicate the suspected anatomy and interventions during transfer. Prenatal or postnatal detection of an anomaly is not the same as physiological stability: an infant with a normal initial examination may deteriorate as ductal flow closes, bowel obstruction progresses, hemorrhage accumulates, or pulmonary hypertension worsens. Re-examine after every change in color, perfusion, abdominal tension, urine output, respiratory requirement, or neurologic state.
Pearl: In a newborn with an unusual external appearance, prioritize function before nomenclature: protect the airway, decompress the stomach, obtain access, assess perfusion and hemorrhage, define anatomy with the least destabilizing study, and involve the responsible surgical or subspecialty team before deterioration removes the safest options.
Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making
- ▸Discharge requires demonstrated stability across cardiorespiratory status, temperature, feeding, growth, medications, caregiver skills, transport, screening, and follow-up, with axillary temperature maintained at 36.5-37.5°C in an open cot while appropriately clothed unless prescribed technology is required.
- ▸Use teach-back: caregivers should explain the plan in their own words, demonstrate required tasks, identify whom to call, and have a documented escalation plan for danger signs or device failure.
- ▸For developmental surveillance, corrected age equals chronological age minus the weeks born before 40 weeks’ gestation, while chronological age remains the reference for immunization, screening, medication, and public-health decisions.
Discharge is a physiologic and social transition, not a date on the calendar. Release the infant only when cardiorespiratory stability, temperature control, feeding, growth, medication administration, caregiver competence, transport, and follow-up arrangements have been assessed together. A caregiver’s ability to repeat instructions is more useful than a signed information sheet; health-literacy assessment should examine how understanding is created during clinician-caregiver interactions, not only what facts the caregiver can recall [246].
| Discharge domain | Minimum criterion | Responsible clinician | Required documentation | Postdischarge action |
|---|---|---|---|---|
| Physiologic stability | No clinically significant apnea, bradycardia, desaturation, cyanosis, respiratory distress, unexplained hypothermia, or hemodynamic instability for a period appropriate to gestational age and disease; the infant must remain stable without unplanned escalation | Neonatologist or attending physician, with nursing and respiratory therapy input | Stability review, relevant event-free observation period, current respiratory support and oxygen prescription | Written escalation plan and urgent-care thresholds; early primary-care or neonatal follow-up |
| Thermoregulation | Maintains an axillary temperature of 36.5-37.5°C in an open cot while appropriately clothed, unless discharge requires a prescribed incubator or other technology | Neonatologist and bedside nurse | Serial temperatures, cot or incubator assessment, caregiver demonstration of thermal care | Home-temperature and clothing advice; review at the first visit |
| Feeding and growth | Demonstrated safe oral feeding or a documented tube-feeding plan; intake, hydration, stooling, and urine output are adequate; weight trajectory and fortification or formula preparation are understood | Neonatologist, nurse, lactation consultant, dietitian, and feeding therapist when indicated | Feeding assessment, prescribed volume and frequency, breast-milk or formula preparation, weight and growth plan, tube-care competency if applicable | Weight check and feeding review arranged promptly; define signs requiring same-day assessment |
| Medication competence | Every medication has a named indication, dose, route, frequency, duration, storage instruction, and prescribing clinician; caregivers can measure and administer each dose and know what to do after a missed or vomited dose | Prescribing clinician and pharmacist | Reconciled medication list, prescriptions, teach-back record, pharmacy access | Medication review at follow-up and after every transition of care |
| Caregiver readiness | Caregivers demonstrate feeding, medication administration, temperature measurement, equipment use, safe sleep, infection reduction, and recognition of danger signs; language, sensory, cognitive, transport, housing, and safeguarding barriers have been addressed | Nurse coordinator with multidisciplinary team | Named primary caregiver, interpreter use, teach-back results, emergency contacts, safeguarding assessment, social-work plan | Telephone or home-health contact when risk warrants; provide a single point of contact |
| Safe transport | An appropriate rear-facing infant restraint is available, correctly installed, and compatible with the infant’s size and medical needs; oxygen or monitoring requirements are secured for travel | Nurse, respiratory therapist, or transport team | Car-seat or transport assessment, equipment checklist, oxygen prescription, travel plan | Reassess equipment at follow-up and after growth or respiratory change |
| Screening and prevention | Newborn bloodspot screening, hearing assessment, critical congenital heart disease screening, immunization review, and indicated prophylaxis are completed or have a dated plan for completion; unresolved abnormal results must not be lost during discharge | Neonatologist or designated newborn clinician | Results, specimen date and adequacy, repeat or confirmatory appointments, immunization record, pending-result tracker | Closed-loop result notification and documented responsibility for every pending test |
| Follow-up ownership | Each specialty, primary-care, developmental, feeding, ophthalmology, audiology, cardiology, renal, and technology-related appointment has an owner, date, location, and transport plan | Discharge coordinator and relevant specialty clinicians | Consolidated discharge summary and appointment schedule sent to caregivers and receiving clinicians | Confirm attendance; actively rebook missed high-risk appointments |
The discharge summary should communicate the infant’s birth and neonatal course, diagnoses, procedures, respiratory and nutritional support, transfusions, neurologic findings, imaging, microbiology, immunizations, screening results, medication changes, equipment settings, pending investigations, and explicit contingency plans. Give caregivers a one-page version in plain language. Ask them to explain the plan in their own words, demonstrate the tasks they will perform, and identify whom they will call. Early participation in care and timely peer or mentorship support can accelerate caregiver progression from uncertainty to independent expertise, a finding derived from qualitative interviews of caregivers of infants with critical congenital heart disease [247].
Structured follow-up
Assign infants born preterm, with fetal growth abnormality, major illness, brain injury, prolonged respiratory support, severe infection, congenital anomalies, or prolonged hospitalization to a high-risk infant program when available. Follow corrected age for developmental assessment: corrected age equals chronological age minus the weeks born before 40 weeks’ gestation. Continue to record chronological age for immunization, screening, medication, and public-health decisions. The assessment should combine neurologic examination, growth, feeding, vision, hearing, language, cognition, motor function, social interaction, family mental health, and social determinants of health rather than relying on a single developmental score.
Arrange serial review for with respiratory examination, oxygen and equipment assessment, growth, feeding safety, sleep-related symptoms, pulmonary hypertension risk, and medication reconciliation. Wean oxygen or respiratory technology only against documented physiology and a reliable home plan. A history of extubation failure identifies infants at increased risk of later respiratory morbidity but does not establish that extubation failure itself caused the outcome; this distinction prevents prognosis from being presented as therapeutic certainty [2].
Complete examinations according to national eligibility and ophthalmology scheduling criteria. Discharge is unsafe if an examination is due but has no booked date, responsible clinician, or transport plan. Prediction tools may help prioritize already eligible infants, but they must not replace established screening or exclude an eligible infant; a two-center retrospective model explicitly warned that its exploratory cutoff should not determine screening eligibility and requires external validation [251].
Arrange audiology follow-up after failed or incomplete newborn hearing screening and maintain surveillance when congenital infection, severe hyperbilirubinemia, meningitis, prolonged intensive care, or other auditory risk is present. Congenital deserves particular vigilance because it is a leading infectious cause of sensorineural hearing loss and neurodevelopmental impairment [90].
Neurologic follow-up should be offered after , seizures, intracranial hemorrhage, periventricular white-matter injury, stroke, meningitis, abnormal neurologic examination, or extreme prematurity. Use serial examinations and, when available, General Movements Assessment during early infancy; refer promptly for physiotherapy, occupational therapy, speech and language therapy, or early-intervention services when abnormalities emerge. At school age, clinically significant non-cerebral-palsy motor difficulties affected 25.5% of children born extremely preterm in one Swedish registry study, yet only 16.9% of those with relevant data had received physiotherapy [5]. This gap supports surveillance based on observed function rather than cerebral palsy diagnosis alone.
Assess cognition, language, behavior, hearing, vision, and motor function at corrected-age visits. A normal early examination does not guarantee normal later development, while an abnormal screening result is a reason for assessment and intervention, not a fixed prediction. Maternal mental health belongs in the infant’s developmental plan: in a cohort of infants born before 30 weeks, maternal mental-health treatment was associated with higher odds of low cognitive and language scores, although residual confounding prevents a causal conclusion [257].
Monitor infants with feeding difficulty for aspiration, unsafe suck-swallow-breathe coordination, oral aversion, reflux-like symptoms that impair intake, tube dependence, micronutrient deficiency, and faltering growth. Use a multidisciplinary feeding pathway when oral skills, respiratory reserve, or growth remains inadequate. For infants with , , nephrocalcinosis, hypertension, renal dysplasia, or prior acute kidney injury, arrange renal function, blood-pressure, electrolyte, urinalysis, growth, and medication review with pediatric nephrology when indicated. Severe congenital heart disease in very-low-birth-weight infants is associated with higher neonatal mortality and greater risk of growth failure and neurodevelopmental impairment at 18-24 months’ corrected age, supporting coordinated cardiology, nutrition, and developmental surveillance [249]. Cardiology follow-up must specify lesion, physiology, medication, feeding and oxygen targets, activity advice, planned imaging, and the threshold for urgent review; poor documentation and overly early repeat imaging have been associated with non-adherence to congenital-heart-disease follow-up guidance [248].
Technology dependence changes discharge from an event into a supervised care pathway. For home oxygen, tracheostomy, ventilatory support, feeding tubes, monitors, or infusion access, confirm stable settings, backup equipment, power and oxygen supply, emergency training, caregiver availability, home nursing or community support, and a clinician who can respond to alarms or deterioration. Document what the device can and cannot diagnose; an alarm is not a diagnosis, and caregivers need symptom-based escalation instructions. Address social barriers directly: a systematic review of congenital-heart-disease surgery found that social determinants were associated with mortality, complications, longer interstage periods, readmission, and resource use [250].
Outcomes and communication
Counsel families using a defined time horizon and denominator: survival to discharge, survival at one year, major morbidity, duration of intensive care, neurodevelopmental outcome, feeding and growth, family well-being, and the child’s later function. Separate what is known about this infant from estimates derived from populations, and distinguish association from causation. Explain uncertainty as a range of plausible futures, update it when new examination, imaging, or developmental information becomes available, and avoid presenting a prediction model or a single test as destiny.
Use shared decision-making when more than one medically reasonable pathway exists. Establish the infant’s best interests, elicit the family’s goals and understanding, clarify burdens and benefits, and recommend a plan proportionate to the expected benefit rather than transferring the decision to parents without professional guidance. Health-literacy tools in critical-care research commonly measure prognosis, treatment, neonatal care, readiness for discharge, and decision-making, but the review concluded that these tools should be paired with interaction-focused communication [246]. Use professional interpreters, allow time for questions, and document the participants, information provided, values expressed, options considered, recommendation, and agreed review point.
Proportionality requires treatment that offers a plausible benefit commensurate with its burdens. Do not equate disability with an unacceptable life, and do not equate technological possibility with an obligation to continue every intervention. When treatment cannot achieve its physiological goal, cannot restore a meaningful possibility of survival, or imposes burdens disproportionate to benefit, convene the relevant specialists and an ethics service where available. Offer alongside disease-directed treatment for symptom control, family support, and anticipatory planning; palliative care is not limited to the final hours of life.
Withholding and withdrawing life-sustaining treatment are ethically and clinically equivalent when the treatment no longer serves the infant’s goals or best interests; the difference is whether an intervention is not started or is stopped. Make the decision through multidisciplinary review and shared deliberation with the family, document the medical rationale and alternatives, and continue warmth, analgesia, dyspnea relief, feeding or hydration according to goals, skin-to-skin contact, privacy, and spiritual or cultural support. Do not initiate interventions judged nonbeneficial solely because of professional discomfort, fear of criticism, or an attempt to postpone a difficult conversation. Reassess whenever the clinical trajectory changes, and seek an independent ethics or legal opinion when disagreement persists or local law requires it.
Discuss sensitively and according to jurisdictional law and institutional policy, using an authorized donation specialist rather than allowing donation considerations to influence treatment recommendations. Provide bereavement support before and after death, offer memory-making and culturally appropriate rituals, explain what happens next, and arrange follow-up contact. Screen caregivers for traumatic stress, depression, anxiety, complicated grief, and practical needs; refer promptly when symptoms impair safety or functioning.
Safeguarding begins before discharge. Assess unexplained injury, inconsistent history, unsafe sleep plans, caregiver intoxication or severe mental illness, domestic violence, coercion, neglect, inability to obtain essential medicines or nutrition, and threats to technology safety. Use a trauma-informed approach, involve social work and safeguarding professionals, and do not discharge until an immediate safety plan exists. Caregivers should leave knowing the danger signs, breathing difficulty, cyanosis, apnea, fever or hypothermia, seizure, marked lethargy, worsening jaundice, bilious vomiting, blood in stool, dehydration, feeding deterioration, or device failure, and exactly where to seek help; caregiver reports describe fear, delayed care-seeking, geographical barriers, and limited health literacy as causes of delayed professional assessment [259].
Pearl: Safe discharge is demonstrated by a stable infant, a capable caregiver, a closed-loop plan for every pending result and follow-up need, and a documented pathway for deterioration, uncertainty, and disagreement.
References
- [1]
Jawad S, Prevost AT, Gale C. “Intracluster correlation coefficients for neonatal trials: an analysis of national population level clinical data.” Trials (2026). PMID: 42894246 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [2]
Ali K, Aljarbou T, Algarni S et al.. “Extubation failure in very preterm infants: associations with respiratory outcomes in a nine-year cohort study.” BMC pediatrics (2026). PMID: 42897501 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes, Neonatal Respiratory Disease and Escalation of Respiratory Support, Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [3]
Kulkarni A, Richards J, Fatima T et al.. “Effects of Neurally Adjusted Ventilatory Assist on Lung Ultrasound Aeration and Diaphragmatic Function in Extremely Preterm Infants With Evolving or Established Bronchopulmonary Dysplasia.” Pediatric pulmonology (2026). PMID: 42895257 ↗
Journal Article, Observational StudyCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [4]
Yaprak D, Saygılı Karagöl B. “Biochemical and anthropometric assessment of nutritional status at discharge in very-low-birth-weight infants: a retrospective cohort study.” Journal of perinatal medicine (2026). PMID: 42895101 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [5]
Nosko D, Padilla N, Svensson K et al.. “Motor difficulties, motor-related health care, and associating factors in children born extremely preterm.” Developmental medicine and child neurology (2026). PMID: 42893548 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes, Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [6]
Xu Y, Khan K, Roberts N et al.. “A systematic review of medication costs associated with preterm infants.” Cost effectiveness and resource allocation : C/E (2026). PMID: 42894222 ↗
Journal Article, ReviewCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [7]
Mekonnen E, Darebo T, Girma A et al.. “Determinants of low birth weight among newborns in selected public hospitals in Southwest Ethiopia: a multi-center unmatched case-control study.” Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives (2026). PMID: 42892074 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [8]
Alansari AN, Sabbah AF, Salim A et al.. “The impact of armed conflict exposure on preterm birth, stillbirth, and neonatal anthropometric measures: a systematic review and meta-analysis.” International journal of public health (2026). PMID: 42889079 ↗
Journal Article, Systematic Review, Meta-Analysis, ReviewCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [9]
Sun X, Wang W, Fuentes D. “Temporal trends in surfactant replacement therapy among U.S. infants, 2016-2024.” Frontiers in pediatrics (2026). PMID: 42890236 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [10]
Marques DP, da Silva AKF, de Medeiros IU et al.. “Potential Drug-Drug Interactions in Critically Ill Neonates: Association With Clinical Outcomes in a Prospective Cohort.” Critical care research and practice (2026). PMID: 42889513 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [11]
Çuvadar A, Çuvadar Baş Y, Özçalkap N et al.. “Effect of a structured healthcare professional-supported kangaroo care model on clinical outcomes in preterm neonates: A retrospective quasi-experimental cohort study.” Irish journal of medical science (2026). PMID: 42895622 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [12]
Al-Wassia H, Bamehrez M, Kurdi M et al.. “Association of Red Blood Transfusion With Necrotizing Enterocolitis in Very Low Birth-Weight Neonates: A 7-Year Retrospective Cohort Study in Saudi Arabia.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42896071 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes, Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders, Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [13]
Courtney A, Oei JL. “Validating a Wearable Bluetooth Oximeter for Infants in the Neonatal Intensive Care Unit.” Journal of paediatrics and child health (2026). PMID: 42888495 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [14]
Hoffman J, Farmer M, Pelkmans J et al.. “Examining the Association Between Shift Length, Fatigue, and Perceived Safety in NNP Practice.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42896080 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [15]
Mohammad K, El-Dib M, Chalak L. “The education pillar of the neuro-NICU: A framework for competency-based neonatal neurocritical care.” Seminars in perinatology (2026). PMID: 42897044 ↗
Journal Article, ReviewCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [16]
Pyeon SY, Kwon H, Kim HJ et al.. “KSMFM factsheet on obstetric complications after myomectomy or adenomyomectomy: uterine rupture and placenta accreta spectrum.” Obstetrics & gynecology science (2026). PMID: 42893824 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [17]
Namutebi S, Ishimwe MPS, Kasujja M et al.. “Early Adverse Neonatal Outcomes Among Women With Diabetes in Pregnancy in Uganda: Incidence, Distribution and Associated Factors in a Multicenter Prospective Cohort Study.” Health science reports (2026). PMID: 42891101 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes, Antenatal Risk Assessment and Perinatal Preparation, Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [18]
Leybovitz-Haleluya N, Gutvirtz G, Bendet A et al.. “Short-term obstetrical and neonatal complications in women with endometriosis.” Archives of gynecology and obstetrics (2026). PMID: 42894015 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [19]
Goel S, Singh C, Appannagari V et al.. “Natural history and perinatal outcomes of antenatally diagnosed CPAM in a resource-limited setting.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2026). PMID: 42891504 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [20]
Wang S, Xiao Y, Liu H et al.. “Trimester-specific associations of maternal vitamin D metabolic markers with risks of small vulnerable newborns: a prospective birth cohort study.” BMC medicine (2026). PMID: 42897644 ↗
Journal ArticleCited in: Neonatology: Scope, Population, Levels of Care, and Core Outcomes - [21]
Hooper SB, Te Pas AB, Kitchen MJ. “Respiratory transition in the newborn: a three-phase process.” Archives of disease in childhood. Fetal and neonatal edition (2015). PMID: 26542877 ↗
Journal Article, Research Support, Non-U.S. Gov't, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [22]
Hooper SB, Te Pas AB, Lang J et al.. “Cardiovascular transition at birth: a physiological sequence.” Pediatric research (2015). PMID: 25671807 ↗
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [23]
Hooper SB, Roberts C, Dekker J et al.. “Issues in cardiopulmonary transition at birth.” Seminars in fetal & neonatal medicine (2019). PMID: 31607487 ↗
Journal Article, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [24]
van Vonderen JJ, Te Pas AB. “The first breaths of life: imaging studies of the human infant during neonatal transition.” Paediatric respiratory reviews (2015). PMID: 25962858 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [25]
Chakkarapani AA, Roehr CC, Hooper SB et al.. “Transitional circulation and hemodynamic monitoring in newborn infants.” Pediatric research (2023). PMID: 36593283 ↗
Journal Article, Review, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [26]
Ramachandrappa A, Jain L. “Elective cesarean section: its impact on neonatal respiratory outcome.” Clinics in perinatology (2008). PMID: 18456075 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [27]
Richardson BS, Wakim E, daSilva O et al.. “Preterm histologic chorioamnionitis: impact on cord gas and pH values and neonatal outcome.” American journal of obstetrics and gynecology (2006). PMID: 16677589 ↗
Journal Article, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [28]
Tingay DG, Farrell O, Thomson J et al.. “Imaging the Respiratory Transition at Birth: Unraveling the Complexities of the First Breaths of Life.” American journal of respiratory and critical care medicine (2021). PMID: 33545023 ↗
Journal Article, Observational Study, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [29]
Gaertner VD, Büchler VL, Waldmann A et al.. “Deciphering Mechanisms of Respiratory Fetal-to-Neonatal Transition in Very Preterm Infants.” American journal of respiratory and critical care medicine (2024). PMID: 38032260 ↗
Journal Article, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [30]
Gaertner VD, Ramin-Wright L, Waldmann AD et al.. “The first breaths after birth-early lung function in healthy term infants.” American journal of respiratory and critical care medicine (2026). PMID: 41738190 ↗
Journal Article, Observational StudyCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [31]
Singh Y, Tissot C. “Echocardiographic Evaluation of Transitional Circulation for the Neonatologists.” Frontiers in pediatrics (2018). PMID: 29868528 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [32]
Baik N, Urlesberger B, Schwaberger B et al.. “Foramen ovale (FO) - The underestimated sibling of ductus arteriosus (DA): Relevance during neonatal transition.” Early human development (2016). PMID: 27648971 ↗
Journal Article, Observational StudyCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [33]
Sankaran D, Lakshminrusimha S. “Pulmonary hypertension in the newborn- etiology and pathogenesis.” Seminars in fetal & neonatal medicine (2022). PMID: 35963740 ↗
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [34]
Lakshminrusimha S. “The pulmonary circulation in neonatal respiratory failure.” Clinics in perinatology (2012). PMID: 22954275 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [35]
Suciu LM, Prelipcean I, Făgărășan A et al.. “Normative echocardiography data of myocardial adaptation to extrauterine life: a review of prospective studies.” Frontiers in pediatrics (2023). PMID: 37397152 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [36]
van Vonderen JJ, te Pas AB, Kolster-Bijdevaate C et al.. “Non-invasive measurements of ductus arteriosus flow directly after birth.” Archives of disease in childhood. Fetal and neonatal edition (2014). PMID: 24966129 ↗
Journal Article, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [37]
Sehgal A, Allison BJ, Miller SL et al.. “Impact of Acute and Chronic Hypoxia-Ischemia on the Transitional Circulation.” Pediatrics (2021). PMID: 33622795 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [38]
Lakshminrusimha S, Saugstad OD. “The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy.” Journal of perinatology : official journal of the California Perinatal Association (2016). PMID: 27225963 ↗
Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov'tCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [39]
Tin W. “Defining neonatal hypoglycaemia: a continuing debate.” Seminars in fetal & neonatal medicine (2013). PMID: 24148999 ↗
Journal Article, ReviewCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [40]
Lamary M, Bertoni CB, Schwabenbauer K et al.. “Neonatal Golden Hour: a review of current best practices and available evidence.” Current opinion in pediatrics (2023). PMID: 36722754 ↗
Review, Video-Audio Media, Journal ArticleCited in: Fetal-to-Neonatal Transition: Respiratory, Cardiovascular, and Metabolic Adaptation - [41]
Yasin R, Tam Y, Rizvi A et al.. “Antenatal interventions to support newborn survival: updates for the Lives Saved Tool.” Journal of global health (2026). PMID: 42825345 ↗
Evidence Synthesis, Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [42]
Sarrato SEZ, Martín TÁ, Chamorro IP et al.. “Perinatal management and delivery-room stabilization in congenital complete heart block: an 11-year experience at a tertiary center.” European journal of pediatrics (2026). PMID: 42878774 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation, Delivery-Room Stabilization and Neonatal Resuscitation - [43]
Kamra S, Moon D, Green N et al.. “Clinical, economic, and health-related quality of life impact of intrapartum group B Streptococcus (GBS) tests for prevention of neonatal GBS infection: a systematic literature review.” The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026). PMID: 42869779 ↗
Journal Article, Systematic ReviewCited in: Antenatal Risk Assessment and Perinatal Preparation - [44]
Teuscher JL, Lohrmann F, Herting E et al.. “Time to rethink prevention of neonatal group B streptococcal disease.” Seminars in immunopathology (2026). PMID: 42747473 ↗
Journal Article, ReviewCited in: Antenatal Risk Assessment and Perinatal Preparation, Neonatal Infection, Sepsis, and Perinatal Viral Disease - [45]
Bonato I, Calandrino A, Caruggi S et al.. “Impact of antenatal corticosteroid exposure on glycemic control in preterm infants assessed by continuous glucose monitoring: preliminary results from a single center study.” Frontiers in endocrinology (2026). PMID: 42890723 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation, Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [46]
Li H. “Perinatal teach-back health education combined with comprehensive nutritional intervention reduces fasting blood glucose and improves maternal and neonatal pregnancy outcomes in women with gestational diabetes mellitus.” Endocrine (2026). PMID: 42804033 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [47]
Nantale R, Mukunya D, Wandabwa JN et al.. “Introducing the Moyo device for intrapartum fetal heart rate monitoring among women with high-risk pregnancies in a low-resource setting: a quasi-experimental study.” BMJ open (2026). PMID: 42833709 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [48]
Kapudere B, Aydın R, Aydın Ö et al.. “Conventional statistical and machine learning-based prediction of neonatal outcomes in late-onset fetal growth restriction.” Journal of perinatal medicine (2026). PMID: 42836772 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [49]
Huang L, Tian X, Zeng Y et al.. “Factors associated with the development of neonatal acute respiratory distress syndrome in preterm infants: a retrospective cohort study.” European journal of pediatrics (2026). PMID: 42814210 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [50]
Panneflek TJR, Dekker J, Bizet GMS et al.. “The impact of histological chorioamnionitis and funisitis on breathing effort of premature infants receiving physiological based cord clamping: a retrospective analysis.” Early human development (2026). PMID: 42843082 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation, Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [51]
de Araujo FGB, Silveira RC, Teixeira DG et al.. “Neonatal outcomes of hypertensive pregnancy subtypes in very preterm infants: a multicenter cohort study.” BMC pediatrics (2026). PMID: 42750010 ↗
Journal Article, Multicenter Study, Observational StudyCited in: Antenatal Risk Assessment and Perinatal Preparation - [52]
Müller LM, Oelmeier K, Schmitz R et al.. “Amniotic-Umbilical-to-Cerebral Ratio (AUCR) as a diagnostic tool for predicting adverse perinatal outcome in pregnancies complicated by preeclampsia.” Archives of gynecology and obstetrics (2026). PMID: 42766167 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [53]
Chowdhury O, Armali C, Devion C et al.. “Mapping obstetric biobanks: A scoping review highlighting gaps in the study of alloimmunized pregnancies.” Transfusion (2026). PMID: 42811743 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [54]
Trahan MJ, Wen T, Huang Y et al.. “Maternal Outcomes Among Periviable Births by Cesarean Delivery.” JAMA network open (2026). PMID: 42758508 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [55]
Radhakrishna V, Balachander B, Hansoge Somanath S et al.. “Association between surgical repair timing and mortality in neonates with congenital diaphragmatic hernia: a systematic review and meta-analysis.” Clinical and experimental pediatrics (2026). PMID: 42755081 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation, Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [56]
Feng C, Hou M. “Serum biomarkers and their association with disease severity and perinatal outcomes in preeclampsia: a retrospective study.” BMC pregnancy and childbirth (2026). PMID: 42897535 ↗
Journal ArticleCited in: Antenatal Risk Assessment and Perinatal Preparation - [57]
Mohebi A, Pathirana MM, Arstall MA et al.. “Metabolic syndrome during pregnancy and adverse pregnancy outcomes: A systematic review and meta-analysis.” Women & health (2026). PMID: 42788828 ↗
Journal Article, Meta-Analysis, Systematic ReviewCited in: Antenatal Risk Assessment and Perinatal Preparation - [58]
Zhao M, Zheng H, Qi D et al.. “Prenatal allostatic load and adverse pregnancy outcomes: a systematic review and meta-analysis.” PeerJ (2026). PMID: 42802863 ↗
Journal Article, Systematic Review, Meta-AnalysisCited in: Antenatal Risk Assessment and Perinatal Preparation - [59]
Kociszewska-Najman B, Stanojević M, Czaplińska N et al.. “Neonatal and long-term outcomes in infants born to mothers after solid organ transplantation: a narrative review with Polish cohort data.” Journal of perinatal medicine (2026). PMID: 42757421 ↗
Journal Article, ReviewCited in: Antenatal Risk Assessment and Perinatal Preparation - [60]
Heo JS, Jung YH, Kim AE et al.. “2025 Korean Guidelines for Cardiopulmonary Resuscitation: Part 9. Neonatal resuscitation.” Clinical and experimental emergency medicine (2026). PMID: 42297412 ↗
Guideline, Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [61]
Kuitunen I, Davis PG. “How consistent are recent neonatal resuscitation guidelines?” Resuscitation plus (2026). PMID: 42027799 ↗
Journal Article, ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [62]
Gaertner VD, Mileder LP, Springer L et al.. “Corrective steps during neonatal mask ventilation - a narrative review of the evidence behind the MR SOPA acronym.” Resuscitation plus (2026). PMID: 41909182 ↗
Journal Article, ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [63]
Kawakami MD, Kong JY, de Almeida MF et al.. “Initial vascular access for neonatal resuscitation: a systematic review.” Resuscitation (2026). PMID: 42508602 ↗
Journal Article, Systematic ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [64]
Pillai A, Sidaraddi S, Kumar A et al.. “From clamp to care: evidence-based insights to cord management in non-vigorous neonates.” Journal of perinatal medicine (2026). PMID: 42173652 ↗
Journal Article, ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [65]
Yang MJ, Douglass M, Carpenter RJ et al.. “Respiratory Management for the Infant with Congenital Diaphragmatic Hernia.” Clinics in perinatology (2026). PMID: 42276721 ↗
Journal Article, ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [66]
Roberts DS, Gilliland K, Sims C et al.. “Laryngeal Mask Airway: An Alternative for Neonatal Resuscitation in a US Safety-Net Hospital.” Respiratory care (2026). PMID: 42153354 ↗
Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [67]
Cavigioli F, Bresesti I, Castoldi F et al.. “Initial CPAP of 5 versus 8 cmH2O during delivery room stabilisation of very preterm infants: the PHILODENDROOM pilot randomised trial.” European journal of pediatrics (2026). PMID: 42608615 ↗
Journal Article, Randomized Controlled Trial, Comparative StudyCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [68]
Bloemhof MM, Dekker J, van den Berg SMA et al.. “Gentle limb fixation for a faster reliable heart rate obtained with pulse oximeter at birth.” Resuscitation (2026). PMID: 42264172 ↗
Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [69]
Kolachena V, Priyadarshi M, Singh P et al.. “Optimal site of tactile stimulation during initial steps of neonatal resuscitation: a three-arm randomized controlled trial.” Resuscitation (2026). PMID: 42361894 ↗
Journal Article, Randomized Controlled TrialCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [70]
Bayih WA, Eastwood K, Liley HG et al.. “A systematic review of mortality and severe morbidities following newborn chest compressions at birth.” Resuscitation (2026). PMID: 42069040 ↗
Journal Article, Systematic ReviewCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [71]
Pickett B, Pan B, Crawford S et al.. “Clinical and Nonclinical Factors and Advanced Neonatal Resuscitation Interventions.” JAMA network open (2026). PMID: 42060305 ↗
Journal Article, Research Support, Non-U.S. Gov'tCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [72]
de Almeida MF, Guinsburg R, Helenius K et al.. “Variation in Stabilization and Resuscitation Practices at Birth of Preterm Infants Among 12 National or Regional Neonatal Networks.” Acta paediatrica (Oslo, Norway : 1992) (2026). PMID: 42275456 ↗
Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [73]
Ghosh A, Munian D, Mandal K et al.. “Effect of intact cord resuscitation versus conventional cord clamping on clinical outcomes in very preterm neonates: a randomized controlled trial from Eastern India.” European journal of pediatrics (2026). PMID: 42584505 ↗
Journal Article, Randomized Controlled Trial, Comparative StudyCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [74]
Seiersen KV, Schaaning S, Andelius TCK et al.. “Epinephrine versus saline volume expansion in neonatal resuscitation: a blinded randomized piglet study.” Pediatric research (2026). PMID: 42141204 ↗
Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [75]
Zhou M, Liu JQ, Ramsie M et al.. “Effect of sustained inflation on pharmacokinetics and pharmacodynamics of endotracheal and supraglottic airway epinephrine in a neonatal piglet model.” Pediatric research (2026). PMID: 42493553 ↗
Journal ArticleCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [76]
Ali N, Law B, Thomas AR et al.. “Development and implementation of educational modules on management of neonates with critical congenital heart disease in the delivery room (LEARN-CHD).” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42209698 ↗
Journal Article, Randomized Controlled Trial, Multicenter StudyCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [77]
Tan MV, Davis P, Dawson J et al.. “Resuscitation of Preterm Infants: More Oxygen or More Trials?” Journal of paediatrics and child health (2026). PMID: 42695231 ↗
EditorialCited in: Delivery-Room Stabilization and Neonatal Resuscitation, Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [78]
Conlon S, Sammour I. “Laryngeal Mask Airway: An Underutilized Option for Neonatal Resuscitation.” Respiratory care (2026). PMID: 42579722 ↗
EditorialCited in: Delivery-Room Stabilization and Neonatal Resuscitation - [79]
Hao X, Huang X, Yang R et al.. “Progress and Prospects of Newborn Screening in China.” International journal of neonatal screening (2026). PMID: 42782616 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [80]
Stark Z, Lunke S, Boemer F et al.. “International experiences of genomic newborn screening: Lessons from over 10,800 newborns.” American journal of human genetics (2026). PMID: 42767216 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [81]
Sontag MK, Steyermark A, Shannon CM et al.. “Long-Term Follow-Up for Newborn Screening: A Roadmap and Guide With Programmatic Considerations.” Pediatrics (2026). PMID: 42674593 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [82]
Smith HS, Stein S, Henry MW et al.. “Decision Analysis to Inform Screening of the Young: An Interactive Newborn Screening Model.” Pediatrics (2026). PMID: 42674594 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [83]
Bailey DB, Gehtland LM, Peay H et al.. “Early Check: The First 5 Years.” Pediatrics (2026). PMID: 42674592 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [84]
Garvey G, Norris S, Scarfe J et al.. “Newborn Screening: Equity for Aboriginal and Torres Strait Islander Families in the Context of Emerging Genomics.” The Medical journal of Australia (2026). PMID: 42686408 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [85]
Zhao Z, Wang Y, Qiu H et al.. “Pediatric hearing loss in the universal newborn hearing screening era: etiologies, risk indicators, and clinical phenotypes.” Frontiers in public health (2026). PMID: 42852302 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [86]
Mackey AR, Löfkvist U. “Parental awareness of childhood hearing loss, risk factors and communication milestones following newborn hearing screening.” International journal of pediatric otorhinolaryngology (2026). PMID: 42531672 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [87]
Li L, Tang Y, Zhao J et al.. “Population-based newborn screening for inherited metabolic diseases in Beijing, China: findings from 404,990 infants.” Molecular genetics and metabolism (2026). PMID: 42664530 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [88]
Tuli G, Munarin J, Pavanello E et al.. “Newborn screening for congenital adrenal hyperplasia: a 3 years study embedded in 25 years of regional experience in Italy.” Endocrine (2026). PMID: 42803878 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [89]
Pessi AV, de Lima Spode Coutinho V, Dos Santos BB et al.. “Global birth prevalence of galactosemia and the role of neonatal screening: A scoping review.” Molecular genetics and metabolism (2026). PMID: 42594557 ↗
Journal Article, Scoping ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [90]
Bolchová J, Gkentzi D, Tomé RP et al.. “Temporal trends in the clinical presentation, management, and outcomes of children with congenital cytomegalovirus infection.” European journal of pediatrics (2026). PMID: 42873372 ↗
Journal Article, Multicenter StudyCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care, Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [91]
Abusalah MAHA, Abusalah MAHA, Raheem S et al.. “PCR-based detection of cytomegalovirus in neonates and children, with emphasis on congenital and neonatal-screening cohorts: A systematic review and meta-analysis.” SAGE open medicine (2026). PMID: 42676890 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [92]
Grünert SC, Bhattacharya K, Karall D et al.. “International Guideline on the Diagnosis, Treatment, and Monitoring of Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD).” Journal of inherited metabolic disease (2026). PMID: 42779363 ↗
Journal Article, Practice Guideline, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [93]
Crenshaw MM, Nading EB, Mills J et al.. “Early detection in action: developing and refining newborn screening for Pompe disease in North Carolina.” Molecular genetics and metabolism (2026). PMID: 42691781 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [94]
Korkmaz Ç, Akpınar OT, Kılıç A et al.. “Residual-Function and Splicing CFTR Variants Characterize False-Negative IRT Newborn Screening: A Ten-Year Single-Center Cohort From Türkiye.” Pediatric pulmonology (2026). PMID: 42834588 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [95]
Rehman B, Arif M, Akbar A et al.. “Growth and Neurodevelopmental Outcomes of Children With Congenital Hypothyroidism Identified Through Dried Blood Spot Newborn Screening at a Tertiary Care Hospital in Pakistan.” Endocrinology, diabetes & metabolism (2026). PMID: 42632077 ↗
Journal ArticleCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [96]
Kemper AR, Lam WKK, Ojodu J et al.. “Evidence Regarding Duchenne Muscular Dystrophy Newborn Screening.” Pediatrics (2026). PMID: 42674588 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [97]
Lam WKK, Ream MA, Grosse SD et al.. “Evidence Regarding Metachromatic Leukodystrophy Newborn Screening.” Pediatrics (2026). PMID: 42674587 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [98]
Silva AHL, Rabbat J, Amin S. “Approach and Management of Abnormal T-Cell Receptor Excision Circles on Newborn Screening.” NeoReviews (2026). PMID: 42815926 ↗
Journal Article, ReviewCited in: Initial Examination, Gestational-Age Classification, Monitoring, and Routine Newborn Care - [99]
Zanetto L, Bonadies L, Salvadori S et al.. “Bronchopulmonary dysplasia and prematurity-associated lung disease: emerging therapies to improve lifelong respiratory outcomes.” European journal of pediatrics (2026). PMID: 42700273 ↗
Journal Article, ReviewCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [100]
Osman AAM, Russo C, Rojas-Reyes M et al.. “Strategies for caffeine administration in preterm infants: route, dosing, monitoring, and adjunctive interventions - a systematic review.” Italian journal of pediatrics (2026). PMID: 42778959 ↗
Systematic Review, Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care, Neonatal Respiratory Disease and Escalation of Respiratory Support - [101]
Mehralizada FN, Erdeve Ö, Köstekci YE et al.. “Unit-based evaluation of retinopathy of prematurity screening practices in Turkiye within the framework of current guidelines.” International ophthalmology (2026). PMID: 42766227 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [102]
Figueras-Aloy J, Carbonell-Estrany X, Botet-Mussons F et al.. “Gestational age-dependent risk patterns in small for gestational age preterm infants: a large multivariable cohort study.” Frontiers in pediatrics (2026). PMID: 42723840 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [103]
Ali K, Aljarbou T, Algarni S et al.. “Temporal changes in bronchopulmonary dysplasia severity distribution associated with evolving respiratory practices in very preterm infants.” BMJ paediatrics open (2026). PMID: 42754395 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care, Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [104]
Jaramillo-Cerezo A, Castrillón-Acosta S, Ortiz-Piedrahita D et al.. “Incidence and factors associated with bronchopulmonary dysplasia: a cohort study in a high-risk Colombian neonatal intensive care unit.” Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo (2026). PMID: 42788605 ↗
Journal Article, Observational StudyCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [105]
Kuzmanic D, Toso A, Viviani P et al.. “Retinopathy of prematurity: Incidence throughout a 15-year period in the NEOCOSUR Neonatal Network.” Early human development (2026). PMID: 42710370 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [106]
Mechnikov P, Di Fiore JM, Janampalli M et al.. “Intraventricular Hemorrhage in Extremely Preterm Infants with Low Plasma Choline.” Pediatric research (2026). PMID: 42716988 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [107]
Murukesan VM, Nangia S, Saili A et al.. “Early versus Late Initiation of Enteral Feeding in Premature Infants (28-34 Weeks GA) with Growth Restriction and Absent or Reversed End-Diastolic Flow on Umbilical Artery Doppler: A Randomised Controlled Trial.” Indian journal of pediatrics (2026). PMID: 42789183 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [108]
Alsherbini L, Alrahili M, Aljarbou T et al.. “Longitudinal post-discharge growth according to bronchopulmonary dysplasia severity in very preterm infants: a cohort study.” European journal of pediatrics (2026). PMID: 42844452 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [109]
Launay A, Camacho A, Remmer E et al.. “Feasibility of an Expanded Holding Protocol for the NICU.” Journal of obstetric, gynecologic, and neonatal nursing : JOGNN (2026). PMID: 42843418 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [110]
Cushing A, Donovan K, Lewis J et al.. “Extrinsic Environmental Factors Influencing the Achievement of Independent Oral Feeding in Preterm Infants.” The American journal of occupational therapy : official publication of the American Occupational Therapy Association (2026). PMID: 42698322 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [111]
Kaushik L, Nehra K, Arya S et al.. “Effect of zero-separation in mother-newborn care unit on preterm infant's stress and growth.” The Indian journal of medical research (2026). PMID: 42690858 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [112]
Estifanos AS, Negash H, Getachew S et al.. “Health system readiness for immediate Kangaroo Mother Care (iKMC) among network of care facilities in the Sidama region, Ethiopia: a mixed-method study.” Gates open research (2026). PMID: 42732094 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [113]
Prado Del Rey E, Johnston V, Huffman P. “Iron-Clad Care for Neonates: Precision Iron Supplementation Using Reticulocyte Hemoglobin Values, a Quality Improvement Project.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42766924 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [114]
Bachim A, Balaji S, Tibe CA et al.. “Inter-rater and intra-rater reliability of quantitative ultrasound in preterm infants: an observational cohort study.” JBMR plus (2026). PMID: 42689218 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [115]
Shen F, Jin C, Wang F et al.. “Development of a machine learning-based multicenter study for predicting severe intraventricular hemorrhage in preterm infants using perinatal variables.” Frontiers in neurology (2026). PMID: 42889107 ↗
Journal Article, Multicenter StudyCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [116]
Desai S, Joseph M, George K et al.. “Intraventricular haemorrhage (IVH) and associated clinical characteristics in outborn preterm infants <32 weeks undergoing neonatal transport in Western Australia: a retrospective cohort study (2011-2021).” BMJ open (2026). PMID: 42680492 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care, Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [117]
McGrath CP, Boyle MA. “A gestation-dependent association between chorioamnionitis and early transepidermal water loss in extremely preterm infants.” Pediatric research (2026). PMID: 42697923 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [118]
Huang YC, Kao S, Yang HW et al.. “Post-traumatic stress disorder and adverse pregnancy and birth outcomes: a population-based study.” European journal of psychotraumatology (2026). PMID: 42735071 ↗
Journal ArticleCited in: Prematurity, Fetal Growth Abnormality, and Extremely Low Birth Weight Care - [119]
Stephenson N, Carr CB, Park D et al.. “Applications of lung ultrasound in preterm infants: implications for respiratory distress syndrome and bronchopulmonary dysplasia.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42897226 ↗
Journal Article, ReviewCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [120]
Hibner A, Hietalati S, Leibel SL. “Occlusive versus non-occlusive CPAP interfaces in neonatal respiratory care: a comparative review of efficacy and safety.” European respiratory review : an official journal of the European Respiratory Society (2026). PMID: 42778200 ↗
Journal Article, ReviewCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [121]
Heidarzadeh F, Pournajaf S, Akbarian-Rad Z et al.. “Effectiveness of Surfactant Administration in Two Different Methods (MIST, INSURE) on the Short-Term Outcome of Preterm Infants With Respiratory Distress Syndrome: A Randomized Clinical Trial.” Pediatric pulmonology (2026). PMID: 42876349 ↗
Journal Article, Randomized Controlled Trial, Comparative StudyCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [122]
Su J, Ruan M, Wang Y et al.. “Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as initial respiratory support during minimally invasive surfactant therapy in preterm infants with respiratory distress syndrome: a retrospective real-world cohort study.” Translational pediatrics (2026). PMID: 42866080 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [123]
Blom FA, van Leuteren RW, de Jongh FH et al.. “Triggering modalities to synchronise non-invasive respiratory support in preterm infants: a systematic review and meta-analysis.” BMJ paediatrics open (2026). PMID: 42716543 ↗
Journal Article, Systematic Review, Meta-AnalysisCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [124]
Prasath C H, Kumar PA. “Machine learning models for prediction of continuous positive airway pressure failure and high-flow nasal cannula failure in preterm neonates with respiratory distress.” European journal of pediatrics (2026). PMID: 42848056 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [125]
Coskun Y, Ercin S, Kayas K et al.. “Noninvasive Respiratory Support Strategies for Transient Tachypnea of the Newborn: Impact of Nasal CPAP and Bi-level CPAP on Clinical Outcomes.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42775890 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [126]
Krishna S, Reinhart R, Meshkati M et al.. “Reducing Intervention and Length of Stay for Neonates With Transient Tachypnea of the Newborn.” Pediatrics (2026). PMID: 42843824 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [127]
Chetan C, Majumder S, Kaur R et al.. “Expanded versus classical assessments for identifying mandate for lung ultrasound-guided surfactant therapy in preterm neonates (EXCLAIM-LUS): a retrospective comparative study.” European journal of pediatrics (2026). PMID: 42766165 ↗
Journal Article, Observational StudyCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [128]
Wang Y, Song Y, Xing C et al.. “Electrical impedance tomography in neonatal respiratory diseases: a clinical review of applications and evidence.” Respiratory research (2026). PMID: 42897548 ↗
Journal Article, ReviewCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [129]
Sanmoto Y, Gao Q, Hitaka D et al.. “Development and evaluation of a deep learning model for computer-aided diagnosis of neonatal pneumothorax on chest radiographs.” Pediatric radiology (2026). PMID: 42730927 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [130]
Liu J, Guo YL, Jiang P et al.. “Lung Ultrasound-Guided Non-Fiberobronchoscopic Bronchoalveolar Lavage for Neonatal Atelectatic Pulmonary Disease Treatment: Clinical Practice Guidelines Based on International Expert Consensus.” Diagnostics (Basel, Switzerland) (2026). PMID: 42739144 ↗
Guideline, Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [131]
Gonzalez T, Simpkin CT, Dias Maia P et al.. “Flow versus resistance: hemodynamic phenotyping of pulmonary hypertension in infants with shunts and concurrent lung disease.” Frontiers in pediatrics (2026). PMID: 42807509 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [132]
Wren JT, Patel N, McNamara PJ et al.. “Hemodynamic Phenotypes in Congenital Diaphragmatic Hernia: Unresolved Questions and Future Directions.” Children (Basel, Switzerland) (2026). PMID: 42794157 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [133]
Dadon Y, Mimouni FB, Arad I et al.. “Magnesium therapy in persistent pulmonary hypertension of the newborn: a scoping review.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42722769 ↗
Journal Article, Scoping ReviewCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [134]
Puligandla P, Baird R, Beltempo M et al.. “Congenital diaphragmatic hernia guidelines compliance and outcomes in Canada.” Journal of pediatric surgery (2026). PMID: 42759835 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [135]
Fuentes-Mendoza J, Sernaqué-Paz M, Cruz-Riquelme D et al.. “Sildenafil in bronchopulmonary dysplasia-associated pulmonary hypertension: developmental and translational insights.” Pediatric research (2026). PMID: 42811096 ↗
Journal Article, ReviewCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [136]
Sharma S, Khan AA, Debata P et al.. “Cannula with long and narrow tubing versus short binasal prongs for nasal intermittent positive pressure ventilation in preterm infants with respiratory distress syndrome: a randomised non-inferiority trial.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42727984 ↗
Journal ArticleCited in: Neonatal Respiratory Disease and Escalation of Respiratory Support - [137]
Stapleton I, Dempsey E. “The Use of Cardiotonic Drugs in Neonates.” Clinics in perinatology (2026). PMID: 42556983 ↗
Journal Article, ReviewCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [138]
Anza OA, Jaber MA, Salkini A et al.. “Intravenous Prostaglandin E1 (Alprostadil) Bolus in Ductus Arteriosus-Dependent Congenital Heart Disease: A Case Series.” Pediatric cardiology (2026). PMID: 42788988 ↗
Journal Article, ReviewCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [139]
Kumar RK, Oei JL, Madappa R et al.. “Managing Neonatal Pulmonary Hypertension in Low-Resource Settings.” Journal of paediatrics and child health (2026). PMID: 42639853 ↗
Journal Article, ReviewCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [140]
Elgendy MM, Nath S. “Pulmonary hypertension and acute hypoxic respiratory failure in preterm neonates.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42570944 ↗
Journal Article, ReviewCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [141]
Ozdemir O, Bornaun H, Guzeltas A et al.. “What determines survival in transposition of the great arteries? Insights from a 10-year cohort of prenatally diagnosed cases.” The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026). PMID: 42721384 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock, Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [142]
Chonnak U, Tongprasert F, Anuwutnavin S et al.. “Sagittal aortic-arch assessment for prenatal diagnosis of coarctation of the aorta: comparative evaluation of 10 published methods and a new predictive model.” Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2026). PMID: 42762540 ↗
Journal Article, Comparative Study, Multicenter Study, Validation StudyCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [143]
Diamond S, Spray B, Qasim A et al.. “Novel echocardiographic markers for the assessment of pulmonary hypertension in infants.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42374147 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [144]
Imanov E, Nasibova EM, Nasibova EM. “Balloon aortic valvuloplasty for critical aortic stenosis in neonates and infants: early outcomes from a single-center cohort.” BMC cardiovascular disorders (2026). PMID: 42401830 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [145]
Morrison TM, Poorvu T, Leeman K et al.. “Severe Fetal Cardiomyopathy: Considerations for Extracorporeal Cardiopulmonary Resuscitation During Neonatal Resuscitation.” NeoReviews (2026). PMID: 42674615 ↗
Case Reports, Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [146]
Zhong D, Gao W, Ren J et al.. “Vasoactive-Inotropic Score and in-hospital mortality in preterm infants < 34 weeks' gestation with early pulmonary hypertension in the setting of respiratory distress and sepsis.” The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026). PMID: 42509534 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [147]
Šlabek E, Manestar Rukavina K, Drašković D et al.. “Five-Minute Oxygen Saturation and Delivery Room Oxygen Requirements as Early Markers of Illness Severity in Preterm Infants ≤32 Weeks of Gestation: A Single-Centre Retrospective Cohort Study.” Medicina (Kaunas, Lithuania) (2026). PMID: 42512968 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [148]
Butun Turk S, Akin MS, Ozturk S et al.. “Diagnostic value of lactate/albumin and lactate dehydrogenase/albumin ratios in newborns with hypoxic-ischemic encephalopathy.” Journal of perinatal medicine (2026). PMID: 42405959 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [149]
Gotchac J, Rousseau A, Arcourt A et al.. “Point-of-care echocardiographic assessment of right ventricle systolic function in infants with severe bronchiolitis: a prospective observational study.” European journal of pediatrics (2026). PMID: 42498874 ↗
Journal Article, Observational StudyCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [150]
Ceran B, Dizdar EA, Beyoğlu R et al.. “Predictive value of cerebral doppler resistive index in premature infants with hemodynamically significant patent ductus arteriosus.” BMC pediatrics (2026). PMID: 42482026 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [151]
Liu JF, Wang ZC, Sun KP et al.. “Cerebral hemodynamic changes in neonates with different types of patent ductus arteriosus: a study using transcranial Doppler ultrasound.” BMC pediatrics (2026). PMID: 42449262 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [152]
Ozturk M, Selcuk A, Tongut A et al.. “Outcomes of Delayed Norwood Operation in High-Risk Patients-Time to Reconsider the Dogma of a Primary Norwood Operation?” Interdisciplinary cardiovascular and thoracic surgery (2026). PMID: 42663575 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [153]
Junshu X, Fufen Y, Xiuju Y et al.. “Integrated pregnancy and perinatal management of complex fetal congenital heart disease: a preliminary retrospective study.” BMC pregnancy and childbirth (2026). PMID: 42469655 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [154]
Lima GP, Levy P, Zaniletti I et al.. “Risk Factors for Mortality and Age at Discharge in Infants with Congenital Heart Disease Born Preterm.” The Journal of pediatrics (2026). PMID: 42386127 ↗
Journal ArticleCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [155]
Guasti E, Tardini G, Buratti S et al.. “Alveolar Capillary Dysplasia With Misaligned Pulmonary Veins (ACDMPV): Description of Two Cases and Literature Review.” Pediatric pulmonology (2026). PMID: 42324883 ↗
Journal Article, Review, Case ReportsCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [156]
Jeong J, Lee BS, Eun H et al.. “Preliminary Report of a Nationwide Prospective Cohort of Congenital Diaphragmatic Hernia in Korea.” Journal of Korean medical science (2026). PMID: 42411239 ↗
Journal Article, Multicenter StudyCited in: Neonatal Cardiovascular Disease, Ductal Circulation, and Shock - [157]
Effatpanah H, Razaghi Z, Hossein Tehrani MJ et al.. “The Effects of Phototherapy on Magnesium, Vitamin D, Albumin, Calcium Levels, and Platelet Counts in Neonates With Hyperbilirubinemia.” Journal of lasers in medical sciences (2026). PMID: 42892847 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [158]
Zdraveska N, Kostovski A, Reich T et al.. “Accuracy of non-invasive smartphone bilirubin measurements on neonates before and during phototherapy.” European journal of pediatrics (2026). PMID: 42836900 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [159]
Lapucci I, Tambascia G, Zucchini L et al.. “Community-based monitoring of neonatal jaundice using the point-of-care Bilistick® System 2.0.” Pediatric research (2026). PMID: 42855462 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [160]
Wang HC, Chen SY. “Response to comment on "Intermittent phototherapy in neonatal hyperbilirubinemia: A pilot randomized controlled trial in Taiwan".” Journal of the Formosan Medical Association = Taiwan yi zhi (2026). PMID: 42855316 ↗
LetterCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [161]
Bhutani VK, Lane S. “Are both hemolysis and impaired myocyte integrity associated with glucose-6-phosphate dehydrogenase deficiency?” Seminars in perinatology (2026). PMID: 42892600 ↗
Journal Article, ReviewCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [162]
Mulugeta C, Emagneneh T, Ejigu B et al.. “Global, Regional and National Burden of Hemolytic Disease and Other Neonatal Jaundice, 1980/90-2021, and Projections to 2050: A Global Burden of Disease Study 2021.” Health science reports (2026). PMID: 42851842 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [163]
Ren H, Luo H, Ding H et al.. “Molecular basis of anti-CD36 alloimmunization: transcriptomic evidence linking intronic splice-site mutations to CD36 loss-of-function.” Frontiers in immunology (2026). PMID: 42865421 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [164]
Fujitani K, Ashina M, Yamamoto N et al.. “Prolonged Fluctuating Thrombocytopenia in a Neonate Born to a Mother with Immune Thrombocytopenia.” Indian journal of pediatrics (2026). PMID: 42873422 ↗
LetterCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [165]
Arora S, Goel R, van Daelen J et al.. “Umbilical cord red blood cell transfusions in very premature neonates: A physiologically aligned transfusion strategy.” Transfusion (2026). PMID: 42841546 ↗
Journal Article, ReviewCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [166]
van Daelen JH, Gangaram-Panday NH, Huisman EJ et al.. “Gestational age references and trajectory of fetal haemoglobin in relation to outcome in neonates born before 30 weeks of gestation: a single-centre retrospective cohort study in The Netherlands.” EClinicalMedicine (2026). PMID: 42872021 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [167]
Hasan Z, Prasad R, Purbey OP et al.. “Concurrent biliary atresia and intestinal atresia: a systematic review of clinical characteristics, pathogenesis, management, and outcomes.” Pediatric surgery international (2026). PMID: 42853333 ↗
Journal Article, Systematic ReviewCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [168]
Asdell NF, Slaughter JL, Joshi S et al.. “Urinary neutrophil gelatinase-associated lipocalin concentration: a baseline study for establishing reference ranges in preterm neonates.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42844325 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [169]
Alwadani I, Elwahsh T, Albahrani B. “Case Report: Bladder perforation in an extremely preterm neonate secondary to multifactorial etiology.” Frontiers in pediatrics (2026). PMID: 42890911 ↗
Case Reports, Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [170]
Allana A, Ahmed ST, Sandhu T et al.. “Neonatal extracorporeal membrane oxygenation in congenital urinary tract obstruction with pulmonary hypoplasia: a case complicated by alveolar capillary dysplasia emphasizing importance of early rapid genetic testing.” Pediatric nephrology (Berlin, Germany) (2026). PMID: 42853405 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [171]
Leahy C, Williams T, Knudson S et al.. “Perinatal outcomes among pregnancies with diabetes by rural, suburban, and urban birth location.” The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026). PMID: 42893932 ↗
Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [172]
Pan D, Li X, Zhang Y et al.. “Neonatal-onset familial hemophagocytic lymphohistiocytosis type 2: a case report.” Frontiers in pediatrics (2026). PMID: 42856772 ↗
Case Reports, Journal ArticleCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [173]
Vidavalur R. “Global, regional, national trends and economic evaluation of neonatal hyperbilirubinemia burden, 2003-2023.” Pediatric research (2026). PMID: 42839038 ↗
Journal Article, ReviewCited in: Glucose, Electrolyte, Renal, Hematologic, and Bilirubin Disorders - [174]
Ntaganzibwa JN, Nanci FI, Zigabe SM et al.. “Early-onset neonatal sepsis in the Eastern Democratic Republic of the Congo: Microbiology, antimicrobial resistance, and clinical outcomes.” Pediatrics and neonatology (2026). PMID: 42692879 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [175]
Jiang S, Liu J, Schaffer K et al.. “Trends in Pathogens Causing Late-Onset Sepsis in Very Preterm Infants: 2010-2023.” Pediatrics (2026). PMID: 42637238 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [176]
Menzella N, Costa S, Fattore S et al.. “Invasive Neonatal Enterovirus Infection: A Case Series and Review of the Literature.” Children (Basel, Switzerland) (2026). PMID: 42794266 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [177]
Li X, Chen Y, Deng C et al.. “A case of neonatal herpes simplex virus type 2 encephalitis with TLR3 gene mutation and literature review.” Frontiers in neurology (2026). PMID: 42620976 ↗
Journal Article, Case Reports, ReviewCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [178]
Gualtieri R, Tzani A, Papis S et al.. “Epidemiology, Early Therapy and Sequelae Predictors in Congenital CMV: A Nationwide Cohort Study.” The Pediatric infectious disease journal (2026). PMID: 42764414 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [179]
Jiang N, Zhu M, Xiao X et al.. “Clinical characteristics and outcomes of early-onset neonatal bacterial meningitis: a 20-year retrospective comparison of preterm and full-term infants.” BMC pediatrics (2026). PMID: 42661190 ↗
Journal Article, Comparative StudyCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [180]
Schnee SV, Lohrmann F, Matheisl D et al.. “Infection or contamination - Clinical attribution of blood culture-positive episodes in neonatal intensive care: an 11-year retrospective single-center study.” BMC infectious diseases (2026). PMID: 42888396 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [181]
Tądel K, Dudek A, Drozdowska-Szymczak A et al.. “Temporal Changes in Inflammatory Markers and Laboratory Parameters in Relation to Risk of Neonatal Sepsis.” Journal of clinical medicine (2026). PMID: 42882086 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [182]
Guiterrez A, Mir I, Stumpf K et al.. “Risk assessment of early-onset sepsis in extremely preterm infants: implications for antibiotic stewardship.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42629396 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [183]
Abu Shqara R, Domfrocht T, Perez Y et al.. “Infectious morbidity and microbiological findings in early and late preterm prelabor rupture of membranes managed expectantly.” International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2026). PMID: 42830711 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [184]
Uygun SS, Turk Dagi H, Alkan G et al.. “Neonatal Intensive Care Unit Outbreak of Ralstonia pickettii Bacteremia Associated with Contaminated Sterile Distilled Water: Clinical, Environmental, and Molecular Epidemiological Investigation.” Pathogens (Basel, Switzerland) (2026). PMID: 42796721 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [185]
Pillai A, Kabra N, Nayak A et al.. “Transforming central line associated blood stream infection prevention in neonates: Results from a multimodal quality improvement initiative.” World journal of clinical pediatrics (2026). PMID: 42625981 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [186]
Forster CS, Nelson C, El Feghaly R et al.. “Urinary Tract Infection Diagnosis-A Companion to the American Academy of Pediatrics' 2026 Clinical Practice Guideline on the Diagnosis and Management of Urinary Tract Infection: Technical Report.” Pediatrics (2026). PMID: 42803592 ↗
Journal Article, Practice GuidelineCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [187]
Lashkar MO, Nahata MC. “Treatment of Urinary Tract Infections in Neonates and Young Infants: Evidence and Recommendations.” Antibiotics (Basel, Switzerland) (2026). PMID: 42650713 ↗
Journal Article, ReviewCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [188]
Liu S, Al Gharaibeh FN, Park WY et al.. “Antibiotic Duration and Critical Illness after Culture-Negative Late-Onset Sepsis Evaluation in Infants Born Preterm.” The Journal of pediatrics (2026). PMID: 42785515 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [189]
Whelan SO, Kelleher G, Campbell S et al.. “Interleukin-6 as a sepsis biomarker in neonatal and pediatric care: A retrospective real world cohort study.” European journal of pediatrics (2026). PMID: 42622709 ↗
Journal Article, Multicenter StudyCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [190]
Aletayeb SMH, Dehdashtian M, Malakian A et al.. “Colistin therapy and survival outcomes in neonatal carbapenem-resistant gram-negative sepsis.” Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2026). PMID: 42806191 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [191]
Huang J, Wang S, Lin Y et al.. “Admission red cell distribution width-to-albumin ratio and risk of neonatal pneumonia or culture-proven sepsis in preterm infants: a retrospective cohort study.” Frontiers in pediatrics (2026). PMID: 42688469 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [192]
Andersson E, Data S, Kreyenbaum L et al.. “Use of antibiotics in newborns with infections at rural referral hospital in Uganda: compliance with empirical guidelines.” Frontiers in pediatrics (2026). PMID: 42780869 ↗
Journal ArticleCited in: Neonatal Infection, Sepsis, and Perinatal Viral Disease - [193]
Noureldein M, So V, Hayawi LM et al.. “Haemodynamic and neurophysiological assessments for 2-year outcome prediction in neonates with hypoxic-ischaemic encephalopathy treated with therapeutic hypothermia: a systematic review and meta-analysis.” BMJ paediatrics open (2026). PMID: 42829213 ↗
Journal Article, Systematic Review, Meta-AnalysisCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [194]
Vicente Elcano L, Rondagh M, van Steenis A et al.. “Association between cerebral proton magnetic resonance spectroscopy and school-age neurodevelopment after perinatal asphyxia and therapeutic hypothermia: a cohort study.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42785971 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [195]
Martinello KA, Crawford TM. “Rising tide of preterm low-grade intraventricular haemorrhage: cause for concern?” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42863970 ↗
EditorialCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [196]
Getaneh T, Homaira N, Chughtai A et al.. “Neurodevelopmental impairment and morbidity patterns across two epochs among extremely preterm infant survivors in Australia and New Zealand.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42697710 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [197]
Variane GFT, Leandro DMK, Mimica MJ et al.. “From promise to practice: digital health through the lens of neonatal care.” Lancet regional health. Americas (2026). PMID: 42701419 ↗
Journal Article, ReviewCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [198]
Otile J, Atwebembere R, Tukakira J et al.. “Causes of and risk factors for asphyxia neonatorum in sub-Saharan Africa: a study protocol for systematic review and meta-analysis.” BMJ open (2026). PMID: 42849956 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [199]
Liu GXH, Marcovecchio L, Beardsall K. “Clinical performance and practical implications of continuous glucose monitoring in very preterm infants: a cohort study.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42810838 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [200]
Hercberg A, Gomez Fernandez E, Gomez Gerez C et al.. “Congenital syphilis.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42810840 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [201]
Wolfsberger CH, Schwaberger B, Baik-Schneditz N et al.. “Duration of surfactant administration and its impact on stabilisation of vital parameters in very preterm neonates <28 weeks of gestational age (SurfStab): 1 min versus 5 min-study protocol for a prospective randomised-controlled phase IV trial.” Frontiers in pediatrics (2026). PMID: 42877269 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [202]
Minotta Negret S, Llano López LH, Goldfeder S et al.. “Training and Use of Point-of-Care Ultrasound (POCUS) in Pediatrics and Neonatology in Latin America: A Multinational Survey Study.” Pediatric emergency care (2026). PMID: 42872833 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [203]
McBain H, Tuvey S, Williams AG et al.. “Barriers and enablers to the implementation of a perinatal care bundle: the Perinatal Excellence to Reduce Injury in Premature Birth project.” Frontiers in pediatrics (2026). PMID: 42819493 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [204]
Kenny A, Vaher K. “Studying the microbiome-gut-brain axis in early life: how, why, the challenges and clinical implications.” Archives of disease in childhood. Education and practice edition (2026). PMID: 42791066 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [205]
Sequeira Gomes R, Gayen Nee' Betal S, Addya S et al.. “Sequential exposure to histological chorioamnionitis and postnatal hyperoxia alters gene expression in cord blood monocytes.” Frontiers in pediatrics (2026). PMID: 42812615 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [206]
Mattia C, Leonardi R, Distefano C et al.. “The Inferior Vena Cava Collapsibility Index as a Non-Invasive Haemodynamic Tool in Mechanically Ventilated Surgical Neonates: A Monocentric Observational Study.” Children (Basel, Switzerland) (2026). PMID: 42794258 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [207]
Yang J, Zheng Q, Li J et al.. “Neonatal apnea research: a bibliometric analysis of trends, clusters, and paradigm shifts.” Translational pediatrics (2026). PMID: 42871650 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [208]
Shi J, Zhang H, Xu Y et al.. “Development and validation of a risk prediction model for respiratory tract Ureaplasma urealyticum infection in preterm infants.” Translational pediatrics (2026). PMID: 42724413 ↗
Journal ArticleCited in: Neonatal Neurologic Injury, Seizures, and Neurodevelopmental Protection - [209]
Lamport L, Samavat H, Gomes A et al.. “Early enteral nutrition with mothers' own milk, donor human milk, or a combination of both on neonatal feeding milestones: a cross-sectional study.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42897225 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [210]
Cornelius V, Boardman JP, Quine D et al.. “Real-world data-enabled, 2-randomisation, adaptive trial to determine the clinical efficacy and safety of widely used enteral feeds in preterm babies: the COLLABORATE trial - protocol.” BMJ open (2026). PMID: 42838577 ↗
Clinical Trial Protocol, Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [211]
Yates L, Gregory S, Katakam L et al.. “Optimizing Enteral Nutrition During and After Therapeutic Hypothermia: An Evidence-Based Practice Initiative.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42879805 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [212]
Rubio-Granda A, Suárez-Rodríguez M, Cardo González L et al.. “Nutritional, trace element and heavy metal stability in human milk during standard milk bank processing.” The British journal of nutrition (2026). PMID: 42878034 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [213]
Jacobs S, Gibbs D, Smith C et al.. “Mothers' experiences of feeding their premature infants after discharge from the hospital: a systematic review and thematic synthesis.” International breastfeeding journal (2026). PMID: 42830287 ↗
Journal Article, Systematic ReviewCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [214]
Silva AC, Palma S, Antunes M. “Supporting Breast Milk Expression During Mother-Infant Separation: A Scoping Review of Interventions, Technologies, and Service Delivery Models.” Healthcare (Basel, Switzerland) (2026). PMID: 42881736 ↗
Journal Article, ReviewCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [215]
Burhanuldin A, Razman R, Ishak S. “Modifiable Determinants of Exclusive Breastfeeding at NICU Discharge among Infants Born before 32 Weeks' Gestation: A Cross-Sectional Study in Malaysia.” Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine (2026). PMID: 42864978 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [216]
Oh TK, Song IA. “Total parenteral nutrition exposure in neonates and the risk of long-term food allergy: A retrospective cohort study.” JPEN. Journal of parenteral and enteral nutrition (2026). PMID: 42857902 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [217]
Lauritsen JV, Heiring C, Wulff L et al.. “Development of an anthropometric-based algorithm to estimate feeding tube insertion depth in neonates.” Journal of pediatric gastroenterology and nutrition (2026). PMID: 42872516 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [218]
Guo Y, Chen X, Zhu J et al.. “Necrotizing enterocolitis in very preterm infants: an epidemiological study in Jiangsu, China.” Frontiers in pediatrics (2026). PMID: 42846627 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [219]
Yan XL, He Y, Liu XC et al.. “Energy Metabolic Reprogramming Characterized by Succinate Accumulation Aggravates Necrotizing Enterocolitis.” International journal of molecular sciences (2026). PMID: 42883936 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [220]
Aveline AS, Bottle A, Milan A et al.. “Association between prophylactic hydrocortisone and focal intestinal perforations in preterm infants born before 28 weeks gestation: an observational propensity matched population study in England and Wales.” Archives of disease in childhood. Fetal and neonatal edition (2026). PMID: 42843981 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [221]
Wen T, Pu C, Chen L et al.. “The bowel loss was preserved with surgical intervention based on multi-item scoring in infants with necrotizing enterocolitis.” Frontiers in surgery (2026). PMID: 42851446 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [222]
Chawla D, Belet A, Pessoa T et al.. “Mortality, bowel preservation, and surgical strategy in closing and closed gastroschisis: A systematic review and individual participant data meta-analysis.” Journal of pediatric surgery (2026). PMID: 42838374 ↗
Journal Article, ReviewCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [223]
Pakel A, Duman Senol H, Topyildiz E et al.. “Short-term early exposure to cow's milk formula increases the risk of cow's milk allergy: A critical window in early life.” Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2026). PMID: 42830732 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [224]
Anagnostatou N, Vakonaki E, Panteris E et al.. “Human Milk Melatonin Across Early Lactation in Preterm Birth: Maternal, Pregnancy, and Neonatal Correlates.” Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine (2026). PMID: 42844707 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [225]
Khanal L, Cernioglo K, Smilowitz JT et al.. “Does nicotinamide riboside supplementation increase milk production in postpartum women with infants admitted to a neonatal intensive care unit? Protocol for the MOONRISE randomised, double-blind, placebo-controlled pilot feasibility trial.” BMJ open (2026). PMID: 42843881 ↗
Journal Article, Clinical Trial ProtocolCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [226]
Janssens E, Eerdekens A. “Implementation of a non-separation pathway for late preterm infants in a tertiary care center: a prospective feasibility study.” Frontiers in pediatrics (2026). PMID: 42840287 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [227]
DeVane-Johnson S, Meier P, Johnson TJ et al.. “Matriarchal Influence on Black Women's Decisions to Provide Mother's Own Milk for Preterm Infants: An Integrative Review.” Advances in neonatal care : official journal of the National Association of Neonatal Nurses (2026). PMID: 42896072 ↗
Journal ArticleCited in: Human Milk, Parenteral Nutrition, Feeding Development, and Neonatal Gastrointestinal Disease - [228]
Thomas AR, Trulsen LN, Levy PT et al.. “Video-based assessment of delivery room stabilization in newborns with prenatally diagnosed congenital heart disease: Insights beyond chart review.” Journal of perinatology : official journal of the California Perinatal Association (2026). PMID: 42722768 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [229]
Maya A, Badillo A, Varda BK. “Neonatal management of patients with anorectal malformations.” Current opinion in pediatrics (2026). PMID: 42560353 ↗
Journal Article, ReviewCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [230]
Morag S, Lowenthal A, Abuelhija H et al.. “Specialty-Based Variation in Prostaglandin E1 Use for Neonates With dextro-Transposition of the Great Arteries: An International Cross-Sectional Survey of Neonatologists and Pediatric Cardiac Intensivists.” World journal for pediatric & congenital heart surgery (2026). PMID: 42709749 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [231]
Geraghty A, Smith P, Arnold K et al.. “Pulmonary Hypoplasia.” NeoReviews (2026). PMID: 42538023 ↗
Journal Article, Review, Research Support, Non-U.S. Gov'tCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [232]
Almayali HS, Shareef KN. “Outcomes of delayed CSF diversion protocol in Infants with lumbosacral myelomeningocele: impact of timing of presentation on hydrocephalus development and postoperative complications.” Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2026). PMID: 42786282 ↗
Controlled Clinical Trial, Journal Article, Multicenter StudyCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [233]
Chawla D, Singh S, Yu L et al.. “Tapering enteroplasty versus primary anastomosis without tapering in neonatal small bowel atresia: a systematic review and meta-analysis.” Pediatric surgery international (2026). PMID: 42635794 ↗
Journal Article, Systematic Review, Meta-Analysis, Comparative StudyCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [234]
Lindert J, Stigler L, Sternke-Curvello C et al.. “Appendix tip biopsy for Total colonic aganglionosis: technical aspects and diagnostic accuracy in a prospective cohort of 107 pediatric patients.” Pediatric surgery international (2026). PMID: 42789101 ↗
Journal Article, Observational StudyCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [235]
Gong J, Li J, Teng Z et al.. “A neonate with giant omphalocele complicated by mechanical intestinal obstruction requiring left hepatic lobe resection: a case report.” Frontiers in pediatrics (2026). PMID: 42564503 ↗
Case Reports, Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [236]
Leister N, Achterrath S, Trieschmann U et al.. “A Sedation Protocol for Endoscopic Baton-Plate Adjustment in Neonates With Pierre Robin Sequence.” Paediatric anaesthesia (2026). PMID: 42609088 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [237]
Chen X, Cui J, Li L et al.. “Comparative outcomes and predictive factors in vacuum, forceps, and sequential vacuum-forceps operative vaginal deliveries.” The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2026). PMID: 42675011 ↗
Journal Article, Comparative StudyCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [238]
Duncan E, Grabinski Z, Koyfman A et al.. “High risk and low incidence diseases: Acyanotic congenital heart disease.” The American journal of emergency medicine (2026). PMID: 42691793 ↗
Journal Article, ReviewCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [239]
Athiel Y, Van den Eede E, de Saint Denis T et al.. “Prenatal findings and postnatal outcomes in cases of closed spinal dysraphism: 10-year two-center cohort study.” Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2026). PMID: 42763785 ↗
Journal Article, Multicenter StudyCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [240]
Kurimoto M, Nawashiro T, Kato M. “Multiple congenital dermal sinus tracts: a case-based review involving a unique triple-tract configuration that challenges current embryological concepts.” Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery (2026). PMID: 42665681 ↗
Journal Article, Case Reports, ReviewCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [241]
Chen X, Ni Y, Zhan C. “Congenital encephalomeningocele presenting as a giant orbital mass in a neonate: a case report.” BMC ophthalmology (2026). PMID: 42687160 ↗
Journal Article, Case ReportsCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [242]
Hu X, Chen Y, Chen W et al.. “Brain MRI findings in near-term and term infants admitted to a neonatal ward.” Frontiers in neurology (2026). PMID: 42609317 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [243]
Veljkovic J, Binder J, Krall C et al.. “Development of an age-adapted simplified acute physiology score II using first-24-hour variables in pediatric patients with congenital diaphragmatic hernia: the CDH-SAPS.” European journal of pediatrics (2026). PMID: 42684427 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [244]
Sletten IN, Winge MI, Jokihaara J. “Time of diagnosis of congenital upper limb anomalies: a cohort study of 703 patients from a local registry in Norway.” Acta orthopaedica (2026). PMID: 42770475 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [245]
Chourou H, Ben Aziza R, Belhadj Ammar W et al.. “Congenital Lung Malformations in Neonates: A 9-Year Tunisian Cohort Highlighting Diagnostic Challenges and Outcomes in a Resource-Limited Setting.” Pediatric pulmonology (2026). PMID: 42779300 ↗
Journal ArticleCited in: Congenital Anomalies, Birth Injury, and Neonatal Surgical Emergencies - [246]
Poulin TG, Krewulak KD, Arakawa NMC et al.. “Tools Measuring Health Literacy in Critically Ill Patients and Their Caregivers: A Scoping Review.” Critical care medicine (2026). PMID: 42872943 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [247]
Casey S, Pickens N, Poskey G. “The Process to Caregiver Expertise: A Constructivist Grounded Theory Study of Parents of Infants With Critical Congenital Heart Disease.” Child: care, health and development (2026). PMID: 42864864 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [248]
Hammad ZAA, Coo H, Suntharalingam H et al.. “Are we Adhering to Guidelines for Follow-up Imaging in Neonates with Simple Congenital Heart Defects? What are the Healthcare Costs of Non-adherence?” Pediatric cardiology (2026). PMID: 42886362 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [249]
Kwak JI, Kim SH, Yoo K et al.. “Neonatal and 18-24-Month Growth and Neurodevelopmental Outcomes in Very Low Birth Weight Infants With Severe Congenital Heart Disease: A Korean Neonatal Network Study.” Korean circulation journal (2026). PMID: 42885733 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [250]
Sakowitz S, Nelson JS, Robinson J et al.. “Impact of social determinants of health on perioperative and interstage outcomes in congenital heart surgery a systematic review.” Frontiers in cardiovascular medicine (2026). PMID: 42871349 ↗
Journal Article, Systematic ReviewCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [251]
Lawanaskol S, Patumanond J, Phinyo P et al.. “Predicting Retinopathy of Prematurity in Thailand: A Practical Model for Risk-Based Screening.” Diagnostics (Basel, Switzerland) (2026). PMID: 42882362 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [252]
Wade A, Thomas S, Walker A et al.. “Renal outcome at 2 years in neonates with nephrocalcinosis and bronchopulmonary dysplasia: a case-control study.” BMJ paediatrics open (2026). PMID: 42887906 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [253]
van Immerzeel TD, Ba A, Tairrou F et al.. “Early Detection of Infants Aged Under Six Months at Risk of Poor Growth and Development: Secondary Analysis of a Prospective Cohort in Senegal.” Maternal & child nutrition (2026). PMID: 42885779 ↗
Journal Article, Observational StudyCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [254]
Mukunya D, Ndeezi G, Namazzi G et al.. “Predicting neurodevelopmental delay among two-year-old infants in Northern Uganda.” Global health action (2026). PMID: 42876325 ↗
Journal Article, Randomized Controlled TrialCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [255]
Jung K, Lenz J, Neumayr K et al.. “General movement assessment and early motor abnormalities in infants with prenatal toxin and isolated alcohol exposure: A prospective cohort study.” Early human development (2026). PMID: 42879970 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [256]
Aizawa CYP, Monobe BL, de Souza CB et al.. “Socioeconomic level influences the early motor repertoire of infants at biological risk in a low- and middle-income country setting.” Early human development (2026). PMID: 42879969 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [257]
Clifford D, Murray DM, Walsh BH. “Maternal mental health impacts 2-year cognitive and language outcomes in infants born before 30 weeks of gestation.” Frontiers in pediatrics (2026). PMID: 42877178 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [258]
Kotby A, Adel A, Hussein BA et al.. “Neonatal and pediatric nutritional care: a modified Delphi consensus on dietary management for infants with congenital heart disease in four Middle Eastern countries.” Frontiers in pediatrics (2026). PMID: 42876672 ↗
Journal Article, ReviewCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [259]
Augustin B, Anuchithra S. “Care seeking behaviour and expressed experiences of mother and caregivers regarding newborn danger sign.” Midwifery (2026). PMID: 42887419 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [260]
Zhan X, Zhang Y, Lu H. “Association between early blood lactate trajectories and mortality in neonates: a retrospective cohort study.” Frontiers in pediatrics (2026). PMID: 42876756 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [261]
Flynn N, Hogg S, Moat SJ. “Impact of dried blood spot diameter and transit time on analyte concentrations and cut-off classification in routine newborn screening.” Clinical chemistry and laboratory medicine (2026). PMID: 42897791 ↗
Journal ArticleCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making - [262]
Farhath F, Kumar K S. “Clesrovimab in the new era of RSV prevention: one season, one dose, one chance.” Pediatric research (2026). PMID: 42881266 ↗
Journal Article, ReviewCited in: Discharge Readiness, Follow-up, Outcomes, and Ethical Decision-Making